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“Nowhere in these ancient communities of the Eurasian land mass, where it is so 
common and feared, is there a record of its beginning. Throughout history, it had 
always been there, a familiar evil, yet forever changing, formless, unknowable. Where 
other epidemics might last weeks or months, where even the bubonic plague would be 
marked forever afterwards by the year it reigned, the epidemics of tuberculosis would 
last whole centuries and even multiples of centuries. Tuberculosis rose slowly, silently, 
seeping into homes of millions, like an ageless miasma. And once arrived, it never went 
away again. Year after year, century after century, it tightened its relentless hold, 
worsening whenever war or famine reduced the peoples' resistance, infecting virtually 
everybody, inexplicably sparing some while destroying others, bringing the young down 
onto their sickbeds, where the flesh slowly fell from their bones and they were consumed 
in the yearslong fever, their minds brilliantly alert until, in apocalyptic numbers, they 
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Palavras-chave: complexo Mycobacterium tuberculosis; Mycobacterium bovis; 
tuberculose bovina; testes de DNA; diagnóstico molecular. 
 
Os membros do complexo Mycobacterium tuberculosis (MTC) são agentes causadores 
de tuberculose em humanos e animais. A tuberculose bovina tem sido sujeita nas 
últimas décadas a programas de erradicação bastante dispendiosos, na maioria dos 
países desenvolvidos, envolvendo a análise laboratorial de tecidos de animais suspeitos 
para a detecção dos membros do MTC, nomeadamente Mycobacterium bovis. O 
diagnóstico definitivo é obtido através da cultura bacteriológica, o que pode levar 6-12 
semanas, período durante o qual a carcaça do animal suspeito e a exploração de origem 
permanecem sob embargo sanitário. Neste trabalho, descreve-se um protocolo de 
extracção de DNA de fácil utilização adaptado aos tecidos, o qual é acoplado a um 
semi-nested PCR em tempo real, utilizando como alvo a IS6110, por forma a melhorar a 
detecção directa de bactérias pertencentes ao MTC em animais, abreviando o período 
necessário ao diagnóstico. O ensaio foi avaliado num grupo de 128 amostras de tecido 
provenientes de bovinos, javalis, veados e raposas. O desempenho global do teste 
corresponde a uma sensibilidade e especificidade de diagnóstico de 98,2% e 88,7%, 
respectivamente. Foi observado um coeficiente kappa de 0,859 entre o ensaio de semi-
nested PCR e a cultura bacteriológica. Este ensaio permite a detecção rápida de 
micobactérias tuberculosas em amostras de animais com alta sensibilidade e 
especificidade, sendo acessível e de baixo custo para uma utilização num laboratório de 
diagnóstico veterinário. 
As espécies do MTC são geneticamente muito semelhantes, mas podem divergir na sua 
epidemiologia, nomeadamente na distribuição geográfica e preferência pelo hospedeiro, 
factores de virulência e padrões de susceptibilidade antimicrobiana. No entanto, o 
diagnóstico laboratorial convencional não diferencia rotineiramente as espécies do 
MTC. Foi desenvolvido um algoritmo de identificação rápido e robusto, baseado em 
PCR em tempo real, dirigido para cinco alvos genómicos para a identificação das 
espécies do MTC vulgarmente associadas à tuberculose nos bovinos e outros animais. O 
primeiro passo permite a confirmação dos membros do MTC nas culturas, através da 
detecção da IS6110, ou como uma espécie micobacteriana, pela presença do 16S rDNA. 
Se uma espécie do MTC for identificada, o segundo passo do algoritmo permite avaliar 
a presença ou ausência das regiões genómicas RD1, RD4 e RD9. O padrão 
correspondente permite inferir a espécie do isolado como M. tuberculosis (se todas as 
RDs estiverem presentes), M. caprae (se apenas a RD1 e RD4 estiverem presentes) ou 
M. bovis (se apenas a RD1 estiver presente). O algoritmo de identificação desenvolvido 
demonstrou um coeficiente kappa de 0,970 com o resultado da análise bacteriológica. O 
ensaio pode ser implementado em laboratórios de diagnóstico veterinário, 




Tem-se registado uma procura crescente por métodos de diagnóstico de doenças 
infecciosas rápidos, de fácil utilização e acessíveis, passíveis de serem utilizados em 
pontos-de-decisão. A detecção dos membros do MTC é geralmente realizada por 
diversos métodos convencionais baseados na cultura, que normalmente necessitam de 
oito semanas. Foram também desenvolvidas estratégias de diagnóstico molecular, mas a 
maioria requer operadores qualificados e equipamentos e infra-estruturas sofisticadas. 
Recentemente, a técnica de Loop-Mediated Isothermal Amplification (LAMP) mostrou-
se promissora para o desenvolvimento de testes rápidos, de baixo custo, sensíveis e 
específicos para a detecção de agentes patogénicos. Neste trabalho, foram optimizados 
dois sistemas LAMP em formato duplex (dLAMP) para a identificação do MTC e 
Mycobacterium tuberculosis, e do MTC e M. bovis, apresentando valores de 
sensibilidade e especificidade comparáveis a outras abordagens em que se utiliza o PCR 
convencional. Os resultados das amplificações são avaliados colorimetricamente 
utilizando dispositivos de fluxo lateral, simples e comercialmente disponíveis, para a 
detecção de ácidos nucleicos (NALF). 
Os resultados apresentados nesta dissertação contribuem para a melhoria das estratégias 
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Keywords: Mycobacterium tuberculosis complex; Mycobacterium bovis; bovine 
tuberculosis; nucleic acid testing; molecular diagnosis 
 
Members of Mycobacterium tuberculosis complex (MTC) are causative agents of 
tuberculosis in both humans and animals. Bovine tuberculosis has been tackled for 
decades by costly eradication programs in most developed countries, involving the 
laboratorial testing of tissue samples from allegedly infected animals for detection of 
MTC members, namely Mycobacterium bovis. Definitive diagnosis is usually achieved 
by bacteriological culture, which may take up to 6-12 weeks, during which the suspect 
animal carcass and herd are under sanitary arrest. In this work we describe a user-
friendly DNA extraction protocol adapted for tissues and coupled with an IS6110-
targeted semi-nested real-time PCR assay to enhance the direct detection of MTC 
bacteria in animal specimens, reducing the time to achieve a diagnosis. The assay was 
evaluated with a group of 128 fresh tissue specimens collected from bovines, wild 
boars, deer and foxes. Overall, the full test performance corresponds to a diagnostic 
sensitivity and specificity of 98.2% and 88.7%, respectively. An observed kappa 
coefficient was estimated in 0.859 for the overall agreement between the semi-nested 
PCR assay and the bacteriological culture. This novel IS6110-targeted assay allows the 
fast detection of tuberculous mycobacteria in animal specimens with very high 
sensitivity and specificity, being amenable and cost effective for use in the routine 
veterinary diagnostic laboratory with further automation possibilities. 
MTC species are genetically very similar but may differ in their epidemiology, namely 
geographic distribution and host preferences, virulence traits and antimicrobial 
susceptibility patterns. However, the conventional laboratory diagnosis does not 
routinely differentiate between the species of the MTC. We developed a rapid and 
robust two-step five-target probe-based real-time PCR identification algorithm, based 
on genomic deletion analysis, to identify the MTC species most commonly associated 
with TB in livestock and other animals. The first step allows the confirmation of the 
cultures as MTC members, by targeting their IS6110 element, or as a mycobacterial 
species, if only a 16S rDNA product is detected in the duplex amplification reaction. If 
a MTC member is identified, the second amplification step allows to assess the presence 
or absence of the RD1, RD4 and RD9 genomic regions. The correspondent pattern 
allows to infer the species of the isolate as M. tuberculosis (if all RDs are present), M. 
caprae (if only RD1 and RD4 are present) and M. bovis (if only RD1 is present). The 
identification algorithm developed presented an almost perfect agreement with the 
results of the routine bacteriological analysis, with a kappa coefficient of 0.970. The 
assay is able to be adaptable to automation and implementation in the routine 





Rapid, user-friendly and affordable diagnostic tests for use in the point-of-decision or 
point-of-care settings are in high demand globally. Detection of MTC members is 
generally performed by cumbersome conventional culture-based methods, which 
usually takes up to eight weeks. Molecular diagnosis strategies were also developed but 
most of these requires skilled operators and sophisticated equipments and facilities. 
More recently, the Loop-Mediated Isothermal Amplification (LAMP) technique showed 
promise for the development of rapid, low-cost, sensitive and specific tests for detecting 
pathogens. In this work we have optimized duplex LAMP (dLAMP) assays for the 
identification of MTC and Mycobacterium tuberculosis, and MTC and M. bovis, 
presenting similar sensitivities and specificities when compared to standard PCR 
approaches. The amplification results are assessed colorimetrically by using simple and 
commercially available nucleic acid lateral flow (NALF) strips. 
With the work described in this dissertation we aim to modestly contribute to the 
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1.1. Tuberculous mycobacteria and tuberculosis 
Tuberculosis (TB) is an epidemic and serious infectious disease of global proportions, 
responsible for the death of approximately two million people per year, being estimated 
that one third of the world's population is latently infected [1]. Although curable, 
tuberculosis is still the leading cause of death in humans in many countries, and 
increasing numbers of cases of disease are reported in many regions of the world. The 
disease also affects animals, particularly livestock, with tremendous economic impacts. 
This disease is thus still a serious public health problem [1]. Despite being one of the 
most documented infectious diseases since the first records of the mankind [228], the 
main etiological agent of human tuberculosis, the Koch bacillus, was discovered by 
Robert Koch only in 1882 [2]. Today, it is known that tuberculosis is caused by several 
members of the Mycobacterium tuberculosis complex (MTC), a group of 
phylogenetically-related species including: M. tuberculosis, the principal agent of 
human tuberculosis; and M. bovis and M. caprae, most associated with tuberculosis in 
cattle and goats, respectively [3]. In the genus Mycobacterium, besides the MTC 
members, there are more than 120 recognized species, of which at least 20 to 30 may 
cause disease in humans [4] (Table 1.1). 
 
Table 1.1. Mycobacteria species frequently found in Medicine, according to the risk of 
infection (adapted from [6]). 
Classification Species 
Strict pathogens M. tuberculosis; M. bovis; M. africanum; M. leprae; M. 
ulcerans; M. szulgai; M. marinum 
Potential or 
opportunistic pathogens 
M. avium; M. intracellulare; M. scrofulaceum; M. kansasii; 





M. fortuitum; M. peregrinum; M. chelonae; M. abscessus; M. 
thermoresistibile; M. gordonae; M. triviale; M. gastri; M. 








1.1.1. Classification and general characteristics of mycobacteria 
The genus Mycobacterium is one of the oldest bacterial genus described. The formal 
classification of mycobacteria started in 1896 when Lehmann and Neumann proposed 
for the first time the creation of the genus Mycobacterium, encompassing a number of 
microorganisms whose growth, forming branching filamentous forms on the surface of 
the liquid culture media, was similar to fungi (the Greek prefix "myco" means "fungus") 
(Figure 1.1). 
Mycobacteria are dispersed in nature, either as saprophytic or as pathogenic species, 
having the last ones a wide range of hosts, ranging from plants to humans (Table 1.1). 
The genus Mycobacterium belongs to the family Mycobacteriaceae of the order 
Actinomycetales and, as mentioned above, includes more than 120 validly described 
species [4, 5]. Some of these species are strict or opportunistic (or potential) pathogens 
that affect both humans and animals. Among the strict pathogens, the principal species 
affecting humans include Mycobacterium tuberculosis, the causative agent of 
tuberculosis, M. leprae, which causes leprosy, and M. bovis that causes tuberculosis in 
animals but can also cause disease in humans. Opportunistic pathogens comprise a 
variety of mycobacterial species, including M. avium and M. kansasii, among others [6]. 
Mycobacteria are Gram-positive, rod-shaped, aerobic, non-motile, non-sporulating, and 
requiring aerobic conditions for their growth. Its optimum temperature for growth varies 
between 30 ºC and 45 ºC [6]. One peculiar characteristic of the genus consists in the 
chemical and structural complexity of the cell wall that is unique among prokaryotes, 
comprising a high percentage of long-chain lipids, including mycolic acids of high 
molecular weight with 60 to 90 carbon atoms [7]. 
 
 





Figure 1.1. Colonies of Mycobacterium tuberculosis, strain H37Ra, grown on 
Middlebrook 7H10 solid medium (original from Pedro Costa). 
 
Among other features, the mycobacterial cell wall gives the property of acid-alcohol 
resistance and mainly contributes to the hydrophobic nature of the cells surface, which 
leads to the formation of lumps when grown in liquid medium. The differences in the 
number of carbon atoms, and of their chemical bonds, in mycolic acids are important 
for the classification of mycobacteria. Other microorganisms such as Corynebacterium, 
Nocardia and Rhodococcus also produce mycolic acids, although with different 
molecular structures and lower molecular weight [6]. 
The different growth rates in specific culture media have led to the traditional division 
of mycobacteria into two groups: the rapidly growing and the slow growing 
mycobacteria (Figure 1.2). This traditional division scheme distinguishes mycobacteria 
that grows in less than seven days, without additional growth factors, from those whose 
growth occur after seven days and requiring additional growth factors added to the 
media. The first group includes for example saprophytic species such as M. smegmatis 
and M. fortuitum. The second slow-growing group encompasses pathogenic species, 
including M. tuberculosis, M. bovis, M. avium subsp. avium and M. avium subsp. 
paratuberculosis. The identification of mycobacteria is conventionally performed on the 
basis of their phenotypic characteristics, including morphological, cultural and 
biochemical features [6]. 
The pathogenic mycobacteria were initially separated into two groups, the 
Mycobacterium tuberculosis complex (MTC) and the non-MTC, or atypical, 




mycobacteria species, being their discrimination performed according to phenotypic 
identification criteria in the majority of clinical diagnostic laboratories [129].  
The evolution of genomic studies have permitted to establish relationships between the 
genetic and phenotypic characteristics of mycobacteria, e.g., leading to the genetic 
differentiation between the slow and fast growing species and to the description of new 
species and reclassification of the existing ones [8] (Figure 1.2). Overall, the members 
of the genus Mycobacterium have a high content of guanine and cytosine in genomic 
DNA, in the order of 62% to 70% (except for M. leprae, which is about 58%), and 










Figure 1.2. Phylogenetic tree of mycobacteria based on the 16S rRNA gene sequences 
(Adapted from [9]). 
 
1.1.2. The Mycobacterium tuberculosis complex 
The species of Mycobacterium that are agents of tuberculosis (tuberculous 
mycobacteria) are gathered in the so-called Mycobacterium tuberculosis complex 
(MTC). These species share about 99.95% of sequence homology, with a greatly 
reduced genetic diversity at the nucleotide level, and present identical sequences in the 
16S ribosomal gene, [10, 11]. The genome of the MTC members is longer than in other 
intracellular microorganism’s genomes, with approximately 4.4 million base pairs, 
which reflects the biochemistry complexity of its life cycle as facultative intracellular 




parasites, and also contains a higher GC content of about 65%. The exchange of genetic 
material, such as horizontal gene transference, is virtually non-existent in these species 
which results mainly in a clonal evolution, relying on extensive deletions of the 
nucleotide sequences (LSPs, Large Sequence Polymorphisms), rearrangements and 
chromosome point mutations [3, 12].  
The MTC is currently constituted by various species and subspecies with human and 
veterinary clinical importance: M. canettii, M. africanum, M. pinnipedii, M. microti, M. 
caprae, M. bovis, M. tuberculosis, M. mungi, M. orygis and the Dassie bacillus [13-17]. 
MTC mycobacteria are strict pathogens, depending on the host for its survival. Despite 
of the high degree of conservation of their genomes, the MTC species demonstrate 
important phenotypic differences, adaptations to different hosts and show different 
degrees of virulence [18]. For example, M. tuberculosis, the main agent of human 
tuberculosis, is almost always associated with the human. Otherwise, M. bovis is found 
primarily associated with cattle, M. caprae to goats and M. pinnipedii to marine 
mammals [18]. However, the adaptation of these species to each host is not necessarily 
strictly as it is for other pathogenic bacteria. All members of the MTC can cause disease 
in humans and other mammals that were not initially considered as primary hosts (Table 
1.2) [4]. It is noteworthy that M. bovis and M. caprae represents a significant potential 
of zoonotic transmission to Human [19, 20]. There is evidence pointing to the  
possibility of person-to-person transmission of the zoonotic Mycobacterium species 
[21], but the main routes of transmission are the contact with infected animals and 
intake of dairy improperly pasteurized or unpasteurized [1, 22]. Mycobacterium bovis 
species is responsible for between 0.5 and 7.2% of human tuberculosis cases in 
industrialized countries and it is estimated that it is responsible for 10 to 15% of new 
cases in developing countries [23]. Studies on the prevalence of human tuberculosis 
caused by these species are scarce in Portugal. 
 








Other Hosts Characteristics 
M. tuberculosis Human Other mammals Species almost exclusively found in humans. 
However, there are records of infections in 
other mammals [24-28]. 
M. bovis Cattle Sheep, goats, 
dogs, cats and 
humans 
Species with the highest number of possible 
hosts [6, 29-32]. 
M. caprae Goats Human Formerly considered a subspecies of M. bovis, 
but genetic differences have led to it being 
considered a distinct species [33].  
M. africanum Human - Species phenotypically intermediate between 
M. tuberculosis and M. bovis and whose area 
of focus is almost exclusively restricted to the 
African continent. Two varieties were 
described [34]. 
M. microti Rodents Human Pathogenicity level lower than the remaining 
species, being a potential substitute for BCG 
vaccine strains [35-37]. 
M. canettii Human - Species most divergent from MTC and 
allegedly nearest the ancestral species 
precursor of the complex [3, 38, 39].  
M. pinnipedii Seals Humans and other 
mammals 
Species first isolated in seals in South America 
with lesions of tuberculosis [40] and has also 
been associated with cases of tuberculosis in 
mammals in other zoos [41]. 
M. mungi Banded 
mongooses 
- The causative TB agent among banded 
mongooses, first isolated in Botswana. Host 
spectrum and transmission dynamics remain 
unknown [13]. 
Dassie bacillus  Hyrax or 
Dassie 
- An infrequent variant of the M. tuberculosis 
complex characterized as being most similar to 
M. microti, is the causative agent of 
tuberculosis in the dassie (Procavia capensis) 
[42]. 
M. orygis ? Mammals Oryx bacilli have been isolated from members 
of the Bovidae family, i.e., oryxes, gazelles, 
deer, antelope, and waterbucks, although their 
exact host range remains unsettled. No human 
disease caused by the oryx bacilli has been 
reported [14]. 
 




Phylogenetic relationships and evolutionary scenario 
As mentioned above, the MTC members share 99.95% of genetic homology, with a 
greatly reduced genetic diversity at the nucleotide level. Although genetically very 
similar, the members of the complex can be distinguished from each other by stable 
molecular differences, such as deletions or single nucleotide polymorphisms (SNPs), 
which have been the basis for evolutionary studies of these mycobacteria [3, 43]. The 
irreversible deletions of chromosomal regions, called Regions of Difference (RDs), 
were recognized in a much larger number in the genome of M. bovis compared to other 
members of the complex [3]. The analysis of these deletions allowed Brosch and 
collaborators [3] to outline a new phylogenetic tree for the MTC, later on confirmed by 
another independent study [11], in which M. bovis and M. bovis BCG appear as the last 
descendants of the complex (Figure 1.3). The vaccine strains of M. bovis BCG still 
exhibit an additional deletion in RD1, exclusive of these strains, and whose absence is 
associated with lower virulence [44]. The various members of the MTC that infect 
animals have in common the absence of RD9, which is present in the other members, 
like M. tuberculosis [3]. Other genomic data, including that resulting from the whole-
genome sequencing of M. bovis [45] and M. tuberculosis [46], corroborate the 
evolutionary scenario proposed by Brosch et al. (2002) for the MTC, in which M. bovis 
was the last descendant in the phylogeny (Figure 1.3). This new hypothesis came to 
oppose the previous one, based on epidemiological evidence, that M. bovis was the 
precursor species due to its wider hosts preferences range, and have served as a basis for 
the evolution of M. tuberculosis, by adaptation phenomena and specialization to Human 
host [47].  





Figure 1.3. Phylogeny of the Mycobacterium tuberculosis complex based on the 
analysis of Regions of Difference and Single Nucleotide Polymorphisms. Each orange 
box represents a deletion of one or more specific RDs in a given species [4]. Blue boxes 
indicate the SNPs; superscripts mark the position of the mutation at either the nucleotide 
(n) or the codon (c) of the respective genes. Adapted from [3], including information 
from [4, 14, 17, 50, 158]. 
 
Other phylogenies were produced for the MTC using additional molecular markers, 
such as deletions of spacer sequences of the Direct Repeat (DR) region and the 
identification of Single Nucleotide Polymorphisms (SNPs) [48-52], which are 
consistent with the proposal presented by Brosch et al. (2002). In 2009, in an overall 
phylogenetic analysis of the MTC bringing together all these molecular markers, this 
group of microorganisms appears as a set of ecotypes adapted to different hosts, 
corresponding the different affinities of the host to different niches (Figure 1.4) [4, 53]. 
The MTC members harbouring animals as their main hosts share the absence of RD9, 
which is present in M. tuberculosis, and also other common features (e.g. deletion of 
specific DR spacer sequences and SNPs). 














Figure 1.4. Evolution of members of Mycobacterium tuberculosis complex lacking the 
RD9. The predecessor species are numbered from Anc1 to Anc6 (Adapted from [4, 
53]). 
 
Clonal complexes of Mycobacterium bovis 
Bovines are the main hosts of M. bovis, which determines the disease called bovine 
tuberculosis (bTB). This term is also often used to describe the infection by M. bovis in 
other species, including wild animals and humans, to demonstrate the cattle as a source 
of infection. Although bovine tuberculosis has been reported on every continent where 
there are breeding of cattle, it was assumed to have originated in a particular geographic 
location, and since then has spread throughout the globe [54]. Historical data indicate 
that bovine tuberculosis has its origins in Europe and, especially during the colonial 
period, was distributed from that continent to the rest of the world. Myers and Steele 
(1969) suggested that M. bovis reached the northern Italy and from there moved to 
Western Europe and the UK. Webb (1936) also reasoned that the spread through the 
world was favoured by the export of infected cattle originated from the UK (mainly) 
and the Netherlands to their respective colonies [55]. The intensification of the dairy 
industry in combination with the movement of bovine animals has contributed to the 




transmission of M. bovis, especially in the absence of appropriate control and 
eradication measures [56].  
Modern methods of typing, based on the analysis of genetic characteristics, have 
determined progress in the knowledge of the geographical distribution of M. bovis and 
allowed the identification of dominant clonal complexes within broader geographic 
areas [57]. The cattle trade between neighbouring regions and countries leads to the 
dispersion of M. bovis and the dominance of clonal complexes in large areas [58]. These 
clonal complexes were mainly defined by the presence of specific patterns of deletions, 
namely in the DR region, by a reverse-hybridization typing technique named 
spoligotyping. Phylogeographic analysis have confirmed the existence of four major M. 
bovis clonal complexes: African 1 (Af1), African 2 (Af2), European 1 (Eu1) and 
European 2 (Eu2) [54, 58-60]. Two of these complexes are geographically located in 
Africa (Af1 and Af2), a third complex exhibit a global distribution (Eu1), and the fourth 
complex has a strong geographical predominance in the Iberian Peninsula (Eu2). The 
Af1 clonal complex (dominant in Cameroon, Nigeria, Mali and Chad) and the Af2 
complex (common in East Africa) were identified by Berg et al. (2011) and Muller et 
al. (2009), the clonal complex Eu1 (common in Ireland, UK and overseas countries) 
was identified by Smith et al. (2011), and the clonal complex Eu2 (predominantly in the 
Iberian Peninsula) was described by Rodriguez-Campos et al. (2012).  
Most members of the Af1 clonal complex are characterized by a specific chromosomal 
deletion (RDAf1) and the absence of the DR spacer 30 by spoligotyping. The RDAf1 
deletion is frequently found in isolates from Mali, Cameroon, Nigeria and Chad, 
although this deletion was not observed in other African countries such as Algeria, 
Burundi, Ethiopia, Madagascar, Mozambique, South Africa, Tanzania and Uganda [58]. 
The Af2 clonal complex is characterized by the chromosomal deletion RDAf2 and by 
the absence of spacers 3-7 in the spoligotyping pattern. This complex was identified 
with high frequency in isolates from Uganda, Burundi, Tanzania and Ethiopia. The 
RDAf2 deletion was not detected in isolates from Algeria, Mali, Chad, Cameroon, 
South Africa and Mozambique, suggesting that the Af2 clonal complex is located in 
East Africa. The absence of spacers 3-7 was rarely observed in isolates from outside 
Africa and the few isolates detected showed an intact RDAf2. An interesting fact is that 
Af2 M. bovis members mostly possess four or more copies of the IS6110, in contrast to 




most other strains that have only one or fewer copies. The deletion RDAf2 were intact 
in Af1 clonal complex strains, as well as RDAf1 deletion showed intact for the Af2 
strains, allowing to conclude that the strains of clonal complexes Af1 and Af2 are 
mutually exclusive and do not share any phylogenetic history with the latest common 
ancestor of each clonal complex, suggesting that the mixing between the cattle 
populations in that countries is uncommon [54, 59]. 
The clonal complex Eu1 is characterized by the deletion of the chromosomal region 
RDEu1 and was identified by the analysis of spoligotyping patterns available in the 
database of M. bovis (www.mbovis.org). Over 1000 strains from over 30 countries were 
analysed. This complex is frequently found in the Republic of Ireland and UK, represent 
less than 14% of the isolates in France, Spain and Portugal and proved rare in other 
European Community countries and Iran. However, Eu1 complex was found with high 
frequency in countries that had cattle trade relations with the UK (USA, South Africa, 
New Zealand, Australia and Canada). In the American continent, with the exception of 
Brazil, the Eu1 was also found with high frequency in Argentina, Chile, Ecuador and 
Mexico. Isolates from Korea and Kazakhstan were also associated with Eu1 clonal 
complex. The simplest explanation for the worldwide distribution of Eu1 is that it was 
spread by infected cattle from the UK, such as the Hereford cattle breed created in the 
18
th
 century, to old trading partners, although there is no evidence of secondary spread 
since then. This was the first identification of a clonal complex of M. bovis globally 
dispersed, which tries to explain much of the current global distribution of this major 
causative agent of bTB [54]. The Eu2 clonal complex, unlike the other clonal 
complexes mentioned above, is characterized by the absence of the spacer 21 and by a 
SNP in the guaA gene [61]. The Eu2 isolates of M. bovis are from the Iberian Peninsula, 
where they are found with high frequency. Eu2 is also found in France, Italy and the 
British Isles but with a very low frequency. Previous studies have revealed that about 
70% of the strains of M. bovis in Portugal [62] and Spain [63] were characterized by the 
absence of spacer 21.  
In summary, the MTC includes a highly clonal group of strains [53] and the genetic 
diversity found among its members is in part caused by genomic deletions that should 
represent diverse genetic events [64]. These deletions, termed large sequence 
polymorphisms (LSPs), have been explored in an attempt to disclose a new evolutionary 




scenario for the MTC, based on regions of difference [3]. SNPs have also been used, 
however with a more targeted application for phylogenetic studies [39, 53]. The 
analysis of the clonal complexes of M. bovis currently represents a new tool for 
molecular epidemiologists, allowing the creation of hypotheses to investigate the 
demographic distribution and the pathogenicity of these important zoonotic agents of 
global significance [53]. 
 
1.2. Bovine tuberculosis 
As mentioned above, M. bovis is the major etiological agent of bovine tuberculosis, a 
most important chronic and debilitating animal disease. Besides cattle, M. bovis can also 
cause tuberculosis in other mammalian species, including humans. Like human 
tuberculosis, bovine tuberculosis has a worldwide distribution and importance. It is a 
zoonosis with a high socio-economic impact, due to the low productivity of cattle and 
imposed restrictions on animal trade and products thereof, as well as costs associated 
with the implementation of programs to control and eradicate the disease, consisting 
also a major risk to public health [65, 66]. The disease has important implications in 
public health, especially in developing countries [1, 67]. 
Bovine tuberculosis has a predominantly chronic clinical evolution, with the 
development of typical granulomatous lesions, mainly in the lungs and lymph nodes, 
although any organ can be affected. The main routes of infection of bovine tuberculosis 
in animals are the direct infection by inhalation, ingestion and, less frequently, by 
congenital route. The mode of transmission more common is by aerosols inhalation, 
also due to the high survival rate of the agent in aerosols [68]. The infection by indirect 
route can also occur since M. bovis is resistant to adverse environmental conditions, 
surviving for more than 74 days in fomites and from two to six months in faeces, 
depending on the temperature and humidity conditions [69]. The anatomical location of 
the lesions suggests the most likely route of infection: hepatic lesions indicate 
congenital infection, intestinal lesions the infection by the gastrointestinal tract and 
lesions in the respiratory route the infection by aerogenous dissemination. 
The disease, despite having been eradicated or effectively controlled in most developed 
countries, continue to cause major problems in livestock in a large number of 




developing countries [1, 22, 70]. In Portugal, every year, the costs are high, resulting 
from the compensation to producers, slaughter of infected animals and initiatives to 
control and eradicate the disease. Despite the efforts made by the veterinary authorities, 
the eradication of bovine tuberculosis has not yet been achieved in Portugal, although 
the prevalence is low in the European context. A decrease of the incidence of bovine 
tuberculosis has been recorded since 1997 [71, 72]. In 2011, the reported prevalence in 
cattle was 0.17% against 0.07% and 0.09% in 2001 and 2002, respectively. As we can 
see in Table 1.3, there has been an apparent upsurge in the prevalence of the disease in 
Portugal, also potentially related with the maintenance of M. bovis in wildlife [104, 
229]. 
 
Table 1.3. Prevalence of bovine tuberculosis in Portugal (Adapted from [72]). 
Year 




% Positive animals  
(Animal prevalence) 
2001 783.680 546 0.07 
2002 776.231 716 0.09 
2003 958.306 1.221 0.13 
2004 984.527 856 0.09 
2005 976.532 647 0.07 
2006 976.893 425 0.04 
2007 1.006.908 414 0.04 
2008 1.032.586 264 0.03 
2009 1.060.831 885 0.08 
2010 1.036.310 2.702 0.26 
2011 1.063.167 1.835 0.17 
 




1.2.1. Implications for public health 
Since ancient times that M. bovis infects man [73], although M. tuberculosis is the main 
causative agent of human tuberculosis. In the early twentieth century, cases of 
tuberculosis caused by M. bovis in humans showed up as extrapulmonary forms, from 
consumption of unpasteurized milk and affecting mainly children [74]. The prevalence 
of human tuberculosis caused by M. bovis decreased dramatically in countries where 
pasteurization of milk and the campaigns of control and eradication of tuberculosis in 
cattle were implemented [75]. Contact with infected animals and ingestion of 
unpasteurized milk and dairy products, or incorrectly pasteurized, are the main routes of 
transmission of these zoonotic species [23, 75]. As mentioned above, in industrialized 
countries, human TB cases attributed to M. bovis were 0.5 to 7.2% in the last twenty 
years [23]. However, it is estimated that over 94% of the world´s population live in 
countries where there are no strategies for the control of infections caused by M. bovis 
[76]. In these countries, many of which belonging to the African continent, bovine 
tuberculosis poses a significant threat to public health [1, 67, 70], where it is estimated 
to be responsible for 10 to 15% of new cases of human tuberculosis [23]. 
In Portugal, according to the World Health Organization (WHO), the last recorded cases 
of human tuberculosis caused by M. bovis occurred in 2003 and 2004 (Euro TB 
Reports, 1999-2006), but usually, only the Mycobacterium tuberculosis complex is 
identified in clinical laboratories. It was suggested that 3.4% of tuberculosis cases 
detected in Hospital Amadora-Sintra, between 1999 and 2002, were caused by strains 
of M. bovis [77], but subsequent studies have not confirmed the classification of these 
isolates [78, 79]. 
Tuberculosis is especially important in individuals with immunodeficiency, particularly 
in patients infected by human immunodeficiency virus (HIV), which are particularly 
susceptible to infection by mycobacteria [67, 70, 75]. The emergence of multi-resistant 
strains of M. bovis in humans [80], as is the case with M. tuberculosis, and the fact that 
transmission between humans can occur [21, 81], reveals worrying. 
Human tuberculosis caused by M. bovis, from the clinical and pathological point, is 
indistinguishable of the tuberculosis caused by M. tuberculosis. Discrimination between 
these causative agents is possible only through laboratory diagnosis using conventional 




and molecular methods. However, in the laboratorial diagnosis of human tuberculosis 
culture media are generally not suitable for isolation of M. bovis (needs to be 
supplemented with pyruvate – see 1.3.1) and, on the other hand, is carried out only the 
identification of the MTC, raising up the suspicion that M. bovis can be an undervalued 
cause of morbidity and mortality [67, 82]. This finding is particularly relevant in 
developing countries where, due to limited resources, the diagnosis is based only on 
viewing acid-fast bacilli (AFB) in smears [67]. 
 
1.2.2. Epidemiological features 
Transmission of Mycobacterium bovis 
The aerial route is the main and most important route of transmission of bovine 
tuberculosis [76], being facilitated by the high survival rate of M. bovis in aerosols [68]. 
The direct contagion by inhalation thus constitutes the most common route of infection. 
Another important way of transmitting the infection is by ingestion, which may occur 
through contaminated water or pastures, or even through infected replacer milk 
administered to calves [9]. The congenital infection and vertical transmission, as well as 
genital transmission, are rare, especially in regions where eradication plans operate [83, 
84]. It is also uncommon the transcutaneous transmission, which may occur in 
situations of bitten by infected animals [85]. There is reference to the arthropods as 
vectors of infection, since viable M. bovis were detected in ticks, but this transmission 
path is very unlikely [69]. 
The infection by indirect way can occur since M. bovis have some resistance to the 
environmental conditions, being its survival dependant of factors such as temperature, 
humidity and sunlight [69, 86]. These mycobacteria can survive in the environment for 
a limited period (3 to 14 days) when exposed to sunlight, but can survive for a longer 
period (six weeks) under conditions of darkness and moisture. Eventually, mycobacteria 
can resist in fomites and faeces for two to six months [69, 86]. The survival of M. bovis 
in protozoa suggests that these organisms may provide protection against adverse 
environmental conditions [87], thus representing an environmental reservoir of M. bovis 
[88]. 
 




Global epidemiological situation 
Bovine tuberculosis is a disease of worldwide geographical distribution (Figure 1.5), 
with high incidence in many developing countries, where it has great importance [1, 
70]. Thanks to the implementation of eradication programs, several EU countries, 
including Austria, Denmark, Slovakia, Finland, Holland, Luxembourg, Czech Republic 
and Sweden, have managed to eradicate bovine tuberculosis, while other countries, 
including Portugal, only reduced the incidence of the disease (OIE, 2013). 
 
 
Figure 1.5. Worldwide distribution of Bovine tuberculosis (OIE, 2013). 
 
In many countries, the eradication of bovine tuberculosis has been hampered by the 
presence of several wild animals which act as reservoirs in the maintenance of M. bovis, 
among which are the badger (Meles meles), the opossum (Trichosurus vulpecula), bison 
(Bison bison), the African buffalo (Syncerus caffer) and the white-tailed deer 
(Odocoileus virginianus) [89, 104, 229]. 
In Portugal, the plans for the control and eradication of bovine tuberculosis have been 
implemented since 1992, often with the financial support of the European Union. From 
2000 to 2007, the prevalence of this disease in cattle decreased from 0.1% to 0.04%, 
lying now in the final and difficult stage of eradication of the disease [90]. To avoid the 




potential risk of transmission it is important to use all the resources for the early 
detection of infected animals and herds, including serological and molecular ante and 
post-mortem laboratory diagnostic tests [143, 230]. The rapid detection of M. bovis is 
pivotal in contributing to the control and eradication of bovine tuberculosis. 
 
Tuberculosis in free-ranging wildlife populations 
Mycobacterium bovis and other MTC species have been recognized as a global threat at 
the wildlife-livestock-human interface. Several wildlife species have been identified as 
maintenance hosts. Spill over of infection from these species to livestock or other 
wildlife species may have economic and conservation implications, and potential 
infection of humans poses public health concerns. The existence of natural reservoirs 
(maintenance hosts) of the disease, capable of reintroducing it into farms free of 
tuberculosis, has complicated the control and eradication of bovine tuberculosis in many 
countries [76, 91]. 
The study of cases of tuberculosis in free-living fauna is especially difficult, which 
explains the difficulty in controlling this disease once established in these populations. 
The reasons most often cited for this are the limitations on the knowledge of own 
sylvatic populations, both in relation to the number of individuals and their 
identification (usually only relative abundances are known), or with regard to the 
understanding of its importance in the epidemiology of the disease [92, 93]. It is also 
recognized the difficulty of the detection of sick animals in sylvatic populations, since 
the symptoms are non-specific and are absent in most animals (the most common 
symptom is the weight loss which occurs in advanced stages of the disease). 
Furthermore, in many cases there are no plans of epidemiosurveillance, being during the 
hunting the only contact that man has to these animals. Thus, the detection of 
tuberculosis is based on the post-mortem diagnosis, through the observation of the 
characteristic lesions (very important for the hunted animal for consumption), supported 
by histological and bacteriological analyses. The appearance and distribution of the 
lesions can differ in different infected species, particularly between cattle and cervids 
[93, 94]. 




Although tuberculosis has been detected in various sylvatic species, does not mean that 
all these populations constitute a natural reservoir of the disease. Most of these species 
are accidental hosts, i.e., can acquire the disease, but if removing the source of 
infection, there is a reduction in the prevalence of tuberculosis, which is not maintained 
in the population [95]. On the other hand, there are species that are considered 
maintenance hosts, because the infection may persist in the population only by 
horizontal transmission. This ability to act as a reservoir and transmit the disease to 
other susceptible species depends on the prevalence of the disease in the population of 
the maintenance host, their behaviour and their relationships in the ecosystem [93, 96]. 
There are several examples of these sylvatic reservoirs of tuberculosis, responsible for 
the transmission of infection to domestic cattle, hampering the efforts to eradicate the 
disease in certain countries. Some of the most studied are the European badger (Meles 
meles) in the UK and Ireland and the possum (Trichosurus vulpecula) in New Zealand, 
countries where there was an observed decrease in the prevalence of the disease in 
domestic cattle after campaigns based on the elimination of infected populations of 
these sylvatic animals [96, 97]. 
In the state of Michigan, USA, the white-tailed deer (Odocoileus virginianus), also 
known as the Virginia deer or simply as the whitetail, is considered the responsible for 
the re-emergence of the disease in cattle, after bad options of management of this 
cinegetic species. Consequently, due to the practice of supplementary feeding in the 
winter, their number grew beyond the capacity of the ecosystem, encouraging 
behaviours that increase the risk of intra- and interspecific transmission. This 
maintenance host is still the source of outbreaks in several species of carnivores, such as 
the coyote (Canis latrans), raccoon (Procyon lotor), the black bear (Ursus americanus) 
or red fox (Vulpes vulpes), and a potential danger to the hunters [92]. The water buffalo 
or domestic Asian water buffalo (Bubalus bubalis) in Australia is an example of a 
sylvatic maintenance host associated with a well succeed eradication campaign of 
tuberculosis. This required the total slaughter of chronically infected herds and 
restocking with animals originating from a disease-free population [96, 97]. In Africa, 
the most studied natural reservoir of the disease is the African buffalo or Cape buffalo 
(Syncerus caffer), which has proved a source of spreading of the disease to the 
predators, particularly on natural parks of South Africa [95]. This situation raises 




increasing concerns in the preservation of endangered species, including the larger felid 
species, such as lions (Panthera leo), cheetah (Acinonyx jubatus) and leopard (Panthera 
pardus) [98]. 
The first studies on tuberculosis in sylvatic species in the Iberian Peninsula were 
performed in Spain. Several studies have identified the wild boar (Sus scrofa) and the 
red deer (Cervus elaphus) as important reservoirs of the disease, reaching dispersed 
geographically populations and presenting a high prevalence of tuberculosis [95, 99, 
100]. Although in certain European countries the wild boar is considered an accidental 
host, various molecular, anatomopathological and epidemiological studies have 
strengthened the role of the wild boar as a reservoir in Mediterranean ecosystems [101-
103]. 
The population density of wild boar and deer has increased significantly, either by the 
lack of natural predators, or by the practices of cinegetic management of these species, 
such as the improvement of the hunting reserves fences (not relevant in the case of wild 
boar) and the food supplementation in the summer when the pastures are scarce [100]. 
In addition to the features mentioned above, also the behaviour of these animals and the 
evidence that they share M. bovis isolates with the same spoligotype profile as domestic 
cattle [95], make the wild boars and deer a risk factor in the reintroduction of the 
disease in disease-free farms. Also other domestic animals can be infected, including 
goats and Iberian pigs, in farms of extensive-type regime. These natural reservoirs of 
disease constitute a potential threat to public health (especially to the hunters and 
handlers of carcasses) and have also been implicated in transmission to endangered 
species such as the Iberian lynx (Lynx pardinus), endangering their preservation [100].  
The control of tuberculosis in sylvatic wildlife is extremely complicated, an example is 
the partial control of populations of badgers done in some areas of the UK. These 
actions obtained counterproductive results, because the disruption of the normal social 
structure of badgers led to an increase of migration of infected animals, yielding a 
greater number of outbreaks of TB in cattle. On the other hand, the case of the Asian 
buffalo in Australia was the only example of a successful campaign for the eradication 
of this disease in a sylvatic maintenance host. In this case, the method used was the total 




slaughter, but this is seldom adopted by economic, logistical, social and nature 
protection reasons [98]. 
In Portugal, the recognition of the presence of tuberculosis in wild boar and deer is 
longstanding [104, 229]. However, there is no national plan of surveillance of this 
disease in sylvatic species, however, exists only a few actions/studies in certain fields. 
Thus, it is not known the infection status of these populations. Currently, this 
information is summarized in some recent works about tuberculosis in wild boar [102, 
104] and about the genotyping of strains responsible for tuberculosis in deer and wild 
boar [62, 105]. In Portugal, the prevalence of tuberculosis in cattle and the occurrence 
of the disease in wild boars are significantly associated, suggesting a relationship 
between the disease in these species [102]. Furthermore, according to this author, the 
presence of tuberculosis in wild boar is also significantly associated with the density 
and diversity of sylvatic ungulates. Therefore, the wild boar appears to be the 
maintenance host of M. bovis in Portugal, and satisfies the theoretical conditions for 
being regarded as the reservoir of tuberculosis in our country [102]. Nevertheless, the 
great diversity of patterns found in isolates of deer from the same geographical area 
suggests that these animals are accidental hosts and not reservoirs of the disease. 
However, there is strong evidences of transmission of M. bovis between cattle and deer 
or wild boar, although not fully understood the meaning of it [62]. 
 
1.3. Diagnosis of bovine tuberculosis 
In cattle, symptoms of tuberculosis often manifest later, namely by the presence of 
lesions in tissues, so the clinical diagnosis is rare, especially in the course of control and 
eradication plans [23]. In this context, the screening of tuberculosis in live animals (in 
vivo or ante-mortem diagnosis) depends on immunological diagnostic tests, such as the 
single intradermal cervical tuberculin test (SICCT) and the interferon-gamma (IFN-γ) 
test, which are based on the detection of cell-mediated immune responses. The use of 
these tests represents an important step for the eradication and monitoring of the 
disease. The confirmation of the presence of infection and consequently the definitive 
diagnosis of bovine tuberculosis, is made post-mortem usually based on 
anatomopathological and histopathological diagnosis, on the culture and isolation of M. 




bovis in suspicious lesions, and trough molecular analysis to confirm the presence and 
the identification of the etiological agent. Since bovine tuberculosis manifests itself as a 
public health problem, it is an international research priority the development and 
improvement of new methodologies for a more effective diagnosis of this disease, 
whether conventional or molecular based. A rapid and specific laboratory identification 
of the etiologic agent of this disease appears extremely important, contributing to a 
better understanding of its epidemiology and leading, ultimately, to a more effective 
control of the infection in cattle and the improvement of the plans for the eradication of 
bTB. 
 
1.3.1. Conventional methodologies 
Immunologically-based approaches 
The immunological diagnostic tests are fundamentally based on cell-mediated 
immunity, since the cell-mediated response is a major defence mechanisms to infection 
by M. bovis [23]. Only in the later stages of the disease are produced antibodies in 
measurable quantities [84, 106, 107], whereby the diagnostic methods based on the 
humoral response have, in general, low sensitivity for early diagnosis than those that are 
based on cell-mediated response [108, 230]. 
The single intradermal cervical tuberculin test, approved by the European Union, is 
used in Portugal for the diagnosis of tuberculosis in cattle, and is also the reference test 
advocated by the World Organization for Animal Health (OIE) for the international 
marketing of cattle [23]. This test is based on the observed delayed hypersensitivity 
reaction, after intradermal injection of bovine and avian tuberculin, in animals who 
contact with M. bovis (vaccine strain or other). Tuberculins are water-soluble purified 
protein derivatives (PPD), obtained from the growth of certain strains of M. bovis (PPD-
B) and M. avium (PPD-A), namely the AN5 and D4ER strains, respectively, in defined 
culture medium. As with any diagnostic test, there are several factors that can give a 
false-positive or false-negative result with SICCT tests. The first case includes, for 
example, the infections caused by mycobacteria not belonging to the MTC and, in the 
second case, the energy developed in cattle with advanced or generalized tuberculosis. 




It is estimated that the sensitivity of SICCT test ranges from 75% to 95.5%, with a 
higher specificity between 78.8% and 100%, due to the use of the two tuberculins [23]. 
The IFN-γ test is an enzyme immunoassay (ELISA) based on the evaluation of cytokine 
released by lymphocytes previously sensitized, with bovine and avian tuberculin [23]. 
Its sensitivity is high, but has a lower specificity than the SICCT assay. Generally the 
IFN-γ test is used as a complement of the SICCT test, allowing the early detection of 
infection because of the extreme sensitivity that results from the combination of the two 
tests [109]. In Portugal, this test is recommended in cases of doubtful animals to the 
SICCT test or other situations defined by the National Plan for the Eradication of 
Bovine Tuberculosis [72]. 
In addition to the IFN-γ test, there are other laboratory assays based on cellular 
immunity, namely the lymphocyte proliferation and, also, several tests based on 
humoral immunity, namely serological tests. Due to the specialized technical 
implementation and costs involved in its realization, all these tests are presented as 
additional to the SICCT test. 
As mentioned above, most immunological diagnostic tests for bTB uses the tuberculin 
as reagent, which consist of a mixture of peptides with different antigenic properties. 
Many of the false-positive reactions of the cattle to the intradermal inoculation are due 
to the antigenic complexity of the PPD [110]. The characterization of the antigens of M. 
bovis has allowed the development of novel diagnostic tests with higher specificity and 
sensitivity. Several antigens of M. bovis have been studied in the last years, including 
the ESAT-6 and CFP-10 proteins, which have proved useful for the detection of 
infection, being a complement, or even an alternative to the tuberculin [110-115]. These 
antigens are capable of stimulating whether the cell-mediated response or the humoral 
response, and may therefore be used in various immunological tests in vitro and in vivo 
with various objectives, including the discrimination between infected and vaccinated 
animals [116, 117]. 
 
Anatomopathological diagnosis 
The observation of typical macroscopic lesions (tubercles) on post-mortem examination, 
in conjunction with histopathology, allows the presumptive diagnosis of bovine 




tuberculosis [118]. The lesions are often found in the lungs and retropharyngeal, 
mediastinal and bronchial lymph nodes, although they may appear in other organs 
[119]. In microscopic observation, the granulomatous lesion is characterized by a 
central caseous necrosis, sometimes with calcification, surrounded by epithelioid cells, 
multinucleated giant cells, macrophages and lymphocytes, being encapsulated by 
fibrous conjunctive tissue [120].  
The presence of acid-fast bacilli (AFB) in the lesions, revealed in histological sections 
subjected to the specific staining of Ziehl-Neelsen or fluorescent staining with 
auramine, corroborates the presumptive diagnosis of tuberculosis. This technique, while 
rapid and inexpensive, can only show the presence of AFB cells in concentrations 
higher than 10
4
 bacteria per ml and the procedure also does not allow the distinction 
between the members of the family Mycobacteriaceae [121]. It was also shown that the 
Ziehl-Neelsen staining is affected by changes in the cell wall of M. tuberculosis during 
the latency states [122]. Alternatively, the detection and identification of MTC bacteria, 
in histological sections, could be achieved by immunohistochemical techniques using 
antibodies specific for the complex, making it a more sensitive and specific procedure 
[122-124]. In addition to this technique, also molecular techniques, including in situ 
hybridization, have been used in histological sections for the detection and 
identification of MTC species [125].  
Although the microscopic observation of acid-fast bacilli in smears corresponds to 
tuberculosis in most cases, an efficient diagnosis often difficult due to the poor 
sensitivity (e.g. in paucibacillary lesions in cattle) and specificity of the assays, being 
imperative the use of culture-based methods to detect the presence of the etiological 
agent. 
 
Bacteriological diagnosis  
Due to the nature of MTC mycobacteria, bacteriological diagnosis of tuberculosis 
involves biosecurity measures of containment level 3, with very demanding operational 
requirements and physical facilities. This biosafety level limits the number of 
laboratories with conditions able to perform this type of diagnosis. 




The isolation of M. bovis from biological samples, including macerated tissues of 
animals suspected of having tuberculosis, is considered the most effective means for the 
definitive diagnosis of bovine tuberculosis. This method has high specificity, but is not 
particularly sensitive, especially when the culture is obtained from lymph node samples 
of an animal without observable lesions, albeit positive for SICCT or IFN-γ test [23, 
84]. The successful isolation of M. bovis is also influenced by the decontamination 
procedures of the samples, the culture medium used, and the incubation conditions of 
the cultures [118]. The viability of mycobacteria can be affected by the action of the 
reagents used in the decontamination procedures, necessary for the elimination of 
rapidly growing microorganisms existing in the samples. There are several 
decontamination methods available, suitable for each type of biological sample, all 
being based on the use of acids, alkalis or detergents. For animal tissues, the most 
recommended decontamination reagents are sodium hydroxide at a final concentration 
of 2% and the hexadecyl pyridine chloride at 0.075% [126]. Several antimicrobial 
substances have also been used to inhibit the growth of contaminating microorganisms, 
to which the mycobacteria are resistant, such as penicillin derivatives, trimethoprim, 
nalidixic acid, amphotericin B and cycloheximide. Traditionally, the most used selective 
culture media for MTC species are the Lowenstein-Jensen supplemented with pyruvate, 
the Stonebrink and the Middlebrook 7H11 [127]. In these solid media, the growth of M. 
bovis is slow due to the long generation times (16-20h) of this bacteria, and it takes 
three to eight weeks until colonies are visible. The introduction of automatic radiometric 
(e.g. BACTEC 460) and fluorometric (e.g. BACTEC 9000MB or MGIT 960) 
equipment contributed to shorten the culture time for between two to three weeks [82, 
128]. 
The identification of the mycobacterial isolates, based on the analysis of phenotypic 
traits, is carried out by assessing the colony morphology, the production of pigments 
and a set of biochemical tests, such as the susceptibility to the presence of TCH 
(Thiophene-2-carboxylic acid hydrazide), the production of niacin and the reduction of 
nitrate [129]. These identification procedures are also time consuming (three to four 
weeks), and sometimes are non-conclusive, for example, in the case of strains of M. 
bovis with features common to M. tuberculosis [130]. The bacteriological diagnosis of 
tuberculosis is thus an extremely lengthy procedure (eight to ten weeks), and not always 




allowing the discrimination of the MTC species. The species identification may also be 
achieved by the analysis of mycolic acids by high-performance liquid chromatography 
(HPLC) [131]. This technique is, however, sophisticated and requires very expensive 
equipment and highly skilled technicians. The identification of mycobacteria obtained 
by the isolation in culture can be also done using molecular methods. 
 
1.3.2. Rationale of the molecular-based strategies for the assessment of the MTC  
Among the most promising segments of the In Vitro Diagnostics (IVD) market, with 
growing rates of 20% per year, is the molecular diagnosis, mainly based on the analysis 
of nucleic acids (80% of this segment corresponds to the diagnosis of infectious 
diseases). The molecular diagnosis technologies are usually associated with 
improvements in sensitivity, specificity and time response comparing to other 
conventionally methods that are used. The market trend is the increasing substitution of 
the conventional methods by the molecular ones, with some emphasis for the rapid tests.  
 
Detection and identification 
DNA amplification-based assays 
Rapid diagnosis reports to a wide range of novel testing procedures which can 
significantly reduce the reporting time within hours or even minutes compared with that 
of conventional culturing methods. Diagnostic tests should ideally meet certain 
requirements, they must be cheap, robust and simple enough to be used by minimally 
trained health technicians. Technological innovations are emerging that could address 
many of the unmet diagnostic needs for diseases like tuberculosis. In this context, 
various nucleic acid-based techniques have been developed, including Polymerase 
Chain Reaction (PCR), Nested PCR, Real-time PCR, Loop-mediated isothermal 
amplification (LAMP), and sequence-based identification, among others. The molecular 
methods seems promising for a faster and specific diagnosis of tuberculosis, however, it 
is necessary to make them simpler, standardized and accessible to a wider and effective 
use in the routine clinical laboratory.  




There are several PCR protocols to enhance detection sensitivities, especially when 
dealing with small numbers of bacterial cells as target. Nested PCR is one of these 
approaches, allowing the detection of only a few bacteria in clinical specimens [132]. 
The process utilizes two consecutive PCRs. The first PCR contains an external pair of 
primers, while the second contains either two nested primers that are internal to the first 
primer pair or one of the first primer and a single nested primer. The larger fragment 
produced by the first reaction is used as the template for the second PCR [132]. The 
sensitivity and specificity of DNA amplification can be considerably improved by using 
such nested PCR strategies, sometimes with one thousand times more sensitivity than a 
standard PCR.  
Most conventional first-generation PCR assays involved complex procedures for 
detecting the amplification products (e.g. gel electrophoresis and ethidium bromide 
staining). A great technological advance towards the simplification of nucleic acid 
testing assays was the development of quantitative real-time PCR, which involves the 
amplification and detection of amplified products coupled in a single reaction vessel, 
increasing the speed of detection [133]. This allows for the direct detection of the PCR 
product during the exponential phase of the amplification reaction, combining 
amplification and detection in one step. The measurement of the rate of increase of the 
amplification products in real-time also offers the possibility of extrapolating back to 
the starting DNA concentration, thus offering the possibility of quantification [134]. 
The ability to monitor the progress of DNA amplification in real-time depends on the 
chemistry of the reaction and instrumentation used. Generally, chemistries consist of 
special fluorescent probes that must associate a fluorescent signal to the amplification of 
DNA [135]. The initial real-time PCR procedures made use of the dsDNA-specific 
intercalating dye ethidium bromide [136]. dsDNA-specific dyes exhibit little or no 
fluorescence when free in solution, but produce a strong fluorescence signal when 
bound to dsDNA and exposed to the appropriate wavelength of light. Although the use 
of other dyes has been described, SYBR Green I [137] is currently the industry standard 
[135]. Intercalating dyes are the most cost effective chemistry and usually are the first 
choice for many applications in research and diagnostics. A disadvantage of using these 
dyes is that any double stranded DNA will be detected, e.g. non-specific amplicons and 
primer dimers, which may cause problems with the accuracy of quantitative PCR. 




Because of this limitation, other strategies that involve the use of probes that will 
specifically recognize only the target PCR product have been developed. The most 
common probes currently used in real-time PCR assays are the Taqman probes, the 
molecular beacons and fluorescence resonance energy transfer (FRET) probes [138]. 
Taqman probes are one of the most widely used chemistries because the assay design is 
relatively simple and generally robust. These probes have a 5′-end fluorescent reporter 
molecule and a 3′-end quencher molecule (Figure 1.6). The fluorescence of the reporter 
molecule is quenched when in the proximity of the quencher molecules. The hydrolysis 
of the probe by the 5′ exonuclease activity of DNA polymerases separates the reporter 
and quencher molecules and a fluorescent signal is emitted and detected by the real-time 
PCR instrument. The incubation temperature of the DNA polymerization step is critical 
since at higher temperatures (e.g. 72 °C), which are normally used for DNA synthesis in 
conventional PCR, the polymerases will displace the probe rather than degrade it. As a 
result of probe degradation, the fluorescent signal increases as a function of the number 
of amplification cycles and allows the specific detection and quantification of the target 
DNA. Molecular beacons use secondary structure (stem-loops) to hold both the reporter 
and quencher molecules in close proximity when the probe is in solution, preventing the 
production of any fluorescent signal [139]. When the probe anneals to the target DNA, 
they unfold and the distance between the reporter and quencher molecules is sufficient 
to allow the emission of fluorescence. These probes can be used for performing DNA 
melting curve analysis (by measuring the dissociation kinetics of the release of the 
bound probe to the target DNA), allowing a further genetic characterisation of the 
amplified DNA. Fluorescence resonance energy transfer (FRET)-based assays rely on 
the energy transfer between a 3′-end donor fluorophore and a 5′-end reporter 
fluorophore on separate probes, rather than the quenching of a fluorophore as seen with 
molecular beacons and Taqman probes [135, 140]. Melt curve analysis in FRET assays 
measures the temperature at which the bound probes are dissociated from the target 
amplicon and not the melting temperature of the entire amplicon as is the case when 
using intercalating dyes. Thus a single primer set may be used to amplify a region of 
interest, with species/strain discrimination possible by designing the FRET probes to 
bind to variable regions within the region bound by the primer set used for 
amplification. This technology lends itself to SNPs detection, as a single mismatch 




between the probe and target sequences will yield a sufficiently different melting 
temperature to allow detection. 
 
 
Figure 1.6. Schematic representation of TaqMan chemistry (original drawing by Pedro 
Costa).  
 
Over the past years, numerous methods have been described for the molecular detection 
and identification of mycobacteria, including MTC members, using for example nested 
PCR approaches [141-143] and several real-time amplification chemistries [143-150]. 
Some molecular assays are also commercially available, such as AccuProbe (Gen-Probe 
Inc., San Diego, USA), Inno-LiPA (Innogenetics, Ghent, Belgium) and GenoType 
Mycobacteria (Hain Diagnostics, Nerhen, Germany). The detection and identification of 
M. bovis directly in samples suspected of bovine tuberculosis have been achieved by 
several authors by using various DNA amplification-based techniques [151-157], which 




showed varying sensitivities, generally low. The characteristics of the lesions (usually 
with fibrosis and calcification) associated with the presence of few bacilli 
(paucibacillary samples) and inhibitors are responsible for the difficulties encountered 
in the direct identification of M. bovis. The nucleic acid extraction from mycobacterial 
cells is also difficult, associated with the characteristics of the cell wall. Although 
various strategies have been developed to overcome this problem, in particular through 
sequence-capture techniques of specific DNA sequences [154, 155], nested-PCR [153] 
or multiplex real-time PCR [156], the sensitivity of these methods is usually lower, in 
comparison with the bacterial culture, rarely exceeding 75%. Other molecular methods, 
including in situ hybridization techniques, were used for the detection and identification 
of MTC members in tissues [125]. 
The discrimination between species of the MTC is more difficult to achieve due to the 
high genetic homology that exists between them. Sequencing of the genomes of M. 
tuberculosis, M. bovis and M. bovis BCG, coupled with the advances of bioinformatics, 
has contributed to the identification of genomic regions useful in the discrimination of 
the species of the MTC. The analysis of the polymorphisms of the gyrB gene by PCR-
RFLP allows the differentiation between the main members of the complex, with the 
exception of M. tuberculosis and M. africanum type II [158]. The analysis of the gyrB 
gene polymorphisms have also been used for other bacterial genera, for the species 
differentiation and inferring phylogenies. Another molecular approach is the analysis of 
Regions of Difference in the genome of these species [3, 43]. As already mentioned 
above, the pattern of presence or absence of certain RDs appear to reflect its 
evolutionary history, so their respective analysis is presented as a reliable alternative for 
proper identification of these species [147, 159, 160]. Also the differentiation between 
virulent and vaccine (BCG) strains is possible through the analysis of the RDs. There is 
an absence of RD1 in BCG strains, where genes involved in the production of virulence 
factors are located (for example, the ESAT6 protein). Mishra and colleagues (2005) 
reported another molecular approach, based on the analysis of hupB gene by the 
technique of nested-PCR, for the direct detection and identification of M. tuberculosis 
and M. bovis in biological samples of animal origin. Several genomic regions have been 
used as a target for the detection and identification of members of the MTC. For 
example, the analysis of the mtp40 gene, which encodes a phospholipase C, was used to 




differentiate M. tuberculosis and M. bovis, this gene being absent in the second species. 
However, it has been discovered that this gene is also absent in some strains of M. 
tuberculosis [8]. The oxyR pseudogene and pncA gene, which encodes for the 
pyrazinamidase [161-163], have, each one, a single base polymorphism between M. 
bovis and M. tuberculosis, but do not allow the differentiation of other members of the 
complex, such as M. africanum [8]. 
 
Isothermal DNA amplification 
Novel developments in molecular diagnostic tools have demonstrated the possibility of 
nucleic acids amplification under isothermal conditions, i.e. without thermal cycling. A 
most promising method termed Loop-Mediated Isothermal Amplification (LAMP) was 
described that can amplify DNA or RNA with high specificity, efficiency and rapidity 
under isothermal conditions [164]. Unlike PCR, a denatured template is not required 
[165] and DNA is generated in large amounts in a short time. Furthermore, positive 
LAMP reactions can be assessed with the naked eye [166, 167]. The main advantage of 
this technique is its simplicity; only a water bath or heating block is needed to provide a 
constant temperature as the amplification proceeds under isothermal conditions. 
The LAMP method employs a DNA polymerase and a set of four specially constructed 
primers that recognize six distinct sequences on the target DNA. An inner primer pair 
with sequences of sense and anti-sense strands of the target template initiates LAMP. A 
pair of outer primers then displaces the amplified strand with the help of a DNA 
polymerase which has a high displacement activity, to release a single stranded DNA, 
which then forms a hairpin to initiate the starting loop for cyclic amplification. 
Amplification proceeds in cyclical order, each strand being displaced during elongation 
with the addition of new loops with every cycle. The final products are stem loop DNAs 
with several inverted repeats of the target and cauliflower-like structures with multiple 
loops due to hybridization between alternately inverted repeats in the same strand [164] 
(Figure 1.7). The reaction can be accelerated by using two extra loop primers. There are 
several works reporting the use of this technology to detect pathogenic organisms, 
including mycobacteria [168-173]. 




























































































Figure 1.7. Schematic representation of Loop-mediated isothermal amplification assay 
(original drawing by Pedro Costa). LAMP is simple and requires only basic laboratory 
equipment, being characterized by the use of four primers (F3, B3, FIP and BIP), in an 
isothermal (60 – 65 ºC) auto-cycling strand displacement reaction. FIP and BIP primers 
contain two distinct sequences corresponding to sense and antisense segments of the 
target DNA, one for priming in the first stage and the other for self-priming in 
subsequent reaction steps. Amplification products are a mixture of stem-loop DNA 




Immunochromatographic assays were first described in the late 1960s and were 
originally developed to assess the presence of serum proteins [174, 175]. However, over 
the past decade many other applications have been developed for 
immunochromatographic assays, including the detection of bacterial pathogens [176-
180].  




Typical handheld assay devices contain a colloidal gold (or other)-labelled antibody 
dried onto a filter pad affixed to a nitrocellulose strip. A capture antibody is applied in a 
line on the strip and dried. To perform the test, a specimen is suspended and added to 
the pad containing the colloidal gold-labelled antibody. At a critical point of interface, 
clumping of the carrier particles occurs as an indicator of the antigen-antibody 
interactions occurring on the surface of the carriers. A positive reaction is visualized as 
a red line created by the bound colloidal gold. Similar assays using different detection 
systems have been described in the literature, including those based on latex particles 
[175]. The increasing demand for point-of-care (POC) (or point-of-decision) 
diagnostics, led to the development of rapid tests to be used directly in the field. Most of 
these rapid tests rely in the format of dipstick tests, which are based on 
immunochromatographic assays (Figure 1.8). The dipstick tests provide qualitative (or 
semi-quantitative), fast, economical and easy to interpret results, the reading is usually 
taken with the naked eye. Dipstick assays enable endpoint nucleic acid detection. In 
recent decades, dipsticks-based assays were developed for the detection of several 
infectious diseases such as dengue fever [181], malaria [182], hepatitis B [183], among 
others. Assays using this format are rapid, taking approximately 15 min to run, and are 
also user-friendly. These tests are, therefore, of great value in situations where health 
professionals need to make decisions and take immediate measures. Dipstick-based 
assays were also previously described for the diagnosis of tuberculosis [184-186]. 






























Figure 1.8. Schematic representation of immunochromatographic dipstick assay 
(original drawing by Pedro Costa). A common architecture involves the following steps: 
(1) Hybridization of DIG-labeled amplified DNAs with complementary FITC-labeled 
oligonucleotide probes; (2) Deposition of the hybridized products in the sample pad (the 
mixture also contains non-hybridised oligoprobes); (3) After diffusion of the hybridized 
products in the dipstick, a complex with gold-labeled anti-FITC antibodies is generated 
in the conjugate pad; (4) The resulting triple complexes migrate through the membrane 
and pass the test line, where the DIG molecules are captured by anti-DIG antibodies and 
a red test band, resulting from the concentration of gold nano-particles; (5) Non-
hybridized FITC-labeled probe is bound by the gold-labeled anti-FITC antibody to form 
a double complex without DIG and moves through the test line to be trapped at the 
control line, containing anti-FITC antibodies. 
 
Nanotechnology and nanodiagnosis 
The growing interest in increasingly miniaturized materials and devices led to the 
emergence of a new technology field, named nanotechnology [187]. This new branch 
can thus be defined as the technology capable to produce and implement structures, 
machines, devices and systems, with controlled shape and size in a nanometre scale and 
the exploitation of new properties and phenomena that develop at this scale. The 
concept of bionanotechnology, which includes the nanodiagnosis, arises from the 
development of new methodologies and new platforms at nanoscale with biological 
application, in particular, for the development of biosensors, nanodiagnosis of infectious 
diseases, nucleic acid detection, detection of SNPs, "drug delivery", gene therapy, and 




other applications [187]. This technology is now being applied for field detection 
combining microfluidics, nanoprobes, paper based platforms and user-friendly detection 
procedures for the development of low-cost point-of-care diagnosting testing for 
infectious diseases such as TB and leishmaniasis [231, 232].  
The use of nanoparticles (NPs) for the development of molecular diagnostic methods is 
promising, particularly the nanoparticles of noble metals such as gold [188, 189]. NPs 
have a size between 1 and 500 nm and can be found dispersed in solid, liquid or gaseous 
medium. Most of them has a spherical shape, with specific physical and chemical 
properties that allows their detection, analyses and quantification in a more efficient 
manner. The metal NPs can be formed by various noble metals, such as gold (Au), 
platinum (Pt) and silver (Ag). Of all the metal nanoparticles, gold nanoparticles 
(AuNPs) are of the most interesting and led to an intensive study of their optical, 
magnetic and electronic properties. When excited by an incident electromagnetic field, 
these nanoparticles produce an effect known as surface plasmon resonance (SPR), 
which is the collective oscillation of free electrons on the particle surface, producing 
properties of intense absorption and electric scattering. SPR depends on the particle 
size, which is comprised of the material and the shape. The surface plasmon resonance 
of the gold nanoparticles is responsible for their intense colours. In solution, 
monodisperse gold nanoparticles show a red colour, with a peak of the SPR band in the 
region of 520 nm. Conversely, a solution containing aggregated gold nanoparticles 
shows a blue colour, corresponding to a red shift of the SPR band peak to 
approximately 600 nm. These nanoparticles can be functionalized with thiolated 
oligonucleotides [190], yielding the so called gold nanoprobes (Au-nanoprobes). In 
1996, Mirkin and co-workers first described a method of colorimetric detection of DNA 
based on gold nanoprobes [191]. The method consists of using single-stranded DNA 
oligonucleotides that can be detected through two different nanoprobes, each one 
functionalized with an oligonucleotide complementary to one of the target regions. The 
hybridization of the target with the two nanoprobes results in the formation of a 
polymer network (cross-linking method) which promotes the approach of the gold 
nanoparticles enough to result in a change of solution colour from red to blue. 
An alternative strategy uses a single probe which hybridizes to target DNA fragments, 
and an increase in the ionic strength of the solution causes the aggregation of the 




nanoparticles, causing the red-shift of the SPR peak (blue solution). The presence in 
solution of nucleic acids with a sequence complementary to the nanoprobe stabilizes the 
system and the solution maintains the initial red colour. The absence of a 
complementary sequence does not prevent the aggregation of the nanoparticles and the 
solution changes the colour to blue, visually observable, and can be confirmed by 
visible spectrophotometry (Figure 1.9). This colorimetric detection approach, whose 
gold nanoprobe aggregation is induced by increasing the salt concentration in the 
solution, is called of non-cross-linking method and has been used for the detection of 
specific sequences of DNA and RNA, including the characterization of mutations and 
single nucleotide polymorphisms (SNPs) [192-194, 233], the study of gene expression 




Figure 1.9. Gold nanoprobe assay. Colorimetric assay (above) and respective 
spectrophotometry (below) for the Mycobacterium tuberculosis complex (MTC) probe 
(black lines represent the red solutions associated with complementary target: non-
aggregated Au-nanoprobes; the grey line represents the blue solution associated with 








Characterization and genotyping 
Genotyping technologies allow the characterization of different strains of the same 
species, using molecular biology approaches that analyse a part or the entire genome of 
the microorganisms. An efficient molecular typing assay should have a high 
discriminatory power in order to allow a clear differentiation of a large number of 
strains and possess high reproducibility. In the case of bovine tuberculosis, genotyping 
is a very important tool in determining the source of an outbreak and in identifying 
dominant epidemiologic patterns in different countries or geographical regions, to 
clarify the taxonomy of the species and subspecies and to elucidate possible 
associations between genotype and pathogenicity/virulence of different strains [198-
204]. A precise and depth knowledge on the epidemiology of bovine tuberculosis, 
including an understanding of the disease transmission between cattle and the role 
played by other domestic and wild species in the maintenance of the disease, is essential 
to achieve the control and ultimately the eradication of the disease. 
Currently, the genotyping techniques most used to characterize MTC isolates, in 
particular M. bovis, are the so-called Spoligotyping (Spacer Oligonucleotide Typing) 
and MIRU-VNTR (Mycobacterial Interspersed Repetitive Unit-Variable Number 
Tandem Repeats) analysis. These techniques are based on the amplification, by PCR, of 
specific polymorphic regions of the genome. Usually these regions have in common the 
presence of repeated nucleotide sequences, constituting ideal targets for in vitro 
amplification. These PCR-based techniques have the advantage of not requiring 
purification of template DNA and may be directly used in clinical samples [205], on 
stained smears [206] and even in archaeological specimens whose DNA is damaged 
[207-209]. These methodologies have been used in most laboratories where it is done 
the typing of M. bovis, because they are relatively simple, rapid and inexpensive [80]. 
 
Spoligotyping  
Spoligotyping, whose name is derived from Spacer Oligonucleotide Typing, is based on 
the analysis of the polymorphisms of the DR locus [210], present in the genome of 
MTC mycobacteria. The DR region is composed by direct variable repeats (DVR). Each 
one of these DVRs is formed by a repeated sequence of 36 base pairs (DR) and the 




adjacent variable spacer sequence, which has between 34 and 41 base pairs [210-212] 
(Figure 1.10). The order of the spacer sequences in the DR region is conserved [213] 
and polymorphisms are related to the number of direct repeats and the presence or 
absence of specific spacer sequences, with a total of 43 [40, 204, 214]. 
 
 
Figure 1.10. Schematic representation of the structure of the DR locus in the 
mycobacterial genome, constituted by conserved direct repeats, with 36 bp (rectangles), 
interspersed by variable repeat sequences, with 34-41 bp (continuous lines). DR - Direct 
Repeat; 1 to 43 – Spacers that may exist in a given strain (original drawing by Pedro 
Costa). 
 
Spoligotyping applies to all members of the MTC. Some species and subgroups of 
strains may show characteristic spoligotyping profiles, known as signature profiles 
[215] (Table 1.4). For example, strains of M. bovis are characterized by the absence of 
spacer sequences 3, 9, 16, and 39 to 43 [62, 210, 213], while strains of M. caprae are 









Table 1.4. Spoligotyping profiles characteristic of M. bovis and M. caprae.  








 The black squares represent the presence and the white ones the absence of each one 
of the 43 spacer sequences (original drawing by Pedro Costa). 
 
Experimentally, spoligotyping involves the extraction of genomic DNA from the 
mycobacterial isolates and the amplification of the DR locus by PCR, which is then 
used for reverse hybridization in a membrane where DR-specific complementary 
oligonucleotides are immobilized at specific locations. After the revelation of the 
occurrence of hybridization events, each of the present spacers will produce a dark spot, 
while the absence of a specific spacer is indicated by the absence of the dark spot in the 
respective position. The spoligotyping profile can be transformed into a binary code (0 
represents the absence of the spacer sequence and 1 the presence of the same one), 
making it possible to compare the obtained profile with other existing in international 
databases such as Mbovis.org (Figure 1.11). In this database, each profile is denoted by 
SB (Spoligotype Bovis) followed by four numbers, like for example SB1174. 
 
 
Figure 1.11. Illustration of a spoligotype profile (M. caprae) and its correspondent 
binary code. For each spacer the dark band and number 1 indicates the presence of the 
spacer; the absence of the band and a 0 number indicates the absence of the spacer 
(original drawing by Pedro Costa). 




Although the strains of a same MTC species usually lack certain characteristic spacer 
sequences, they may differ intra-specifically in the presence or absence of other spacer 
sequences, and thus may yield specific spoligotype profiles. Therefore, the 
spoligotyping method allows the simultaneous detection and typing of MTC strains 
[210]. However, despite spoligotyping is regarded as the technique of choice, in a first 
approach, for the genotyping of M. bovis isolates [63, 198], due to its good degree of 
reproducibility and discrimination, the discriminatory power is smaller than the MIRU-
VNTR technique [80]. 
 
MIRU-VNTR 
MIRU-VNTR analysis is based on the investigation of multiple loci in the genome of 
the organisms, which have a variable number of tandem repeats (VNTRs). In the 
genome of MTC members, these tandem repeats are referred as MIRUs (Mycobacterial 
Interspersed Repetitive Units) and are sequences with approximately 40 to 100 base 
pairs dispersed in certain intergenic regions [217-220]. The molecular typing by MIRU-
VNTR allows the detection of the existent polymorphisms between different strains, 
namely the hyper-variability on the number of MIRUs present in some of the loci 
analysed. This technique has the advantage that it can be automated, by PCR 
amplification, using primers labelled with fluorophores, making it possible to determine 
the number of tandem repeats for each locus under study, based on the size of the 
amplified products [221, 222]. 
The polymorphism of each locus is variable, and the number of loci studied depends on 
the MTC species and the purpose of the study (e.g. phylogenetic vs. epidemiologic). For 
the isolates of M. tuberculosis one standardization of the technique has been proposed 
by Supply et al. (2006). Therefore, this technique has been adopted for genotyping M. 
tuberculosis and M. bovis with encouraging results in terms of discrimination [223-
225]. 
Forty one MIRU loci were identified in the chromosome of M. tuberculosis H37Rv, of 
which 12 showed polymorphisms in the number of tandem repeats, being designated 
variable number tandem repeats (VNTR) loci [218]. The most appropriate set of loci for 
the typing of M. bovis is not consensual and different laboratories may use different 




selections. Also due to this reason, the spoligotyping remains the most widely used 
technique for the typing of M. bovis isolates. Nevertheless, the MIRU-VNTR analysis 
has proved useful for epidemiological studies, particularly when used in conjunction 
with other techniques, since it increases the power of discrimination between strains 
[226, 227]. 




1.4. Dissertation objectives and outline 
The rapid detection and identification of Mycobacterium tuberculosis complex species 
is critical for the effective control of tuberculosis, with epidemiological importance to 
track outbreaks of zoonotic tuberculosis. The isolation and identification of these 
mycobacteria requires laboratory procedures typically complex and time consuming, 
resulting from the extremely tedious growth of these organisms in artificial culture 
media. The introduction of molecular biology techniques for the diagnosis of bovine 
tuberculosis, mostly based on the amplification and analysis of nucleic acids, has 
contributed to a more rapid detection and identification of the respective etiologic agent. 
However, the use of these techniques directly in biological samples often reveals a low 
sensitivity, also possibly associated with the presence of a small number of infective 
mycobacteria. The main global objective of this work was to develop improved 
molecular methods for the detection and discrimination of Mycobacterium tuberculosis 
complex species, particularly the species most often associated to animal tuberculosis. 
Ultimately, these methods will be adapted to marketable diagnostic molecular assays. 
This work was carried out in close cooperation between Instituto Nacional de 
Investigação Agrária e Veterinária (INIAV, I.P.) and Unidade de Micobactérias do 
Instituto de Higiene e Medicina Tropical (IHMT/UNL), under the framework of the 
novel OMS/OIE concept of "One World, One Health".  
The following specific objectives were defined: 
• To develop and validate an assay based on nested real-time PCR for the 
detection of Mycobacterium bovis and other MTC species directly in animal 
tissue samples; 
• To implement a rapid diagnostic algorithm, based on TaqMan® chemistry, for 
the discrimination of the most veterinary-relevant Mycobacterium tuberculosis 
species; 
• To develop an alternative molecular assay based in isothermal DNA 
amplification and lateral flow-based colorimetrically assessment of results to 
detect MTC members, able to be ultimately used in point-of-need and low-
resource settings. 




This dissertation is divided into five chapters. In the first chapter, a general theoretical 
introduction framing the subject under study is presented, with emphasis to the topics 
regarding the major characteristics of the Mycobacterium tuberculosis complex 
members, and bovine tuberculosis disease and its laboratorial diagnosis. In the second 
chapter, we describe the development of a semi-nested probe-based real-time PCR 
assay allowing an enhanced detection of tuberculous mycobacteria in animal tissues. In 
the third chapter, we describe a rapid identification algorithm for Mycobacterium 
tuberculosis complex species using specific dual-labelled hydrolysis probes in a 
multiplex format. In the fourth chapter, we describe the development of a duplex Loop-
Mediated Isothermal DNA Amplification assay coupled with colorimetric lateral flow 
devices for the identification of Mycobacterium tuberculosis and M. bovis. Finally, in 
the fifth chapter, considerations are highlighted about the work presented and the main 
results that were achieved, and suggestions for future work. 
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2.1. Summary 
Bovine tuberculosis has been tackled for decades by costly eradication programs in 
most developed countries, involving the laboratorial testing of tissue samples from 
allegedly infected animals for detection of Mycobacterium tuberculosis complex (MTC) 
members, namely Mycobacterium bovis. Definitive diagnosis is usually achieved by 
bacteriological culture, which may take up to 6-12 weeks, during which the suspect 
animal carcass and herd are under sanitary arrest. In this work, a user-friendly DNA 
extraction protocol adapted for tissues was coupled with an IS6110-targeted semi-
nested duplex real-time PCR assay to enhance the direct detection of MTC bacteria in 
animal specimens, reducing the time to achieve a diagnosis and, thus, potentially 
limiting the sanitary arrest period. The duplex use of a novel β-actin gene targeted 
probe, with complementary targets in most mammals, allowed the assessment of 
amplification inhibitors in the tissue samples. The assay was evaluated with a group of 
128 fresh tissue specimens collected from bovines, wild boars, deer and foxes. 
Mycobacterium bovis was cultured from 57 of these samples. Overall, the full test 
performance corresponds to a diagnostic sensitivity and specificity of 98.2% (CIP95% 
89.4-99.9%) and 88.7% (CIP95% 78.5-94.7%), respectively. An observed kappa 
coefficient was estimated in 0.859 (CIP95% 0.771-0.948) for the overall agreement 
between the semi-nested PCR assay and the bacteriological culture. Considering only 
bovine samples (n = 69), the diagnostic sensitivity and specificity were estimated in 
100% (CIP95% 84.0-100%) and 97.7% (CIP95% 86.2-99.9%), respectively. Eight negative 
culture samples exhibiting TB-like lesions were detected by the semi-nested real-time 
PCR, thus emphasizing the increased potential of this molecular approach to detect 
MTC-infected animal tissues. This novel IS6110-targeted assay allows the fast detection 
of tuberculous mycobacteria in animal specimens with very high sensitivity and 
specificity, being amenable and cost effective for use in the routine veterinary 
diagnostic laboratory with further automation possibilities. 
 





Tuberculosis (TB) is a leading cause of morbidity and mortality in the world, also 
affecting a wide range of animal species, particularly livestock, in both developed and 
developing countries. The disease is caused by tuberculous mycobacteria belonging to 
the Mycobacterium tuberculosis complex (MTC). This complex consists of several 
closely-related pathogenic species, namely M. tuberculosis, the main agent of human 
TB, and, amongst others, M. bovis and M. caprae that are primary agents of bovine and 
caprine TB, respectively [1]. These species are genetically very similar but may differ in 
host preference and epidemiological characteristics [2]. Mycobacterium bovis and M. 
caprae also represent a high potential for zoonotic transmission to humans [3, 4, 5], 
with evidence of possible person-to-person transmission [6]. However, the main routes 
of transmission are the contact with infected animals and ingestion of unpasteurized 
dairy products. These zoonotic MTC species may be responsible for up to 7.2% and 
15% of human TB cases in industrialized and developing countries, respectively [7]. 
Rapid and reliable laboratory tests for the direct detection of tuberculous mycobacteria 
in biological samples are in high demand, in both human health and veterinary settings, 
and are crucial for an improved TB control.  
In most developed countries, bovine tuberculosis has been tackled during the last 
decades by costly eradication programs, involving the culling of reactor animals and 
laboratorial testing of suspect samples for the definitive confirmation of the presence of 
MTC. Presently, the detection of MTC bacteria in animal tissues is mainly based in 
lengthy and cumbersome conventional methods, involving the examination of Ziehl-
Neelsen stained smears, histopathology and culture in selective media, followed by 
biochemical or molecular identification of typical mycobacteria colonies. The 
microscopic identification of acid-fast mycobacteria is unspecific and highly 
insensitive, particularly in the presence of paucibacillary forms of TB. Culture remains 
the gold-standard method to confirm TB infection but requires several weeks to obtain 
positive results due to the extremely fastidious growth of tuberculous mycobacteria. In 
spite of the significant advances in the development of novel molecular diagnostic 
assays towards a faster and accurate detection of MTC in human samples, only a few 
assays were described for detecting these agents in animal tissues, particularly in fresh 
tissues from livestock [8-12]. Most of these molecular approaches are PCR-based and 




target specific polymorphisms, insertion sequences, and the so-called regions of 
difference in the genome of MTC members [9; 10; 13-18]. Nevertheless, most of the 
amplification-based assays described for detecting MTC nucleic acids directly in fresh 
or formalin-fixed paraffin-embedded tissues only yield a moderate sensitivity, usually 
up to 75%, particularly when testing tissues without the characteristic lesions or 
detectable acid-fast bacilli [8-10; 15; 19]. This limitation is mostly related to the 
inefficiency of mycobacterial DNA extraction procedures from affected animal tissues, 
especially those exhibiting strong fibrosis, calcification, and with no histological 
evidence of acid-fast bacteria [8; 19]. The use of immunomagnetic separation 
approaches to concentrate mycobacteria cells from animal tissues prior to DNA 
extraction may enhance PCR sensitivities [20; 21]. Nevertheless, these approaches 
usually involve more experimental steps and expensive equipment and consumables not 
readily available in veterinary diagnostic settings. 
In the present work we have developed a novel and simple Taqman-based semi-nested 
real-time PCR assay yielding extremely high sensitivity and specificity for the direct 
detection of tuberculous mycobacteria in fresh animal tissues, namely of bovine origin, 
capable of being introduced in the routine diagnostics of veterinary laboratories. 
 
2.3. Materials and Methods 
Bacterial strains 
Reference strains and clinical isolates of MTC, non-MTC mycobacteria and non-
mycobacterial species, maintained at the Portuguese reference laboratory for animal 
diseases (INIAV, IP), were used for optimization of PCR assays (Table 2.1). The 
identification of each isolate was based on standard methodologies [22]. MTC isolates 
were identified to the species level by PCR-restriction endonuclease analysis of the 








Table 2.1. Bacterial reference strains and clinical isolates whose cultures were used in 
the present study for the evaluation of specificity of the amplification assays and 
respective results. 




Mycobacterium tuberculosis ATCC 25177; LNIV 9605 + 
M. bovis AN5; ATCC 27291 (BCG); LNIV 
13027; 5530/0/05; 11265; 7230/4; 
14421/2; 24497/6; 8855; 5889; 
10044; 14577; 13280/6; 13280/4; 
34875; and 20564 
+ 
M. caprae LNIV 17320; 4958/0/05; 8403; 
15244; and 20752 
+ 
M. avium subsp. avium ATCC 25291 - 
M. avium subsp. hominissuis LNIV 23063/4 - 
M. avium subsp. 
paratuberculosis 
LNIV 39888 - 
M. scrofulaceum LNIV 31389 - 
Acinetobacter baumannii LNIV 1628/12 - 
Arcanobacterium pyogenes VLA 1321 - 
Bacillus licheniformis VLA 1831 - 
Corynebacterium striatum LNIV 12352 - 
Enterobacter amnigenus LNIV 6050/II - 
Klebsiella pneumonia VLA 1643 - 
Listeria monocytogenes VLA 1774 - 
Proteus mirabilis LNIV 2269/II - 
Pseudomonas aeruginosa VLA 67 - 
Salmonella Dublin VLA 1272 - 
Staphylococcus aureus VLA 1032 - 
Streptococcus agalactiae VLA 33 - 
Yersinia enterocolitica VLA 1884 - 
ATCC, American Type Culture Collection, USA; LNIV, Laboratório Nacional de 
Investigação Veterinária (currently INIAV, IP), Lisbon, Portugal; VLA, Veterinary 
Laboratory Agency, UK; 
1
Amplification (+) or no amplification (-) of IS6110 element 
using the real-time PCR assay with P_IS6110 TaqMan probe and respective flanking 
primers F_IS6110 and R_IS6110. 
 
Tissue samples 
One hundred and twenty eight animal lymph nodes, liver, spleen or lung tissue samples 
(69 bovines, 35 wild boars, 15 deer and 9 foxes) were used in this work (Table 2.2). No 
animals were sacrificed for the purposes of this specific study. None of the authors were 




responsible for the death of any animals and samples were originally collected for 
purposes other than research, namely: (i) bovine samples were collected from animals 
clinically suspected of having TB, e.g. by a positive reaction in either the single 
intradermal comparative tuberculin test or the gamma-interferon test, or TB-like lesions 
detected during routine abattoir inspection, and were submitted to routine control testing 
under the governmental Portuguese eradication scheme for bovine tuberculosis, 
approved in 1992 by the European Union (Council Decision 92/299/CE) and, since 
2001, cofinanced by the European Union (in the framework of Council Directive 
64/432, as amended) [27]; and (ii) TB suspect samples from wild boar, deer and fox, 
were sent to INIAV reference laboratories following gross pathological evaluation 
performed in the field by local veterinarians in hunting activities or predator control 
actions legally authorized by the "Instituto Nacional da Conservação da Natureza" (the 
Portuguese National Forest Authority), that emits permits for those hunting actions and 
for the respective hunters. Samples were submitted during the fourth trimester of 2011 
to the pathology and bacteriology laboratories of INIAV and analysed using routine 
histological and culture-based methods, according to the OIE standard procedures [22] 
(Table 2.2). Tissues selected for bacteriological analysis were homogenized using a 
pestle and mortar, followed by decontamination with 4% sodium hydroxide. After 
neutralization with hydrogen chloride, the macerated suspensions were divided into 
equal parts. One part was maintained at -80 ºC until further processing for molecular 
analysis and the other was centrifuged and the sediment inoculated into BACTEC 9000 
liquid media and Lowenstein-Jensen with pyruvate and Stonebrink solid media. 
Inoculated media were incubated for a minimum of eight weeks at 37 ºC. Heat-killed 
culture supernatants were kept at -20 ºC until further testing. Species identification of 
presumptive mycobacteria isolates was based on the restriction endonuclease analysis 
with RsaI and SacII of the PCR-amplified gyrB gene, or using the commercial reverse 
hybridization assays INNO-LiPA Mycobacteria (Innogenetics, Belgium) or GenoType 








Table 2.2. Typology of tissue samples used in this study (n = 128) and respective 






















 23 Bovine + M. bovis 23 
I 19 Wild boar + M. bovis 18 
 12 Deer + M. bovis 12 
II 3 Bovine - M. bovis 3 
 39 Bovine - - 0 
III 4 Wild boar - - 0 
 3 Deer - - 0 
IV 2 Bovine - Non-MTC 0 
 3 Wild boar - Non-MTC 0 
 1 Bovine + - 0 
V 5 Wild boar + - 3 
 6 Fox + - 0 
 1 Bovine + Non-MTC 1 
VI 4 Wild boar + Non-MTC 2 
 3 Fox + Non-MTC 2 
1
Presence of lesions compatible with tuberculosis; 
2
Detection of M. bovis or other non-
MTC mycobacteria by culture of tissue samples; 
3
Number of samples for which the 
IS6110 element was amplified by the nested real-time PCR assay. 
 
Spiked tissue samples 
A lymph node tissue from a slaughtered bovine known to be free of TB, as confirmed 
by culture and histopathology, was used for testing as a spiked sample that was 
homogenized as described above. Eight aliquots containing 0.9 ml of tissue macerate 
were spiked with 0.1 ml of ten-fold dilutions of a suspension of M. tuberculosis H37Ra 
(ATCC 25177) cells. Estimated concentrations of mycobacteria in spiked macerate 




 cells/ml. An additional tube was spiked with 0.1 ml 




PBS buffer and used as negative control. Spiked samples were stored at -20 ºC until 
processing for DNA extraction.  
 
DNA extraction from cultures 
DNA extraction from cultures grown in liquid media was achieved by a combined bead 
beating and enzymatic extraction method described elsewhere [28]. Briefly, 0.5 ml 
bacterial culture were washed in PBS buffer and heat inactivated at 100 ºC for 15 min. 
Tubes containing zirconium beads were used to resuspend the culture pellet in lysis 
buffer (SDS-EDTA-proteinase K) for mechanical disruption in the FastPrep 120 
(Savant Instruments, Inc., Holbrook, NY) at 6.5 ms-1 for 45 s, and then incubated 
overnight at 37 ºC, followed by standard phenol–chloroform purification and ethanol 
precipitation of DNA. DNA concentration and purity were estimated by measuring the 
absorbance at 260 nm (A260) and by A260 ⁄A280 and A260/A230 ratios, respectively, 
using a NanoDrop 1000 spectrophotometer (NanoDrop). Genomic DNA suspensions 
were stored at - 20 ºC until further use. 
  
DNA extraction from tissue macerates and spiked samples 
Four hundred and fifty microliters of tissue suspensions were transferred to screw-cap 
microcentrifuge tubes and inactivated in a water bath at 100 ºC for 5 minutes. Samples 
were centrifuged at 14000 rpm for 2 min, the supernatant rejected and 80 µl of PBS and 
an equivalent volume of 100 µl of zirconium beads were added to the tubes. After 
mechanical disruption in a FastPrep Bio 101 bead shaker (Savant Instruments Inc.) at 
6.5 msec
-1
 for 45 seconds, repeated three times, the suspensions were cooled on ice for 
15 minutes. DNA extraction was carried out using the tissue protocol of the QIAamp 
DNA Mini Kit (Qiagen) according to the manufacturer's instructions. The resulting 
genomic DNA suspensions were stored at - 20 ºC until further use. Stock DNA 








Design of TaqMan probes and flanking primers 
Sequences of IS6110 from MTC members and β-actin gene from a wide range of 
mammal species were retrieved from NCBI-GenBank. Comparative analysis of these 
two sets of sequences was achieved through sequence alignment using the CLUSTAL X 
v2.0 software [29]. Complementary regions for a β-actin gene-targeted mammals-
universal TaqMan probe and flanking degenerated primers were found after visual 
inspection of the respective alignments (Table 2.3; Figure 2.1). The amplification of β-
actin gene served as control to detect inhibition of the PCR reactions when using DNA 
extracted from tissues as template. The IS6110-targeted probe (P_IS6110) and 
respective flanking primers (F_IS6110 and R_IS6110) were retrieved from the study of 
Restrepo and colleagues [30] (Table 2.3; Figure 2.2). An additional IS6110-targeted 
forward primer (FN_IS6110) for use in a semi-nested PCR was designed (Table 2.3; 
Figure 2.2). Probes and primers specificities were tested in silico using the BLAST tools 
from NCBI-GenBank. All probes and primers targeting IS6110 and β-actin gene were 
synthesized by MWG Biotech (Germany). 
 
Table 2.3. Sequences of primers and probes used in this study. 
Primer/ 
Probe  
Sequence (5´-3´) Complementary target  
F_Actin GGC TCY ATY CTG GCC TC β-actin gene of mammals 
R_Actin GCA YTT GCG GTG SAC RAT G  
P_Actin
1
 Cy5.5-TAC TCC TGC TTG CTG 
ATC CAC ATC-BHQ2 
 
F_IS6110 GGG TCG CTT CCA CGA TG IS6110 element of MTC 
species 
FN_IS6110 CTC GTC CAG CGC CGC TTC GG  
R_IS6110 GGG TCC AGA TGG CTT GC  
P_IS6110 
2 





Probe labeled with Cy5.5 fluorophore and BHQ-2 quencher; 
2
Probe labeled with 
carboxyfluorescein (FAM) fluorophore and BHQ-1 quencher 





Figure 2.1. Complementary targets of the mammals β-actin gene targeted probe 
and flanking primers. Partial alignment of β-actin gene sequences of several mammal 
species showing the complementary targets of the P_Actin TaqMan probe and 
respective flanking degenerated primers (F_Actin and R_Actin) (gray boxes). The 
GenBank access numbers from which the partial sequences were retrieved are indicated 
for each species inside parenthesis. Mismatches in relation to consensus sequence are 




Figure 2.2. Complementary targets of the MTC-specific IS6110-targeted probe and 
flanking primers. Partial alignment of the IS6110 sequence of Mycobacterium 
tuberculosis complex members with other IS6110-like sequence recently found in M. 
smegmatis (GenBank access numbers are indicated inside parenthesis). The 
complementary targets of the P_IS6110 TaqMan probe and flanking primers 
(FN_IS6110, F_IS6110 and R_IS6110) are indicated (gray boxes). Mismatches in 
sequences are highlighted in red.  





The semi-nested real-time PCR amplification assay using DNA extracted from tissue 
samples as template consisted of two steps: (i) a first standard PCR using primers 
FN_IS6110 and R_IS6110; and (ii) a second duplex real-time PCR using the previous 
amplification product as template and a mixture of IS6110 and β-actin gene targeted 
TaqMan probes (P_IS6110 and P_Actin, respectively) and the corresponding flanking 
primers (F_IS6110/R_IS6110 and F_Actin/R_Actin, respectively) (Table 2.3). IS6110-
targeted amplification reactions were previously optimized using DNA extracted from 
pure cultures as template. The first standard PCR step amplifies an MTC-specific 199 
bp fragment of the IS6110 (Figure 2.2). PCR reactions were carried out in a final 
volume of 25 μl containing 400 μM of deoxynucleotide triphosphates (Promega), 1 U of 
Taq DNA polymerase (Promega), 3.5 mM of MgCl2 (Promega), 0.8 μM of each primer 
(FN_IS6110 and R_IS6110), DNase free water (GIBCO) and 5 μl of extracted DNA 
template. Amplification was performed in a C1000 thermocycler (Bio-Rad) using the 
following program: initial denaturation step at 95 °C for 10 min, 45 cycles of 30 sec at 
95 °C, 30 sec at 65 °C, 30 sec at 72 °C, and a final extension step of 10 min at 72 ºC. 
The amplified products were stored at 4 ℃ until electrophoresis analyses in a 2% 
agarose gel or directly used for the second duplex real-time PCR step. Real-time PCR 
reactions were carried out in a total volume of 20 µl containing 1× SSO Fast Super Mix 
(Bio-Rad), 0.4 μM of each primer, 0.15 μM of TaqMan probe, DNase free water 
(GIBCO) and 5 µl of the previous PCR products. The concentrations of primers and 
probes were maintained when used in the duplex format. The thermal cycling conditions 
were as follows: 1 cycle at 95 °C for 2 min, followed by 45 cycles at 95 °C for 5 s and 
60 °C for 10 s. All samples that probed positive for IS6110 were retested for 
confirmation. Thermal cycling, fluorescent data collection, and data analysis were 
performed in a CFX96 (Bio-Rad) detection system real-time PCR instrument, according 
to the manufacturer’s instructions. 
 
Analytical specificity and sensitivity 
To investigate whether the IS6110-targeted real-time PCR assay specifically amplifies 
DNA from MTC members, MTC and non-MTC mycobacterial isolates were tested, as 




well as other clinically relevant bacteria (Table 2.1). To estimate the detection threshold 
of the assay (analytical sensitivity), a standard curve was constructed using 10-fold 
serial dilutions of DNA extracted from M. tuberculosis H37Ra (ATCC 25177) as 
template. Each template was run in triplicate. The end-point corresponded to the 
dilution at which the assay could not detect the target in at least one of the replicates.  
 
Detection limit of the IS6110-targeted semi-nested real time PCR assay 
The detection limit of the semi-nested duplex real time PCR assay was assessed using 
the serially spiked tissue macerate samples. Each template was tested in triplicate. 
 
Diagnostic specificity and sensitivity 
The tissue samples were stratified in six typologies (Table 2.2): I - lesions compatible 
with tuberculosis are present and M. bovis was cultured from the samples (n = 54); II- 
lesions are not present but M. bovis was cultured from samples (n = 3); III- absence of 
any lesions and mycobacteria were not cultured from samples (n = 46); IV- absence of 
lesions but non-MTC mycobacteria were cultured from samples (n = 5); V- lesions 
compatible with tuberculosis are present but mycobacteria were not cultured (n = 12); 
and VI - lesions are present and non-MTC mycobacteria were cultured from samples (n 
= 8). The culture of M. bovis from tissue samples was used as gold-standard reference 
method for the computation of the diagnostic sensitivity and specificity of the semi-
nested real-time PCR assay. Overall diagnostic sensitivity, specificity and positive 
(PPV) and negative (NPV) predictive values were computed using all culture positive 
(types I + II; n = 57) and negative (types III, IV, V and VI; n = 71) tissue samples 
(Table 2.2). Additionally, these parameters were also computed using only the bovine 
culture positive (n = 26) and negative (n = 43) samples (Table 2.2). Although sample 
types V and VI were also culture negative for M. bovis, lesions compatible with the 
disease were found. For the computation of the kappa coefficient, for measuring the 
agreement between the gold-standard method of bacteriological culture and the IS6110-
targeted semi-nested PCR assay, all tissue samples were used (types I - VI, n = 128). 
Sensitivity, specificity, PPV, NPV and kappa coefficient, with confidence intervals, 








Design of probes and primers 
A novel set of β-actin gene-targeted TaqMan probe and respective flanking primers was 
designed (Table 2.3, Figure 2.1). In silico analysis using the BLAST suite of NCBI-
GenBank confirmed that the complementary regions of this probe, and primers, are 
widespread amongst most mammal species, including livestock animals. In silico 
analysis also confirmed that the complementary regions of the IS6110-targeted probes 
and primers were only present in IS6110 sequences of MTC members (Table 2.3, 
Figure 2.2).  
 
Analytical specificity and sensitivity 
The real-time PCR assay with the IS6110-targeted probe (P_IS6110) and flanking 
primers (F_IS6110 and R_IS6110) yielded amplification products only when using 
DNA extracted from MTC members as template (Table 2.1, Figure 2.3). No non-
specific results were obtained with members of the Mycobacterium avium complex or 
with strains belonging to other diverse bacterial species. The minimum detection 
threshold (analytical sensitivity) of this assay was estimated by the construction of a 
reference curve with serially-diluted suspensions of DNA from M. tuberculosis H37Ra. 
The analytical sensitivity was estimated in 0.3 fg/µL of M. tuberculosis genomic DNA. 
A linear relationship between the logarithm of the starting concentration of DNA and 
the amplification Ct values was obtained, with a -3.222 slope, a Ct = 35 interception in 
the minimum threshold (0.3 fg/µL) and an R
2










Figure 2.3. IS6110-targeted real-time PCR amplification curves obtained in 
specificity tests. Illustration of the MTC-specific amplification curves obtained in FAM 
channel during evaluation of the analytical specificity of the IS6110-targeted real-time 
PCR step. All MTC cultures yielded amplification curves: M. tuberculosis ATCC 25177 
(blue line), M. bovis LNIV 13027 (green line), M. bovis ATCC 27291 (orange line) and 
M. caprae LNIV 17320 (red line). Other bacteria yielded negative results of 
amplification: M. avium subsp. avium ATCC 25291 (yellow line) and M. avium subsp. 
paratuberculosis LNIV 39888 (brown line). No amplification was detected in non-
template negative control (black line). RFU - Relative Fluorescence Units. 
 
Spiked samples 
Tissue samples spiked with serially-diluted suspensions of M. tuberculosis cells were 
used for assessing the detection limit of the β-actin and IS6110-targeted semi-nested 
duplex real-time PCR assay. The detection threshold was estimated to be one 
mycobacteria per ml of tissue macerate (Figure 2.4). The IS6110 amplification curves 
usually harboured a very low Ct (< 3), meaning that the first standard PCR step yielded 
abundant amplification products easily detected by the following real time PCR step. 
The co-amplification of the bovine β-actin gene showed that no apparent inhibition of 
the real-time PCR step occurred due to the presence of inhibitor components of tissues 
or excess of bovine DNA, a significant result for the type of specimens used (animal 
tissues), confirming the efficiency of the extraction and purification procedures used in 
this work (Figure 2.4). 





Figure 2.4. Testing of spiked samples with the semi-nested duplex real-time PCR 
assay.  The analytical sensitivity of the assay was estimated through the use of solutions 
of DNA extracted from tissue samples spiked with serially diluted cellular suspensions 




 cells/ml of tissue 
homogenate). The figure illustrates the IS6110 (solid lines) and mammal β-actin gene 
(dashed lines) targeted amplification curves obtained in FAM and Cy5.5 channels, 
respectively, for the several dilutions: 10
7
 (yellow line), 10
5





 (green line) and 10
0
 (blue line) cells. Positive control: M. tuberculosis ATCC 
25177 culture (red line); Negative controls: unspiked tissue homogenate (orange line) 
and non-template control (grey line). RFU - Relative Fluorescence Units. 
 
Diagnostic specificity and sensitivity 
The results of the semi-nested duplex real-time PCR assays using DNA extracted from 
tissue samples are summarized in Table 2.2. All but one tissue sample from which M. 
bovis was cultured (types I and II) yielded positive amplification results, corresponding 
to a diagnostic sensitivity of 98.2% (CIP95% 89.4-99.9%). Eight DNA-positive tissues 
were obtained among the 71 M. bovis culture negative samples (types III, IV, V and 
VI), yielding a diagnostic specificity of 88.7% (CIP95% 78.5-94.7%). Negative controls 
run with batches of samples did not identify any cross-contaminating DNA. The 
positive and negative predictive values were estimated in 87.5% (CIP95% 76.3-94.1%) 
and 98.4% (CIP95% 90.1-99.9%), respectively, for a prevalence of 44.5% M. bovis 
culture positive samples among all samples analysed. Considering only the bovine 
samples, the diagnostic sensitivity and specificity of the amplification assay were 




estimated in 100% (CIP95% 84.0-100%) and 97.7% (CIP95% 86.2-99.9%), respectively, 
while PPV and NPV were estimated in 96.3% (CIP95% 79.1-99.8%) and 100% (CIP95% 
89.6-100%), respectively, for a prevalence of 37.7% M. bovis culture positive samples. 
No DNA-positive samples were obtained from samples without TB-compatible lesions 
and M. bovis isolation (types III and IV) (Table 2). However, eight DNA-positive 
samples were detected among tissues that were M. bovis culture-negative but that 
harboured TB-compatible lesions (sample types V and VI) (Table 2.2).  
An observed kappa coefficient was estimated in 0.859 (CIP95% 0.771-0.948) for the 
overall agreement between the results obtained by the direct application of the IS6110-
targeted semi-nested PCR assay to fresh tissue samples and the results obtained from 
the gold-standard bacteriological culture. The direct detection procedure allowed the 
detection of MTC infected samples in less than 6 hours while the conventional culture 
takes about 6 to 12 weeks. 
 
2.5. Discussion 
The availability of TB confirmatory tests allowing a fast and conclusive detection of 
tuberculous mycobacteria in suspect animal tissues would be a great advantage in 
improving the efficiency of TB eradication programs and in decreasing the associated 
economic burden. Improvements in specificity, sensitivity and detection limit of 
diagnostic assays are usually introduced by molecular approaches. Nevertheless, only 
few diagnostic PCR-based assays were described for detecting MTC members directly 
in animal specimens, usually yielding limited sensitivities when compared to the 
reference bacteriological culture [8-12; 15; 19]. These moderate sensitivities may well 
be linked to the increased complexity for disrupting and recovering genomic DNA from 
the tough mycobacterial cells and to the paucibacillary nature of many animal tissue 
lesions used for nucleic acids extraction [10]. The presence of amplification inhibitors 
in crude tissue extracts, namely of large amounts of co-extracted eukaryotic DNA, may 
represent an additional problem. An option that has been explored to enhance the 
sensitivity of PCR techniques involves the implementation of more effective DNA 
extraction and purification methods, for example by using sequence capture or 
immunomagnetic separation approaches [8; 9; 12; 21]. Nevertheless, these approaches 




usually involve more experimental steps and eventually expensive and not readily 
available equipment and consumables.  
In this work, an alternative approach was evaluated for enhancing MTC detection 
sensitivities directly from fresh animal tissues. An adapted and optimized user-friendly 
DNA extraction protocol, mainly based in the use of simple commercially obtainable 
extraction kits, was coupled with an IS6110-targeted semi-nested real-time PCR assay 
that allows the direct detection of MTC members in animal tissue specimens with very 
high sensitivity, specificity and positive and negative predictive values, namely in 
bovine specimens. These two last parameters are dependent on the prevalence of the 
tested condition in the population under study, as well as on the sensitivity and 
specificity of the testing assays. The prevalence of MTC (mostly M. bovis) infected 
samples among all TB-suspect samples submitted to the reference laboratory during the 
2002-2010 period (n = 6364) was approximately 40% (reviewed by Cunha and 
colleagues [27]), which compares well with the prevalence values found in this work 
and used for the computation of PPV and NPV. Therefore, the PPV and NPV 
parameters computed may be considered good indicators of the performance of our 
IS6110-targeted assay, when the same is to be used for assessing the presence of MTC 
in specimens collected from animals clinically suspected of having tuberculosis, namely 
cattle, submitted for confirmatory culture analysis in a major reference laboratory. 
Eight DNA-positive amplification results were obtained from tissue samples from 
which M. bovis could not be cultured (Table 2.2). However, lesions compatible with TB 
were observed in these tissues during histological analysis (sample types V and VI) 
(Table 2.2). The culture of tissue samples for the isolation of M. bovis and of other 
MTC members, followed by molecular or biochemical identification procedures, is 
usually the gold-standard method to validate alternative diagnostic assays. However, it 
is known that bacteriological culture is slow and laborious and can yield ambiguous or 
false-negative results, e.g. due to the presence of non-viable mycobacteria, raising 
concerns about its effectiveness as comparison reference method [19; 31]. The results of 
culture assays may be affected by several factors, such as the harsh processing and 
decontamination procedures of samples, which can also have a harmful effect on M. 
bovis viability, as well as the growth media and incubation conditions used and the 
constrained distribution of mycobacteria in tissues [32]. Therefore, although TB-like 




lesions identified by histopathology can be induced by other bacteria or mycobacteria, 
the positive amplification results suggest that MTC members were most probably 
associated with the observed lesions and that the PCR test is more sensitive than 
bacteriological culture for detecting these pathogens in animal tissues. Non-MTC 
mycobacteria such as M. avium and M. scrofulaceum were cultured from five of those 
eight DNA-positive tissue samples (Table 2.2). Eventually, any M. bovis isolates 
present in the sample may have been overgrown by these non-MTC mycobacteria [19]. 
Regardless of some discrepancies, the kappa measure of agreement between 
bacteriological culture and the semi-nested PCR was estimated in 0.859. Although the 
criteria for judging kappa statistic are not completely objective nor universally accepted, 
this value may allow to infer an "almost perfect" agreement between both MTC-
detection methods [33]. 
The enhancement of the MTC detection rates using the semi-nested amplification assay 
need to be balanced against the associated increased risk of cross contamination of 
samples. However, the occurrence of false-positive results was not an issue in this work, 
while working in a veterinary diagnosis laboratory harboring standard conditions for 
molecular analysis, which include working in separate clean rooms and the use of 
positive and negative controls. 
In a preliminary survey the testing of TB positive and negative tissue samples employed 
a standard real-time PCR assay (corresponding to the second step of the semi-nested 
approach). The comparison of this assay with the reference of bacteriological culture 
showed a diagnostic sensitivity of only 40% (data not shown). The inclusion of the first 
step of conventional IS6110-targeted PCR amplification, in a semi-nested design, 
allowed to increase the sensitivity of the assay to near 100%. Previous studies found no 
significant improvements in the detection of MTC members in animal tissue samples 
using nested PCR assays, including with real-time PCR formats [10; 14; 15]. 
Nevertheless, the performance of PCR detection systems is highly dependent on the 
efficiency of the primers and probes, even when using the same genomic targets such as 
the IS6110 element [34]. The MTC-specific IS6110-targeted primers and probe used in 
this work showed to be highly efficient for detecting tuberculous mycobacteria in 
animal tissue samples, although the isolates of the most relevant species, M. bovis, 
usually contain only one copy of this insertion sequence. It has recently been found that 




IS6110-like elements may be present in other non-MTC mycobacteria such as M. 
smegmatis [35]. However, the probe and respective flanking primers used show no 
relevant complementary regions with these IS6110-like nucleotide sequences (Figure 
2.2). 
The protocol for direct detection of MTC from fresh animal tissues, using an optimized 
DNA extraction and purification procedure coupled with a semi-nested real-time PCR 
assay described in this work, revealed to be highly accurate and much faster than 
bacteriological culture, reducing the time for confirmatory TB diagnosis from several 
weeks to few hours, thus also potentially decreasing the sanitary arrest period of the 
suspect animal carcass and herd. The assay is amenable to future automation 
possibilities regarding both the DNA extraction and amplification steps. It may also 
allow the detection of MTC members when these pathogens become nonviable and non-
cultivable or are overgrown by other less fastidious bacteria or mycobacteria also 
present in tissue samples. The use of a novel β-actin gene targeted probe, and respective 
flanking primers, with complementary targets in most mammal species, allowed to 
assess the presence of amplification inhibitors in the DNA extracts. Although the test is 
not able to distinguish between different members of the MTC, particularly M. bovis, 
the identification of any tuberculous mycobacteria infection in domestic or wildlife 
animals would warrant a public health awareness. 
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Rapid identification of veterinary-relevant Mycobacterium tuberculosis complex 




Members of the Mycobacterium tuberculosis complex (MTC) are causative agents of 
tuberculosis (TB) in both humans and animals. MTC species are genetically very 
similar but may differ in their epidemiology, namely geographic distribution and host 
preferences, virulence traits and antimicrobial susceptibility patterns. However, the 
conventional laboratory diagnosis does not routinely differentiate between the species 
of the MTC. In this work we describe a rapid and robust two-step five-target probe-
based real-time PCR identification algorithm, based on genomic deletion analysis, to 
identify the MTC species most commonly associated with TB in livestock and other 
animals. The first step allows the confirmation of the cultures as MTC members, by 
targeting their IS6110 element, or as a mycobacterial species, if only a 16S rDNA 
product is detected in the duplex amplification reaction. If a MTC member is identified, 
the second amplification step allows to assess the presence or absence of the RD1, RD4 
and RD9 genomic regions. The correspondent pattern allows to infer the species of the 
isolate as M. tuberculosis (if all RDs are present), M. caprae (if only RD1 and RD4 are 
present) and M. bovis (if only RD1 is present). The identification algorithm developed 
presented an almost perfect agreement with the results of the routine bacteriological 
analysis, with a kappa coefficient of 0.970 (CIP95% 0.929-1.000). The assay is able to be 
adaptable to automation and implementation in the routine diagnostics framework of 
veterinary diagnostics laboratories, with a particular focus for reference laboratories. 
 
3.2. Introduction 
Members of the Mycobacterium tuberculosis complex (MTC) are causative agents of 
tuberculosis (TB) in both humans and animals. This complex encompasses several 
closely-related pathogenic species, notably M. tuberculosis and M. africanum, main 
agents of human TB, M. bovis, primarily linked to bovine TB but also often isolated 
from a wide range of other domestic and wild animals, and M. caprae, mostly 




associated to caprine TB [1-3]. Other less frequently found MTC species associated to 
TB disease in animals are M. pinnipedii, M. microti, M. mungi and M. orygis [4-10]. 
MTC species, particularly M. bovis and M. caprae, represents a high potential for 
zoonotic transmission to humans [3, 11, 12], with evidence for the possibility of person-
to-person transmission [13, 14]. However, the main routes of transmission are the 
contact with infected animals and ingestion of unpasteurized dairy products [15]. 
MTC species are genetically very similar but may differ in their epidemiology, namely 
geographic distribution and host preferences, virulence traits and antimicrobial 
susceptibility patterns. The discrimination between these species is therefore important 
for the accurate diagnosis and epidemiological assessment of mycobacterial disease in 
both humans and animals, public health surveillance and, if required, appropriate 
therapy management. Bacteriological culture, followed by biochemical and/or 
molecular identification, remains the gold-standard method to confirm MTC infection, a 
time consuming process due to the extremely fastidious growth of these mycobacteria, 
that usually do not differentiate species inside the MTC. In Portugal the National 
Eradication Program for bovine tuberculosis is based on systematic tuberculin testing of 
cattle, slaughter of positive animals, post-mortem inspection and histopathological and 
bacteriological diagnosis at the National Reference Laboratory (INIAV IP) [16-19]. 
Other domestic and wild animals such as deer and wild boar have been also frequently 
tested for TB in this reference laboratory [18, 19, 20]. However, the conventional 
laboratory diagnosis does not routinely differentiate between the species of the MTC. In 
most circumstances the culture-based phenotypic and biochemical assays able to 
discriminate between at least some of the MTC species are slow, cumbersome and time 
consuming, partially due to the fastidious growth of these mycobacteria, may yield 
ambiguous results and may be limited by a degree of technical complexity that rule out 
its routine implementation in most veterinary laboratories [21]. These assays may 
include the assessment of oxygen requirements, niacin accumulation, nitrate reductase 
activity, resistance to pyrazinamide, and use of glycerol and pyruvate by the MTC 
strains [22, 23].  
MTC members harbour identical 16S rDNA sequences, which is the most commonly 
used genomic target in bacteriology for species identification [24]. Nevertheless, in the 
last two decades, the accumulating knowledge of the nucleotide sequences of several 




genes, and of the whole genomes, of MTC members have allowed the development of 
novel molecular assays able to discriminate between these species. Approaches such as 
the analysis of single nucleotide polymorphisms (SNPs) of the gyrB gene, and of other 
genes, or the assessment of the structure of variable repetitive regions (e.g. direct 
repeats) or of large sequence polymorphisms (LSPs) in the genome of MTC members 
have been described that effectively discriminate between these species [21, 25-30], if 
properly framed in an adequate laboratory diagnosis algorithm. Most of these molecular 
approaches are developed 'in house', are PCR-based and involve post-amplification 
processing, such as gel electrophoresis analysis, multistep reverse hybridizations or 
DNA sequencing. As far as we know, there is only one commercially available, reverse-
hybridization based, molecular test for the differentiation of MTC members (the 
Genotype MTBC assay, Hain Lifesciences GmbH, Germany).  
Comparative genomic analysis evidenced that modern MTC species probably evolved 
from a common ancestor through the accumulation of sequential and irreversible 
genomic deletions, named Regions of Difference (RDs), which has been important in 
generating genetic diversity within these closely related mycobacteria [1, 2, 31-34]. The 
pattern of the presence or absence of these RDs in the genome of MTC members 
provides a molecular signature that can clearly discriminate among these mycobacteria 
[1, 2, 8, 10]. Several RDs-targeted amplification-based assays have been previously 
proposed for MTC species discrimination, usually involving standard PCR reactions 
and analysis of products by gel electrophoresis [15, 35, 36], real-time PCR using 
intercalating fluorescent dyes and melting curve analysis [28, 37] and, to a lesser extent, 
dual labelled hydrolysis probes [30, 38, 39]. All these assays were predominantly 
developed for use in human TB laboratorial settings. 
In this work we report the design, development and testing of a rapid and robust 
TaqMan
®
-based real-time PCR identification algorithm, based on genomic deletion 
analysis, to distinguish between the members of the MTC most commonly associated 
with TB in livestock and other animals, able to be used in the routine diagnostics 








3.3. Materials and Methods 
Bacterial strains 
Reference strains and clinical isolates of MTC, non-MTC mycobacteria and non-
mycobacterial species, maintained at the Portuguese reference laboratory for animal 
diseases (Instituto Nacional de Investigação Agrária e Veterinária, INIAV, IP) (animal 
isolates) and at the Instituto de Higiene e Medicina Tropical (IHMT/UNL) (human 
isolates), were used for optimization of PCR assays (Table 3.1). MTC isolates were 
previously identified to the species level by PCR-restriction endonuclease analysis of 
the gyrB gene [16, 17, 20] (at INIAV, I.P.) or by using the Genotype MTBC assay 
(Hain Lifesciences GmbH, Germany) (at IHMT/UNL). 
 
Table 3.1. Reference and clinical strains used in the present study and respective results 
for the duplex (16S rDNA and IS6110) and triplex (Rv3875-RD1, Rv1510-RD4 and 
Rv2073c-RD9) genomic targets amplification. 
Species Strains 16S 
rDNA 
IS6110 RD1 RD4 RD9 
M. tuberculosis ATCC 25177; LNIV 
9605; IHMT 1; 2; 3; 4; 5; 
6; 7; 8; 9; 10; 11; 12; 13; 
14; and 15 
+ + + + + 
M. africanum IHMT 39; 46; 47; and 49 + + + + - 
M. caprae LNIV 17320; 4958/0/05; 
8403; 15244; and 20752 
+ + + + - 
M. bovis AN5; LNIV 13027; 
5530/0/05; 11265; 
7230/4; 14421/2; 
24497/6; 8855; 5889; 
10044; 14577; 13280/6; 
13280/4; 34875; and 
20564 
+ + + - - 
M. bovis BCG ATCC 27291 (BCG); 
IHMT 36; 37; 48 and 50 
+ + - - - 
M. avium subsp. 
avium 








Table 3.1. (cont.) 
Species Strains 16S 
rDNA 
IS6110 RD1 RD4 RD9 
       
M. avium subsp. 
hominissuis 
LNIV 23063/4; IHMT 
31/06; 229/06; 193/08; 
189/05; 8/05; 291/05; 
386/08; 92/06; 78/06; 
327/07; 73/11; 436/05; 
and 68/06 
+ - - - - 
M. avium subsp. 
paratuberculosis 
LNIV 39888 + - - - - 
M. scrofulaceum LNIV 31389 + - - - - 
Acinetobacter 
baumannii 
LNIV 1628/12 - - - - - 
Arcanobacterium 
pyogenes 
VLA 1321 - - - - - 
Bacillus 
licheniformis 
VLA 1831 - - - - - 
Corynebacterium 
striatum 
LNIV 12352 - - - - - 
Enterobacter 
amnigenus 
LNIV 6050/II - - - - - 
Klebsiella 
pneumonia 
VLA 1643 - - - - - 
Listeria 
monocytogenes 
VLA 1774 - - - - - 
Proteus mirabilis LNIV 2269/II - - - - - 
Pseudomonas 
aeruginosa 
VLA 67 - - - - - 
Salmonella Dublin VLA 1272 - - - - - 
Staphylococcus 
aureus 
VLA 1032 - - - - - 
Streptococcus 
agalactiae 
VLA 33 - - - - - 
Yersinia 
enterocolitica 
VLA 1884 - - - - - 
ATCC, American Type Culture Collection, USA; LNIV, Laboratório Nacional de 
Investigação Veterinária (currently INIAV, IP), Lisbon, Portugal; IHMT, Instituto de 
Higiene e Medicina Tropical, Lisbon, Portugal; VLA, Veterinary Laboratory Agency, 
UK; Amplification (+) or no amplification (-). 
 
 




Genomic DNA extraction from purified reference and clinical bacterial strains  
DNA extraction from cultures grown in liquid media was achieved by a combined bead 
beating and enzymatic extraction method described elsewhere [40]. Briefly, 0.5 ml 
bacterial culture were washed in PBS buffer and heat inactivated at 100 ºC for 15 min. 
Tubes containing zirconium beads were used to resuspend the culture pellet in lysis 
buffer (0.4 M NaCl, 40 mM Tris-HCl, pH 8, 2 mM EDTA, 0.6% SDS, 0.034 mg/ml 
proteinase K) for mechanical disruption in the FastPrep FP120 Bio101 (Savant 
Instruments, Inc., Holbrook, NY) at 6.5 ms
-1
 for 45 s, and then incubated overnight at 
37 ºC, followed by standard phenol–chloroform purification and ethanol precipitation of 
DNA. DNA concentration and purity were estimated by measuring the absorbance at 
260 nm (A260) and by A260⁄A280 and A260/A230 ratios, respectively, using a 
NanoDrop 1000 spectrophotometer (NanoDrop). Genomic DNA suspensions were 
stored at - 20 ºC until further use. 
 
Design of TaqMan probes and respective flanking primers 
Sequences of the 16S rDNA gene and of the Regions of Difference 1 (RD1, including 
the Rv3875-esat6 locus), 4 (RD4, including the Rv1510 locus) and 9 (RD9, including 
the Rv2073c locus) from MTC members were retrieved from NCBI-GenBank. 
Comparative analysis of these four sets of sequences was achieved through sequence 
alignment using the CLUSTAL X v2.0 software [41]. Probes and primers were 
designed and specificities were assessed in silico using the BLAST tools from NCBI-
GenBank. All probes and primers were synthesized by MWG Biotech (Germany). 
Mycobacterial 16S rDNA-targeted primers were obtained from the study of Richardson 
and colleagues [42] (forward primer) and Kirschner and colleagues [43] (reverse 
primer), and an additional TaqMan probe complementary to the amplified product was 
designed (Table 3.2). Additionally, an IS6110-targeted probe and respective flanking 
primers were retrieved from the study of Restrepo and colleagues [44] (Table 2).  
Complementary regions for Rv3875-esat6 (RD1), Rv1510 (RD4) and Rv2073c (RD9) 
loci targeted TaqMan probes and respective flanking primers were found after analysis 
of the respective nucleotide sequences (Table 2).  
 




Table 3.2. Sequences of primers and probes used in this study. 






F_16SrDNA CCG CAA GGC TAA AAC 
TCA AA 
149 Mycobacterial 16S 
rDNA 





 TET-TCG ATG CAA CGC 
GAA GAA CCT TAC-
BHQ1 
  
F_IS6110 GGG TCG CTT CCA CGA 
TG 
63 IS6110 element of 
MTC 





FAM-CGC GTC GAG GAC CAT GGA 
GGT-BHQ1 
  
F-esat6 AGG CGT ACC AGG GTG 
TC 
110 RD1 (Rv3875 locus, 
esat6 gene) 





 Cy5.5-ACA ACG CGC TGC 
AGA ACC TGG-BHQ2 
  
F-Rv1510 CCT GCA AGA AAC GAC 
CCG 
105 RD4 (Rv1510 locus) 





 TET-CCA TCG TAC CCA 
TCC GCT GCG-BHQ1 
  
F-Rv2073c AGT CGG TGT GCA CGA 
TGG 
117 RD9 (Rv2073c locus) 





 Texas Red-CTG GTC GCC 




As retrieved from the whole genome sequence of M. tuberculosis strain H37Rv 
(GenBank Accession Number AL123456); 
2
Probe labeled with TET 
(tetrachlorofluorescein) fluorophore and BHQ1 quencher; 
3
Probe labeled with FAM 
(carboxyfluorescein) fluorophore and BHQ1 quencher; 
4
Probe labeled with Cy5.5 
fluorophore and BHQ2 quencher; 
5
Probe labeled with TET fluorophore and BHQ1 
quencher; 
6
Probe labeled with Texas red fluorophore and BHQ2 quencher. 
 




The complementary regions of the P-esat6, F-esat6 and R-esat6 probe and flanking 
primers, respectively, are located in the 6 kDa early secretory antigenic target gene 
(esat6, Rv3875 locus) (as in the sequence with GenBank accession number AL123456, 
region 4352609 - 4352896, of the whole genome of M. tuberculosis strain H37Rv), 
included in the RD1 genomic region, which is present in most MTC members with the 




Figure 3.1. MTC testing algorithm. Schematics of the two-step five-target TaqMan
®
-
based real-time PCR identification algorithm, based on genomic deletion analysis, to 
identify the MTC species most commonly associated with TB in livestock and other 
animals. The target locus of each RD is as follows: Rv3875-esat6 for RD1, Rv1510 
locus for RD4 and Rv2073c locus for RD9. Due to specific deletions spanning at least 
part of the region RD1, including the Rv3875-esat6 locus, the profile expected in the 
second triplex reaction for potential isolates of M. microti and M. mungi would be: RD1 
(-), RD4 (+) and RD9 (-). 
 
 
Other MTC members also present specific RD1 deletions, namely M. mungi (RD1
mun
) 
[9] and M. microti (RD1
mic
, spanning Rv3864 to Rv3876 locus) [45]. Nevertheless, 
esat6-like genes are known to be also present in other non-MTC mycobacteria (Figure 
3.2).  
 




M. tuberculosis (FJ014499) GGAGGCGTACCAGGGTGTCCAGC...CTGAACAACGCGCTGCAGAACCTGGCGCG...AGCCGGTCAGGCAATGGCTTCGACC
M. kansasii (EU888292)     GGAGGCCTACCAGGGTGTCCAGC...CTGAACAACGCGCTGCAGAACCTCTCGCG...AGCCGGTCAGGCCATGGCCTCGACC
M. kansasii (EU888296)     GGAGGCCTACCAGGGTGTCCAGC...CTGAACAACGCGCTGCAGAACCTCTCGCG...AGCCGGTCAGGCCATGGCCTCGACC
M. kansasii (EU888293)     GGAGGCCTACCAGGGTGTCCAGC...CTGAACAACGCGCTGCAGAACCTCTCGCG...AGCCGGTCAGGCCATGGCCTCGACC
M. kansasii (EU888294)     GGAGGCCTACCAGGGCGTCCAGC...CTGAACAACGCGCTGCAGAACCTCTCGCG...GGCCGGTCAGGCCATGGCCTCGACC
M. kansasii (EU888295)     GGAGGCCTACCAGGGCGTCCAGC...CTGAACAGCGCGCTGCAGAACCTCTCGCG...GGCCGGTCAGGCCATGGCCTCGACC
M. kansasii (EU888297)     GGAGGCCTACCAGGGTGTCCAGC...CTGAACAGCGCGCTGCAGAACCTCTCGCG...AGCCGGTCAGGCCATGGCCTCGACC
M. marinum (EU826487)      GGAGGCCTACCAGGGTGTGCAGC...CTCAACAACGCGCTGCAGAACCTGGCTCG...GGCCGGTCAGGCAATGTCCTCCACC
M. riyadhense (EU552926)   GGAGGCCTACCAGGGCGTTCAGC...CTGAACAACGCGCTGCAGAACCTGGCTCG...GGCCGGCCAGGCGATGCAGTCGACC










110 bp  
Figure 3.2. Complementary targets of the Rv3875-esat6 (RD1) targeted probe and 
flanking primers. Partial alignment of the esat6 gene sequence of Mycobacterium 
tuberculosis members with other esat6-like sequences found in non-MTC species 
(GenBank accession numbers are indicated inside parenthesis). The complementary 
targets of the P-esat6 TaqMan probe and flanking primers (F-esat6 and R-esat6) are 
indicated (gray boxes). Mismatches in sequences are highlighted in bold and underlined.  
 
 
The complementary regions of the P-Rv1510, F-Rv1510 and R-Rv1510 probe and 
flanking primers, respectively, are located in the Rv1510 locus coding a conserved 
probable membrane protein (as in the sequence with GenBank accession number 
AL123456, region 1701295 - 1702593), included in the RD4 genomic region, which is 
present in all MTC members with the exception of M. bovis (Figure 3.1).  
The complementary regions of the P-Rv2073c, F-Rv2073c and R-Rv2073c probe and 
flanking primers, respectively, are located in the Rv2073c locus coding a probable short 
chain dehydrogenase (as in the sequence with GenBank accession number AL123456, 
region 2330214 - 2330963), included in the RD9 genomic region, which is present in M. 
tuberculosis but absent from M. bovis and other MTC species (Figure 3.1). 
Nevertheless, by performing a BLAST analysis at the GenBank website with the MTC 
Rv2073c locus sequence, we found putative Rv2073c-like sequences in the publicly 
available whole genome sequences of other non-MTC mycobacteria (Figure 3.3): M. 
kansasii (GenBank Accession Number CP006835, region 416183 - 416932); M. avium 
subsp. paratuberculosis (AE016958, region 1995996 - 1996559); M. intracellulare 
(CP003322, region 2533633 - 2534382); M. indicus pranii (CP002275, region 2474147 
- 2474896); M. liflandii (CP003899, region 2955979 - 2956704); M. avium subsp. 
hominissuis (508732639, region 2953585 - 2954334); and M. marinum (CP000854, 
region 3698256 - 3699005). 
 




M. tuberculosis (AL123456)     CGTAGTCGGTGTGCACGATGGCCAC...GGGCCTGGTCGCCGAGTATCCCGAAGGCCA...GGCCGTGCTCGGCAACGAGCGAAG
M. liflandii (CP003899)        CGTAGTCGGTGTGCACAATGGCGAT...GGGCCTGGTCGCCCAGGATCCCGAAAGCCA...GCCCGTGATCGGCGACGATCGAGG
M. marinum (CP000854)          CATAATCGGTGTGCACAATGGCGAT...GCGCCTGATCACCCAGAATCCCGAAAGCCA...GCCCGTGATCGGCGACGATCGAGG
M. kansasii (CP006835)         CGTAATCGGTGTGCACAATGGCGAC...GGGCCTGCTCCCCCAGGATGCCGAAGGCCA...GTCCGTGCTCGCCGGTGATCGCGG
M. intracellulare (CP003322)   CGTAATCGGTGTGCACGACGGCGAC...GAGCCTGGTCGCCCAGGATTCCGAAGGCCA...GCCCGTGGTCGGCGACGACCGAGG
M. indicus pranii (CP002275)   CGTAATCGGTGTGCACGACGGCGAC...GAGCCTGGTCGCCCAGGATTCCGAAGGCCA...GCCCGTGGTCGGCGACGACCGAGG
M. paratuberculosis (AE016958) CGTAATCGGTGTGCACGATGGCGAC...GGGCCTGATCACCCAGGATTCCGAAGGCCA...GTCCGTGGTCGGCGACGACCGAGG










117 bp  
Figure 3.3. Complementary targets of the Rv2073c (RD9) targeted probe and 
flanking primers. Partial alignment of the Rv2073c locus sequence, located in the RD9 
genomic region of Mycobacterium tuberculosis, with other potential Rv2073c-like 
sequences found in other non-MTC species for which whole genome sequences are 
publicly available (GenBank accession numbers are indicated inside parenthesis). The 
complementary targets of the P-Rv2073c TaqMan probe and flanking primers (F-
Rv2073c and R-Rv2073c) are indicated (gray boxes). Mismatches in sequences are 
highlighted in bold and underlined. 
 
Two-step multiplex real-time PCR algorithm 
The amplification-based identification algorithm using DNA extracted from MTC 
cultures as template consists in two steps: (i) a first duplex real-time PCR targeting the 
mycobacterial 16S rDNA and the MTC-specific IS6110; and (ii) a second triplex real-
time PCR targeting the Rv3875-esat6 (RD1), Rv1510 (RD4) and Rv2073c (RD9) 
genomic regions of MTC (Figure 3.1). All the amplification reactions were previously 
optimized using DNA extracted from reference strains as template. Duplex real-time 
PCR reactions were carried out in a total volume of 20 µl containing 1× SSO Fast Super 
Mix (Bio-Rad), 0.4 μM of each primer (F_16SrDNA, R_16SrDNA, F_IS6110 and 
R_IS6110), 0.15 μM of each TaqMan probe (P_16SrDNA and P_IS6110), DNase free 
water (GIBCO) and 5 µl of the extracted DNA template. The triplex real-time PCR 
reactions used 0.25 μM of F-esat6, R-esat6, F-Rv1510 and R-Rv1510 primers, 0.4 μM 
of F-Rv2073c and R-Rv2073c primers, 0.15 μM of P-esat6 and P-Rv1510 TaqMan 
probes, and 0.25 μM of P-Rv2073c TaqMan probe. The thermal cycling conditions 
were as follows: 1 cycle at 95 °C for 2 min, followed by 45 cycles at 95 °C for 5 s and 
60 °C for 10 s. All samples that probed positive for each one of the targets were retested 
for confirmation. Thermal cycling, fluorescent data collection, and data analysis were 
performed in a CFX96 (Bio-Rad) detection system real-time PCR instrument, according 
to the manufacturer’s instructions. 
  




Analytical specificity and sensitivity of amplification assays 
To investigate whether the probes and respective flanking primers detect their specific 
targets (16S rDNA, IS6110, Rv3875-esat6 (RD1), Rv1510 (RD4) and Rv2073c (RD9)), 
outlined in the two-step multiplex real-time PCR identification algorithm, DNA from 
MTC and non-MTC isolates (Table 3.1) were used as templates in these assays. To 
estimate the DNA detection threshold, the duplex and triplex real-time PCR 
amplification assays were tested with ten-fold diluted DNA reference samples, in 
concentrations ranging from 1 ng/ l to 1 fg/ l, from M. bovis, M. caprae and M. avium 
subsp. avium strains. These DNA reference samples were obtained and tested in the 
frame of an European inter-laboratorial ring-test trial organized in 2013 by the 
European Union Reference Laboratory (EURL) for bovine tuberculosis (VISAVET, 
Centro de Vigilancia Sanitaria Veterinaria, UCM, Madrid, Spain), in order to assess the 
sensitivity and specificity of PCR-based detection assays used in National Reference 
Laboratories (NRLs). For each strain and concentration the PCR assays were performed 
in triplicate. The end-point corresponded to the dilution at which the assay could detect 
the respective DNA targets in all three replicates. 
 
Tissue samples and liquid cultures 
Lymph nodes, liver, spleen or lung tissue samples collected from 117 animals (69 
bovines, 33 wild boars and 15 deer) were used in this work (Table 3.3). Bovine samples 
were collected from animals clinically suspected of having TB, e.g. presenting a 
positive reaction in either the single intradermal comparative tuberculin test or the 
gamma-interferon test, or TB-like lesions detected during routine abattoir inspection, 
and were submitted to routine control testing under the governmental Portuguese 
eradication scheme for bovine tuberculosis [18]. TB suspect samples from wild boar 
and deer sent to INIAV reference laboratories following gross pathological evaluation 
performed in the field by local veterinarians in hunting activities legally authorized. 
Samples were submitted during the fourth trimester of 2011 to the pathology and 
bacteriology laboratories of INIAV and analysed using routine histological and culture-
based methods, according to the OIE standard procedures [46]. Tissues selected for 
bacteriological analysis were homogenized using a pestle and mortar, followed by 




decontamination with 4% sodium hydroxide. After neutralization with 10% 
hydrochloric acid, the macerated suspensions were centrifuged and inoculated into 
BACTEC 9000 liquid media. Inoculated media were incubated until a positive culture is 
detected or for a minimum of eight weeks at 37 ºC. After incubation, the culture 
supernatants (either positive or negative) were subjected to a rapid DNA extraction 
procedure. Briefly, 10 ml of culture was centrifuged at 3800×g for 30 min. The 
supernatant was discarded and the pellet was washed in 10 ml of PBS and suspended in 
250 µl of TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). This suspension was 
heated in a water bath at 95 °C for 25 min and centrifuged at 15000×g for 5 min. A 150 
μl aliquot of the supernatant (containing the DNA) was transferred to a sterile microtube 
and stored at -20°C until further use. Stock DNA suspensions were diluted ten times in 
distilled water before its use as template for real-time PCR assays. DNA extracted 
solutions from positive cultures were used for species identification of presumptive 
mycobacteria isolates as routinely performed at our reference lab, using the commercial 
reverse hybridization assays INNO-LiPA Mycobacteria V2 (Innogenetics, Belgium) or 
GenoType Mycobacterium CM/AS (Hain diagnostics, Germany), following the 
manufacturer’s instructions, and the restriction endonuclease analysis with RsaI and 
SacII of the PCR-amplified gyrB gene (for presumptive MTC isolates) [21]. 
Additionally, DNA extracted solutions from both positive and negative cultures were 
used for assessing the performance of the developed TaqMan®-based real-time PCR 
identification algorithm. 
 




Table 3.3. Results of the application of the duplex (16S rDNA and IS6110) and triplex (Rv3875-RD1, Rv1510-RD4 and Rv2073c-RD9) 



























Bovine + M. bovis 30101; 30221; 30496; 31785; 33758; 
35716; 36632; 37722; 42089; 
30504/11; 30504/12; 30504/14; 
30504/2; 30504/3; 30504/6; 30504/7; 
31719/2;36867/10; 36867/13; 
36867/4; 37720/1; 41679/1 
22 + + + - - 
 - M. bovis 30504/4; 30504/5; 36867/7 3 + + + - - 
 + Non-MTC 35690 1 + - - - - 
 - Non-MTC 37707/2; 31389 2 + - - - - 
 + - 41680/1; 31784 2 - - - - - 
 - - 31093; 31094; 31388; 31786; 32079; 
32451; 33584; 33716; 33757; 33787; 
33788; 36835; 37721; 40038; 40336; 
40849; 40853; 40854; 41542; 41656; 
41678; 30504/1; 30504/10; 30504/8; 
30504/9; 31717/1; 31717/2; 31719/1; 
36867/20; 37707/4; 37707/6; 37720/2; 
39850/2; 39850/3; 40037/1; 40056/2; 
40056/6; 41679/2; 41680/3 
39 - - - - - 
 
 

































+ M. bovis 37481/1; 37481/2; 37481/3; 37481/4; 
37481/5; 37708/1; 37708/3; 37708/2; 
37708/4; 41674/1; 41675/3; 41677/2; 
41677/6; 41677/7; 41677/8; 41963/10; 
41963/2; 41963/7 
18 + + + - - 
 + Non-MTC 33524/2; 35732 2 + + + - - 
 + Non-MTC 38951/5; 37548 2 + - - - - 
 - Non-MTC 37549/2; 37549/3; 41677/9 3 + - - - - 
 + - 33760; 33763/1; 33763/2; 41675/2 4 - - - - - 
 - - 33524/1; 33524/3; 37549/1; 41963/4 4 - - - - - 
Deer + M. bovis 33761; 34827; 37486; 38534; 
34920/1; 34920/2; 34920/3; 34920/4; 
35730/2; 35733/1; 41676/7; 41964/2 
12 + + + - - 
 - - 34917; 41676/5; 41964/1 3 - - - - - 
1
Presence of lesions compatible with tuberculosis; 
2
Detection of M. bovis or other non-MTC mycobacteria by culture of tissue samples; 
3
Amplification (+) or no amplification (-). 
 





For the computation of the kappa coefficient, for measuring the agreement between the 
results of the routinely performed bacteriological culture procedures, including the 
respective molecular identification of the isolates, and the real-time PCR identification 
algorithm herein described, all BACTEC cultures were used (n = 117). The kappa 
coefficient, with confidence intervals, was computed using the clinical research 
calculators of the online VassarStats software (http://vassarstats.net). 
 
3.4. Results 
Design of the identification algorithm 
A two-step identification algorithm, comprising two sequential TaqMan-based 
multiplex real-time PCR reactions, was implemented for the identification of veterinary-
relevant MTC isolates (Figure 3.1). The assays use DNA extracted from mycobacterial 
cultures as template. The first step allows the identification of the cultures as MTC 
members, by targeting their IS6110 element, or as a mycobacterial species, if only a 16S 
rDNA product is detected in the duplex amplification reaction (Figure 3.1). If a MTC 
member is identified, the second amplification step allows to assess the presence or 
absence of the Rv3875-esat6 (RD1), Rv1510 (RD4) and Rv2073c (RD9) loci in the 
respective genome. The correspondent pattern allows to infer the species of the isolate 
as M. tuberculosis, if all loci are present, as M. caprae, if only the Rv3875-esat6 (RD1) 
and Rv1510 (RD4) loci are present, as M. bovis, if only Rv3875 (RD1) locus is present, 
and as M. bovis BCG if all the previous loci are absent (Figure 3.1; see discussion 
below). 
 
Analytical specificity and sensitivity of the identification algorithm  
The algorithm was tested using DNA extracted from previously identified MTC and 
non-MTC reference and clinical strains as template (Table 3.1; Figure 3.4). In the first 
step, the target 16S rDNA region was only detected in mycobacterial species and the 
IS6110 element was only detected in MTC species (Table 3.1). In the second step, the 
Rv3875-esat6 (RD1) locus region was detected in all pathogenic MTC strains, the 




Rv1510 (RD4) region was detected only in M. tuberculosis, M. africanum and M. 
caprae strains, and the Rv2073c (RD9) region was only detected in M. tuberculosis 
strains (Table 3.1). None of these genomic regions were detected in vaccine M. bovis 
BCG strains. The results of the analytical sensitivity were as follows:  
The  first duplex reaction could detect the presence of M. bovis until the dilution 
containing 1 pg/ l  (Ct ≈ 35) of DNA template, with both the 16S rDNA and IS6110 
targets (however, at least one of the three replicates yielded positive amplification 
results further until the dilution containing 10 fg/ l of template DNA). The same 
detection limit of 1 pg/ l was found for the following triplex reaction targeting the 
Rv3875-esat6 (RD1) of M. bovis, and the Rv1510 (RD4) and Rv2073c (RD9) loci were 
not detected, as expected.  
The first duplex reaction detected the presence of M. caprae until the dilution 
containing 1 pg/ l (Ct ≈ 34) and 0.1 pg/ l (Ct ≈ 39) of DNA template, with the 16S 
rDNA and IS6110 targets, respectively. However, at least one of the three triplicates 
yielded positive amplification results further until the dilution containing 1 and 10 fg/ l 
for the 16S rDNA and IS6110 targets, respectively. The following triplex reaction 
showed a detection limit of 10 pg/ l (Ct ≈ 37) of DNA template for both Rv3875-esat6 
(RD1) and Rv1510 (RD4) targets, and Rv2073c (RD9) was not detected, as expected.  
Finally, also as expected, M. avium subsp. avium was only detected in the first duplex 
reaction with the mycobacterial 16S rDNA-targeted probe, with a detection limit of 1 
pg/ l (Ct ≈ 35) of DNA template (however, at least one of the three triplicates yielded 



































































Figure 3.4. Illustration of the real-time PCR amplification curves obtained. 16S 
rDNA and IS6110-targeted duplex (left) and Rv3875-esat6 (RD1), Rv1510 (RD4) and 
Rv2073c (RD9) targeted triplex (right) real-time PCR assays for strains M. tuberculosis 
H37Ra (continuous line), M. caprae LNIV17320 (dashed line) and M. bovis 
LNIV13027 (dotted line) (A, B) and for culture samples 37481/5 (continuous line), 
37708/1 (dashed line) and 38951/5 (dotted line) (C, D). Genomic targets curves colours: 
red (16S rDNA), green (IS6110), RD1 (blue), RD4 (orange) and RD9 (yellow). 
 
  
Application of the identification algorithm to BACTEC cultures of veterinary 
origin  
The identification algorithm was tested using DNA extracted from a set of 117 
sequential liquid cultures, using a simple boiling method, obtained under the routine 
testing of TB-suspected tissue samples originally collected from bovines (n = 69), deer 
(n = 15) and wild boar (n = 33) (Table 3.3; Figure 3.4). Fifty five cultures were 
identified as M. bovis by the routine bacteriological analysis and 10 cultures were 
identified as non-MTC species: M. avium (n = 5), M. scrofulaceum (n = 2) and 
Mycobacterium spp. (n = 3). No bacterial growth was detected in 52 samples. 
Mycobacterium caprae was not identified from any sample. The identification 




algorithm developed, based in the duplex (16S rDNA and IS6110) and triplex (Rv3875-
RD1, Rv1510-RD4 and Rv2073c-RD9) real-time PCR amplification assays, presented 
an almost perfect agreement with the results of the routine bacteriological analysis 
(Table 3), with a kappa coefficient of 0.970 (CIP95% 0.929-1.000).  
All 55 M. bovis liquid cultures yielded amplification results for Rv3875-esat6 (RD1) 
but Rv1510 (RD4) and Rv2073c (RD9) regions were absent. No amplification was 
detected for any of the 16S rDNA, IS6110, RD1, RD4 and RD9 genomic targets in the 
52 negative samples.  
Eight cultures were identified as non-MTC species by routine bacteriology analysis: M. 
scrofulaceum (31389); M. avium (37549/2, 37549/3, 37707/2, 37548 and 38951/5); and 
Mycobacterium spp. (35690 and 41677/9). All these cultures yielded a positive 
amplification result only for the mycobacterial 16S rDNA region when tested with the 
real-time PCR-based identification algorithm (Table 3.3). However, two additional 
cultures from wild boar were identified as non-MTC species by routine bacteriology, M. 
scrofulaceum (33524/2) and Mycobacterium sp. (35732), using the GenoType CM/AS 
Mycobacterium identification assay, but yielded positive amplification results for the 
IS6110 element and Rv3875-esat6 (RD1) locus, compatible with the M. bovis RDs 
profile (Table 3.3). These two BACTEC cultures were obtained from wild boar tissues 




In this work we aimed to implement a fast and straightforward molecular assay to 
identify the most relevant MTC members causing disease in domestic (mainly 
livestock) and big game animals, such as wild boars and deer, commonly received in 
our national reference lab for TB laboratory diagnosis. The MTC comprises a group of 
closely-related TB-associated species, currently including: M. tuberculosis (the 
predominant cause of human TB); "M. canettii" (a very rare MTC biotype); M. 
africanum (mainly associated to human TB in Africa); M. pinnipedii (the cause of 
endemic TB in several seal species); M. microti (with bank voles and other small 
rodents as natural hosts, rarely identified from other mammals); M. mungi (associated to 




TB in banded mongooses in Botswana); M. orygis (a recently described and less known 
rare species, with oryxes, waterbucks, and gazelles as potential hosts in Africa, and 
bovines and rhesus monkeys in South Asia); and M. bovis and M. caprae (the 
worldwide predominant cause of bovine and goat TB, respectively, but also causing 
disease in a wide range of domestic and wild animals, including humans) [5, 6, 8-10, 
47, 48]. In our lab, more than 38% of the samples from suspect cattle previously 
analysed between 2002 and 2010 were confirmed as TB positive and 92% and 1% of 
the mycobacterial isolates were identified as M. bovis and M. caprae, respectively [18]. 
The remaining isolates belonged to Mycobacterium avium complex or to other 
environmental nontuberculous mycobacteria. No other of the above referred MTC 
species were ever isolated in our lab, with the exception of a few M. tuberculosis 
isolates collected from zoo captive mandrills and a dog [49, 50]. Although a rare event, 
infection with M. tuberculosis mostly occurs in animals living in close contact with 
humans, such as pets, pigs, cattle and captive animals [51-57], and reference veterinary 
diagnostic labs should be aware for these infections as they raise important public health 
concerns. Taking into account the above mentioned considerations, we selected M. 
bovis, M. caprae and M. tuberculosis as the relevant target species for the 
implementation of our real-time PCR-based identification assay. 
The proposed identification assay involves a first amplification step where the tested 
isolate will be assigned as an MTC member (by detecting the presence of the MTC-
specific IS6110 element), which is the most relevant case, or, alternatively, as a non-
MTC Mycobacterium species. It has recently been found that IS6110-like elements may 
be present in other non-MTC mycobacteria such as M. smegmatis [58]. However, the 
probe and respective flanking primers used show no relevant complementary regions 
with these IS6110-like nucleotide sequences [19]. 
If an MTC isolate is found, the subsequent RDs-targeted triplex real-time PCR assay 
allow the identification to the species level as M. bovis, M. bovis BCG, M. caprae or M. 
tuberculosis, according to their distinct patterns of presence or absence of Rv3875-esat6 
(RD1), Rv1510 (RD4) and Rv2073c (RD9) loci (Figure 3.1). We decided to target these 
LSPs (RD1, RD4 and RD9) instead of SNPs (e.g. in gyrB gene) to discriminate between 
these MTC members since the PCR-based detection assays to differentiate SNPs may 




be less robust and accurate, requiring a much more strict control of the experimental 
conditions to maintain the specificity.  
All MTC members, with the exception of M. bovis BCG (and also M. mungi and M. 
microti), harbour an intact RD1 genomic region, which include the esat6 gene that 
should be detected by our assay (Figure 3.1). It is widely accepted that the vaccine 
strain M. bovis BCG is not pathogenic in part due to the loss of this RD1 region, which 
include the genes esat6 and cfp10 essential for pathogenesis in M. tuberculosis being 
two of the most important virulence factors of this pathogen [8, 34]. Noteworthy, these 
genes (and homologous RD1-like genomic regions) were also found among 
nontuberculous mycobacteria such as M. kansasii, M. szulgai, M. marinum and M. 
riyadhense [59, 60]. Several of these non-MTC mycobacteria can be also found 
infecting domestic and wild animals [61]. However, as shown in Figure 3.2, the several 
mismatches existing in the complementary regions of our RD1-targeted primers and/or 
TaqMan probe should be sufficient to prevent the amplification and detection of the 
RD1-like sequences of the rare pathogens M. szulgai and M. riyadhense. Although 
Mycobacterium kansasii and M. marinum present less mismatches in the respective 
primers/probe homologous complementary targets (Figure 3.2), and could be potentially 
yield weak false-positive results in sub-optimized amplification assays, these pathogens 
are rarely found infecting domestic and wild mammal species [61] and they lack the 
IS6110 element, therefore previously excluded in our algorithm .  
The RD4 genomic region is considered to be present in all MTC members with the 
exception of M. bovis (and of M. bovis BCG). In fact, the detection of an RD4 deletion 
has been used as a major criterion for distinguishing the major veterinary relevant MTC 
species M. bovis from M. caprae [2, 26, 28, 30, 35]. However, a recent study reported 
that RD4 may be also absent, at least in part, from some M. caprae isolates in Germany, 
which corresponded to their respective geographic origins and genotypes [62]. These 
authors found that, from the twelve M. caprae isolates they have studied, four lacked a 
5 kb region in the left part of the RD4 region, which they called the Karwendel type, 
and another four isolates presented a 38 kb deletion, encompassing the whole RD4, 
which they called the Lechtal type. Four additional isolates presented the usual and 
apparently complete RD4 region (Allgäu type). Apparently, if tested with our RD4 
(Rv1510 locus)-targeted real-time PCR assay, only the Karwendel and Allgäu types of 




M. caprae would yield a positive amplification result and the Lechtal type would be 
misidentified as M. bovis [62]. All five Portuguese M. caprae isolates tested in this 
work were RD4 (Rv1510 locus) positive (Table 3.1) and it is also described that this 
genomic region was detected in the majority of the studied Spanish isolates [63]. 
Therefore, we sustain that the RD4 genomic target, namely the Rv1510 locus, is a 
useful marker allowing the discrimination of the majority of M. caprae clinical isolates 
from M. bovis. However, more studies need to be performed in a wider collection of M. 
caprae isolates, with an extended range of geographical origins, in order to better assess 
the structure of this RD4 genomic region and, if necessary, to update our identification 
algorithm with alternative genomic markers for the effective differentiation of M. 
caprae from M. bovis. 
The RD9 genomic region is considered to be only present in M. tuberculosis (and in the 
rarely found taxa “M. canettii”), being absent from all other MTC species. We have 
found potential Rv2073c-like sequences in other non-MTC Mycobacterium species after 
a BLAST analysis on the respective whole genome sequences available in GenBank, 
namely in M. liflandii (a frog pathogen), M. marinum, M. kansasii, M. intracellulare, M. 
indicus pranii (a non-pathogenic saprophytic organism), M. avium subsp. 
paratuberculosis and M. avium subsp. hominissuis (Figure 3.3). Nevertheless, the 
several mismatches present in the complementary regions of these species for our RD9-
targeting probe and flanking primers will prevent any amplification, and consequent 
potential false-positive detection by our real-time PCR assays. 
In our identification algorithm, M. tuberculosis isolates will present an Rv3875-esat6 
(RD1), Rv1510 (RD4) and Rv2073c (RD9) loci amplification positive profile. 
“Mycobacterium canettii” presents the same profile but this species is very rarely found 
and, as far as we know, was never isolated from animal species. Mycobacterium bovis 
isolates will also present a distinct profile, with Rv3875-esat6 (RD1) amplification 
positive and Rv1510 (RD4) and Rv2073c (RD9) negative (M. bovis BCG isolates will 
lack the RD1 region). Finally, M. caprae isolates will harbour the profile Rv3875 (RD1) 
and Rv1510 (RD4) positive and Rv2073c (RD9) negative. However, other MTC species 
will also present this profile, namely M. africanum, M. pinnipedii and M. orygis [8]. 
Regarding the infection of animals by the predominantly human pathogen M. 
africanum, at least in some cases, this species may have been misidentified and might 




represent the recently described M. orygis instead [10]. Nonetheless, as also mentioned 
at the beginning of this section, all these MTC species are rarely found in domestic 
(particularly livestock) and big game animals, such as deer and wild boar that are 
usually received in our lab for TB testing. Therefore, we sustain that the amplification 
profile RD1 and RD4 positive and RD9 negative is useful for the identification of M. 
caprae isolates in the context of a veterinary diagnostic lab. 
The specificities of the proposed duplex and triplex real-time PCR assays were 
evaluated against a panel of 76 MTC, non-MTC mycobacteria and other bacterial 
species (Table 3.1). All assays were 100% specific for the respective target organisms 
(as assessed by the amplification profiles of the 16S rDNA, IS6110, RD1, RD4 and 
RD9 genomic targets). As expected, tested M. caprae and M. africanum strains 
harboured an identical amplification profile. Additionally, 117 BACTEC positive and 
negative liquid cultures were tested, resulting in an almost perfect agreement with the 
results of the routine bacteriological analysis (Table 3.3). No amplification results were 
obtained for the 52 BACTEC culture negative samples, similarly to the negative 
controls of amplification, also demonstrating that no cross-contaminations and no 
amplification artefacts were produced during execution of the assays.  
Only two discordant cases were found among the results of our identification algorithm 
and the routine bacteriology procedures currently used in our lab (Table 3.3): wild boar 
samples 33524/2 and 35732 yielded non-MTC cultures further identified as M. 
scrofulaceum and Mycobacterium sp., respectively. However, the RDs amplification 
profiles were concordant with M. bovis when DNA extracted from these cultures were 
used as template. The tissue samples used to inoculate these liquid cultures presented 
TB-compatible lesions. Additionally, the presence of MTC was confirmed in these 
samples by an IS6110-targeted semi-nested real-time PCR approach that we also 
recently described [19] (data not shown). Therefore, although TB-like lesions identified 
by histopathology can be induced by other bacteria or non-MTC mycobacteria, the 
IS6110-specific positive amplification results suggest that MTC members were most 
probably associated with the observed lesions. The detection of an M. bovis RDs profile 
by our identification algorithm in samples 33524/2 and 35732 probably reflects that 
they harboured a mixed culture of this species with other non-MTC fast-growing 
mycobacteria. These may potentially overgrow any M. bovis isolate present in the tissue 




samples and mask its presence, being its vestigial template DNA eventually only 
detected by the sensitive real-time PCR amplification assays [19, 64].  
In this work we describe a rapid and robust five-target TaqMan
®
-based real-time PCR 
identification algorithm, based on genomic deletion analysis, to identify the MTC 
species most commonly associated with TB in livestock and other animals. The assay is 
significantly faster and simpler than other SNPs-targeted restriction analysis or reverse 
line probe hybridization-based molecular assays, since it bypasses any post-
amplification experimental steps and can be used with DNA templates extracted directly 
from liquid cultures using a simple, low-cost and fast boiling-based method. The assay 
is able to be further automated and implemented in the routine diagnostics framework of 
veterinary diagnostics laboratories, with a particular focus for reference laboratories. 
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Identification of Mycobacterium tuberculosis and M. bovis using 
duplex Loop-Mediated Isothermal DNA Amplification (dLAMP) 
and colorimetric lateral flow devices 
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Rapid, user-friendly and affordable diagnostic tests for use in the point-of-decision or 
point-of-care settings are in high demand globally. Species included in the 
Mycobacterium tuberculosis complex (MTC) are responsible for tuberculosis in both 
animals and humans. Detection of MTC members is generally performed by 
cumbersome conventional culture-based methods, which usually takes up to eight 
weeks. Molecular diagnosis strategies were also developed but most of these requires 
skilled operators and sophisticated equipments and facilities. More recently, the Loop-
Mediated Isothermal Amplification (LAMP) technique showed promise for the 
development of rapid, low-cost, sensitive and specific tests for detecting pathogens. In 
this work we optimized two duplex LAMP (dLAMP) assays for the identification of 
MTC and Mycobacterium tuberculosis, and MTC and M. bovis, presenting similar 
sensitivities and specificities when compared to standard PCR approaches. The 
amplification results are assessed colorimetrically by using simple and commercially 
available nucleic acid lateral flow (NALF) strips. All the identification process takes 
around 70 minutes.  
 
4.2. Introduction 
The demand for rapid point-of-decision diagnostics for infectious diseases has been 
steadily increasing globally, namely in veterinary medicine [1]. Tuberculosis (TB), 
caused by Mycobacterium tuberculosis, M. bovis and other closely related species of the 
M. tuberculosis complex (MTC), is a major infectious disease of humans, and domestic 
and wildlife animals across the World [2-4]. The laboratorial detection of MTC 
members is generally performed by cumbersome conventional culture-based methods, 
which usually takes up to eight weeks. Nevertheless, molecular diagnostic tests play an 
important role in detecting MTC members and in monitoring the spread of tuberculosis 




in both humans and animals. In the case of animal TB, most described molecular 
detection and identification tests have bovine tuberculosis, and the respective causal 
agents, as target. Most assays are PCR or real-time PCR-based, allowing a rapid and 
highly sensitive and specific laboratorial assessment of TB. However, poorly equipped 
laboratories in low-resource settings face major difficulties for accessing these 
molecular techniques, that are reliant upon expensive, sophisticated and relatively 
fragile equipments. A new group of nucleic acid detection assays that exploit isothermal 
amplification mechanisms have been developed as potential diagnostic tools for use in 
either the field or in low-cost laboratory settings [5-7]. One most promising technique is 
the loop mediated isothermal amplification (LAMP), which is a relatively novel 
approach, and allows nucleic acid amplification with high specificity, sensitivity and 
rapidity under isothermal conditions [8]. The method was originally described by 
Notomi and colleagues in 2000 [8] and have been used for the detection of a wide range 
of viruses, parasites and bacteria [9-14]. The method relies on an autocycling strand 
displacement DNA synthesis by the Bst DNA polymerase large fragment that is a DNA 
polymerase with high strand displacement activity, superseding thermal denaturation 
steps [8]. Therefore, a thermal cycler is not needed, and the reaction can be performed 
with a simple and inexpensive thermostatic water bath or a heating block. LAMP also 
requires a set of a minimum of four primers: two inner primers (forward inner primer - 
FIP, and the backward inner primer - BIP), and two outer primers (F3/B3). Additional 
loop primers can be used, which usually speed up the reaction [15]. LAMP is highly 
specific for the target sequence since it requires the recognition of at least six distinct 
complementary nucleotide segments of the target DNA. The amplification efficiency of 
the LAMP method is extremely high, it can amplify 10
9
 copies of nucleic acid target, 
usually at a temperature between 60-65 °C, within 30-60 min [16, 17]. The 
amplification and identity of the LAMP products can be confirmed by conventional 
agarose gel electrophoresis, by visual inspection of the increase in turbidity, or colour 
change, of the reaction mixture, by the use of spectrophotometric equipments to 
measure the increase of turbidity or by using intercalating fluorescent dyes [18]. 
Equipment-free methods for unambiguous detection and identification of LAMP 
products would increase the feasibility of using LAMP for detection of mycobacteria 
outside the laboratory. One promising approach is the use of lateral-flow devices 




(LFDs) for the detection of labels incorporated into the amplification products, a 
technique sometimes referred to as nucleic acid lateral flow (NALF). Tests in LFD 
format have a number of advantages for use in the field, and specific LFD 
immunoassays have been extremely successful in areas of point-of-care and on-site 
testing [19-23]. Generic commercially available LFD strips can be used for this 
purpose. These chromatographic strips can detect biotin-labelled DNA fragments 
hybridized with complementary FITC-labelled probes. FITC is detected in the strips by 
the formation of complexes with gold-conjugated anti-FITC antibodies. In this work we 
combined the advantages of both LAMP and LFD technologies to implement a simple, 
rapid, sensitive and specific molecular assay to identify MTC members, particularly the 
most relevant M. tuberculosis and M. bovis species, suitable for use in low-resource 
laboratory settings. 
 
4.3. Materials and Methods 
Bacterial strains and DNA extraction 
Reference strains and previously identified clinical isolates of MTC, non-MTC 
mycobacteria and non-mycobacterial species, maintained at the Portuguese reference 
laboratory for animal diseases (Instituto Nacional de Investigação Agrária e 
Veterinária, INIAV, I.P.), were used for optimization of amplification assays (Table 
4.1). MTC isolates were previously identified to the species level by PCR-restriction 




















Table 4.1. Reference and clinical bacterial strains used to assess the specificity of the 
dLAMP-LFD assays and respective amplification results. 
 
Species Strains IS6110 RD4 
flanking 
RD9 
M. tuberculosis ATCC 25177; LNIV 
9605 
+ - + 
M. caprae LNIV 17320; 4958/0/05; 
8403; 15244; and 20752 
+ - - 
M. bovis AN5; LNIV 13027; 
5530/0/05; 11265; 
7230/4; 14421/2; 
24497/6; 8855; 5889; 
10044; 14577; 13280/6; 
13280/4; 34875; and 
20564 
+ + - 
M. bovis BCG ATCC 27291 + + - 
M. avium subsp. avium ATCC 25291 - - - 
M. avium subsp. 
hominissuis 
LNIV 23063/4; IHMT 
31/06; 229/06; 193/08; 
189/05; 8/05; 291/05; 
386/08; 92/06; 78/06; 
327/07; 73/11; 436/05; 
and 68/06 
- - - 
M. avium subsp. 
paratuberculosis 
LNIV 39888 - - - 
M. scrofulaceum LNIV 31389 - - - 
Acinetobacter baumannii LNIV 1628/12 - - - 
Arcanobacterium 
pyogenes 
VLA 1321 - - - 
Bacillus licheniformis VLA 1831 - - - 
Corynebacterium 
striatum 
LNIV 12352 - - - 
Enterobacter amnigenus LNIV 6050/II - - - 
Klebsiella pneumonia VLA 1643 - - - 
Listeria monocytogenes VLA 1774 - - - 
Proteus mirabilis LNIV 2269/II - - - 
Pseudomonas aeruginosa VLA 67 - - - 
Salmonella Dublin VLA 1272 - - - 
Staphylococcus aureus VLA 1032 - - - 
Streptococcus agalactiae VLA 33 - - - 
Yersinia enterocolitica VLA 1884 - - - 
ATCC, American Type Culture Collection, USA; LNIV, Laboratório Nacional de 
Investigação Veterinária (currently INIAV, I.P.), Lisbon, Portugal; IHMT, Instituto de 




Higiene e Medicina Tropical, Lisbon, Portugal; VLA, Veterinary Laboratory Agency, 
UK; Amplification (+) or no amplification (-). 
 
DNA extraction from cultures grown in liquid media was achieved by a combined bead 
beating and enzymatic extraction method described elsewhere [27]. Briefly, 0.5 ml 
bacterial culture were washed in PBS buffer and heat inactivated at 100 ºC for 15 min. 
Tubes containing zirconium beads were used to resuspend the culture pellet in lysis 
buffer (0.4 M NaCl, 40 mM Tris-HCl, pH 8, 2 mM EDTA, 0.6% SDS, 0.034 mg/ml 
proteinase K) for mechanical disruption in the FastPrep FP120 Bio101 (Savant 
Instruments, Inc., Holbrook, NY) at 6.5 ms
-1
 for 45 s, and then incubated overnight at 
37 ºC, followed by standard phenol–chloroform purification and ethanol precipitation of 
DNA. DNA concentration and purity were estimated by measuring the absorbance at 
260 nm (A260) and by A260⁄A280 and A260/A230 ratios, respectively, using a 
NanoDrop 1000 spectrophotometer (NanoDrop). Genomic DNA suspensions were 
stored at - 20 ºC until further use. Furthermore, a group of 50 DNA samples extracted 
from MTC strains, previously isolated from sputum human samples, were also supplied 
by Instituto de Higiene e Medicina Tropical (IHMT) (Table 4.2). 
 




Table 4.2. Results of the dLAMP-LFD #A assay tested with DNA templates extracted from human isolates. 







Human M. tuberculosis IHMT 1; IHMT 2; IHMT 3; IHMT4; 
IHMT 5: IHMT 6; IHMT 7; IHMT 8; 
IHMT 9; IHMT 10; IHMT 11; IHMT 12; 
IHMT 13; IHMT 14; IHMT 15; IHMT 
16; IHMT 17; IHMT 18; IHMT 19; 
IHMT 20; IHMT 21; IHMT 22; IHMT 
23; IHMT 24; IHMT 25; IHMT 26; 
IHMT 27; IHMT 28; IHMT 29; IHMT 
30; IHMT 31; IHMT 32; IHMT 35; 
IHMT 38; IHMT 40; IHMT 41; IHMT 
42; IHMT 43; IHMT 44; IHMT 45  
40 + + 
 M. bovis BCG IHMT 33; IHMT 34; IHMT 36; IHMT 
37; IHMT 48; IHMT 50 
6 + - 
 M. africanum IHMT 39; IHMT 46; IHMT 47; IHMT 
49 
4 + - 
1
Amplification (+) or no amplification (-).




Animal tissue samples, liquid cultures and rapid DNA extraction  
Lymph nodes, liver, spleen or lung tissue samples collected from 117 animals (69 
bovines, 33 wild boars and 15 deer) were used in this work (Table 4.3). Bovine samples 
were submitted to routine control testing in our reference lab under the governmental 
Portuguese eradication scheme for bovine tuberculosis [28]. Wild boar and deer 
samples were sent to our lab following gross pathological evaluation performed in the 
field by local veterinarians in hunting activities. Samples were submitted during the 
fourth trimester of 2011 and analysed using routine histological and culture-based 
methods, according to the OIE standard procedures [29]. Tissues selected for 
bacteriological analysis were homogenized using a pestle and mortar, followed by 
decontamination with 4% sodium hydroxide. After neutralization with 10% 
hydrochloric acid, the macerated suspensions were centrifuged and inoculated into 
BACTEC 9000 liquid media. Inoculated media were incubated until a positive culture is 
detected or for a minimum of eight weeks at 37 ºC. After incubation of the inoculated 
media, the culture supernatants (either positive or negative) were subjected to a rapid 
DNA extraction procedure. Briefly, 10 ml of culture was centrifuged at 3800 ×g for 30 
min. The supernatant was discarded and the pellet was washed in 10 ml of PBS and 
suspended in 250 µl of TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). This 
suspension was heated in a water bath at 95 °C for 25 min and centrifuged at 15000 ×g 
for 5 min. A 150 μl aliquot of the supernatant (containing the DNA) was transferred to a 
sterile microtube and stored at -20°C until further use. Stock DNA suspensions were 
diluted ten times in distilled water before its use as template for LAMP reactions. DNA 
extracted solutions from positive cultures were used for species identification of 
presumptive mycobacteria isolates as routinely performed at our reference lab, using the 
commercial reverse hybridization assays INNO-LiPA Mycobacteria V2 (Innogenetics, 
Belgium) or GenoType Mycobacterium CM/AS (Hain diagnostics, Germany), 
following the manufacturer’s instructions, and the restriction endonuclease analysis 
with RsaI and SacII of the PCR-amplified gyrB gene (for presumptive MTC isolates) 
[30]. Additionally, DNA extracted solutions from both positive and negative BACTEC 
liquid cultures were used for assessing the performance of the developed duplex LAMP 
coupled to a nucleic acid lateral flow dipstick strategy for assessing the results 
(dLAMP-LFD). 






















Bovine + M. bovis 30101; 30221; 30496; 31785; 33758; 
35716; 36632; 37722; 42089; 30504/11; 
30504/12; 30504/14; 30504/2; 30504/3; 
30504/6; 30504/7; 31719/2; 36867/10; 
36867/13; 36867/4; 37720/1; 41679/1 
22 + + 
 - M. bovis 30504/4; 30504/5; 36867/7 3 + + 
 + Non-MTC 35690 1 - - 
 - Non-MTC 37707/2; 31389 2 - - 
 + - 41680/1; 31784 2 - - 
 - - 31093; 31094; 31388; 31786; 32079; 
32451; 33584; 33716; 33757; 33787; 
33788; 36835; 37721; 40038; 40336; 
40849; 40853; 40854; 41542; 41656; 
41678; 30504/1; 30504/10; 30504/8; 
30504/9; 31717/1; 31717/2; 31719/1; 
36867/20; 37707/4; 37707/6; 37720/2; 
39850/2; 39850/3; 40037/1; 40056/2; 
40056/6; 41679/2; 41680/3 



























Wild boar + M. bovis 37481/1; 37481/2; 37481/3; 37481/4; 
37481/5; 37708/1; 37708/3; 37708/2; 
37708/4; 41674/1; 41675/3; 41677/2; 
41677/6; 41677/7; 41677/8; 41963/10; 
41963/2; 41963/7 
18 + + 
 + Non-MTC 33524/2; 37548; 35732 3 - - 
 + Non-MTC 38951/5 1 - - 
 - Non-MTC 37549/2; 37549/3; 41677/9 3 - - 
 + - 33760; 33763/1; 33763/2; 41675/2 4 - - 
 - - 33524/1; 33524/3; 37549/1; 41963/4 4 - - 
Deer + M. bovis 33761; 34827; 37486; 38534; 34920/1; 
34920/2; 34920/3; 34920/4; 35730/2; 
35733/1; 41676/7; 41964/2 
12 + + 
 - - 34917; 41676/5; 41964/1 3 - - 
1
Presence of lesions compatible with tuberculosis; 
2
Detection of M. bovis or other non-MTC mycobacteria by culture of tissue samples; 
3
Amplification (+) or no amplification (-)




Design of LAMP primers and LFD probes 
Sequences of the IS6110 and of the Regions of Difference 4 (RD4, including the 
Rv1510 locus, absent from M. bovis) and 9 (RD9, including the Rv2073c locus, only 
present in M. tuberculosis) from MTC members were retrieved from NCBI-GenBank. 
Two sets of six LAMP primers, including loop primers, were designed, one to target the 
IS6110 element of MTC species and a second one to target the RD9 present in M. 
tuberculosis (Table 4.4; Figure 4.1). Additionally, one set of four primers, without loop 
primers, flanking the RD4 was designed to detect M. bovis species (Table 4.4; Figure 
4.1). Primer design was performed using the online Primer Explorer V4 software 
(http://primerexplorer.jp/elamp4.0.0/index.html) according to Notomi et al. [8]. 
Forward inner primers (FIP) were 5'-end labeled with either biotin or digoxigenin 
(Table 4.4). Oligonucleotide probes labelled with fluorescein isothiocyanate (FITC), 
complementary to the LAMP amplified DNA fragments, were also designed (Table 
4.4). All primers and probes were synthesized as high performance liquid 
chromatography (HPLC)-grade by MWG Biotech (Germany).  
  
Table 4.4. Sequences of LAMP primers and FITC-labelled probes. 




TCA ACC GGG AGC CCA G 











Biotin-CGT AAA CAC CGT AGT TGG CGG 
CGC GCG ATG GCG AAC TCA 
GTG CCC GCA AAG TGT GGC TAA CAG 
TTT GGT CAT CAG CCG TTC 
GAC GCG GCT GAT GTG CT 
AGG TGG CCA GAT GCA CC 









Table 4.4. (Cont.) 




TTC CGA ATC CCT TGT GAA GT 








Dig-GGA AGG CGT CAT GAC CAA ACC 
ATT AAT GTG CGA GCT GAG CG 
GCC TACAAC GGC GCT CTC CAT TGA 
CCA GCT AAG ATA TCC GG 
ATT GTG AAT TCA TAC AAG CC 
F3_RD9 
B3_ RD9 
CCG TGC AAC GCA TCG G 










Dig-TCC TCG GTC GCC GGG ATT CTC 
CAG GCC GGC TTT GG 
GAA CAC CAC CAG CGA TCC CCA CTA 
CGT CGC CCA GGT CAG 
GCG CCA ACT ATG TCT ACG GAT C 
CGC TGC CAG ATG AGT CAG C 




Duplex LAMP reactions using labelled primers 
LAMP reactions were carried out using labelled primers. Two separate LAMP reactions 
for the duplex detection of either MTC species and M. tuberculosis, and detection of 
either MTC and M. bovis, were optimized and carried out in a total volume of 25 µl 
containing 8 U/μl of Bst DNA polymerase (New England Biolabs), 1× Thermopol 
buffer (New England Biolabs), 1.4 mM of dNTPs (Promega), 6 mM of MgCl2 
(Promega), 0.8 M of betaine (Sigma-Aldrich), 0.2 μM of each external primers (F3 and 
B3), 1.6 μM of each internal primers (FIP and BIP), 0.8 μM of each loop primers (LF 
and LB, only for the amplification of IS6110 and RD9 targets), and 3 μl of extracted 
DNA template. LAMP amplification was assessed after the reactions with standard gel 
electrophoresis procedures. 






Figure 4.1. Location of the complementary regions of LAMP primers and FITC-
labelled probes. Partial sequence of M. tuberculosis H37Rv IS6110 element (A), M. 
bovis AF2122/97 RD4 genomic region (B) and M. tuberculosis H37Rv RD9 genomic 
region (C), and location of the complementary regions used to design LAMP primers 
[F3, B3, FIP (F1c-F2), BIP (B1c-B2)], including loop primers for IS6110 and RD9 
regions (LF, LB) and FITC-labelled probes. Arrows indicate the direction of extension. 
 





Detection of LAMP products by LFD 
For detection of LAMP products by LFD, 20 picomoles of the adequate FITC-labeled 
probe were added to the LAMP products. Probes were designed for the detection of 
IS6110 (MTC species), RD4 flanking region (M. bovis) and RD9 (M. tuberculosis) 
targets. After hybridization at 65 ºC for 5 min, 8 l of the hybridized product were 
added to 100 l assay buffer in a new tube, and an LFD strip was dipped into the 
mixture for 2 min. Commercial universal LFD devices for the detection of labelled 
LAMP products were purchased from Milenia Biotec (HybriDetect 2T) and used 
according to the instructions of the manufacturer. 
 
Analytical specificity and sensitivity of LAMP assays 
To evaluate the analytical specificity of the two duplex LAMP-LFD assays, DNA 
samples from MTC and non-MTC strains were tested (Table 4.1). In order to assess the 
minimum DNA detection limit (analytical sensitivity), the two duplex LAMP-LFD 
assays were tested with ten-fold diluted template DNA, in concentrations ranging from 
12.2 ng/ l to 12.2 pg/ l (for the DNA sample from M. bovis LNIV 7257), and from 
12.5 ng/ l to 12.5 pg/ l (for the DNA sample from M. tuberculosis H37Ra). 
 
Statistics 
The kappa coefficient, with confidence intervals, for measuring the agreement between 
the results of the routinely performed identification of the isolates, and the dLAMP-
LFD assays herein described, was computed using the clinical research calculators of 
the online VassarStats software (http://vassarstats.net). 
 
4.4. Results 
Design of LAMP primers and FITC probes 
Based on the IS6110, RD4 flanking and Rv2073c (RD9) genomic regions of the MTC 
members, novel sets of LAMP primers and FITC probes complementary to the 
amplified regions were designed (Table 4.4; Figure 4.1). The complementary regions of 




the LAMP primers set targeting the multi-copy element IS6110 are shared by all MTC 
species (Figure 4.1A). The LAMP primers set targeting the RD4 flanking genomic 
region allow the amplification of products only if the RD4 deletion is present (as in M. 
bovis) (Figure 4.1B). The complementary regions of the LAMP primers set targeting the 
RD9 genomic region are located in the Rv2073c locus, coding a probable short chain 
dehydrogenase, which is present in M. tuberculosis but absent from M. bovis and from 
other MTC species (Figure 4.1C). 
 
Duplex LAMP-LFD strategy 
Two LAMP assays in duplex format combined with lateral flow dipsticks for assessing 
the amplification results were developed. One assay (dLAMP-LFD #A) targets MTC 
species and M. tuberculosis (with potential anticipated application mainly in 
laboratories dealing with the diagnosis of human TB). The assay allows the 
identification of the cultures as MTC members, by targeting their IS6110 element, and 
as M. tuberculosis, by targeting their RD9 genomic region. The second assay (dLAMP-
LFD #B) targets MTC species and M. bovis (with anticipated application in veterinary 
diagnosis laboratories). The assay allows the identification of MTC species through the 
amplification of IS6110, and the identification of M. bovis, by detecting the flanking 
region of RD4. The amplification of only the IS6110 element, for both assays, means 
that we are in the presence of other MTC species beyond M. tuberculosis and M. bovis. 
Both assays were optimized for use with DNA templates extracted from mycobacterial 
cultures. DNA samples can also be extracted directly from BACTEC liquid culture 
bottles, using a simple boiling method. 
 
Analytical specificity and sensitivity 
LAMP assays were tested using DNA extracted from previously identified MTC and 
non-MTC reference and clinical strains as template (Table 4.1; Figure 4.2). For both 
dLAMP-LFD assays, the IS6110 element was only detected in MTC species (Table 4.1; 
Figure 4.2). The dLAMP-LFD #B, targeting the RD4 flanking region, only detected M. 
bovis strains (Table 4.1; Figure 4.2A). The dLAMP-LFD #A, targeting the RD9 region, 
only detected M. tuberculosis strains (Table 4.1; Figure 4.2B). None of these genomic 
regions were detected in other strains not belonging to MTC.  





Figure 4. 2. Specificity tests of the dLAMP-LFD assays. (A) Amplification results of 
the dLAMP-LFD #B assay in an electrophoresis gel run (above) and in the lateral flow 
strips (below): 1 - M. bovis LNIV 7257; 2 - M. bovis LNIV 8016; 3 - M. bovis BCG 
ATCC 27291; 4 - M. caprae LNIV 17320; 5 - M. tuberculosis H37Ra; 6 - M. avium 
subsp. avium ATCC 25291; 7 - M. avium subsp. paratuberculosis LNIV 39888; 8 - 
H2O. (B) Amplification results of the dLAMP-LFD #A assay: 1- M. tuberculosis LNIV 
9605; 2 - M. tuberculosis H37Ra; 3 - M. bovis LNIV 7257; 4 - M. caprae LNIV 17320; 
5 - M. bovis BCG ATCC 27291; 6 - M. avium subsp. avium ATCC 25291; 7 - M. avium 
subsp. paratuberculosis LNIV 39888; 8 - H2O. Lane M represent DNA ladder marker. 
In the lateral flow strips, the first coloured test line (from the bottom) corresponds to the 
detection of the IS6110 element, the second test line to the detection of the specific 
fragment of either M. bovis (RD4 flanking region) or M. tuberculosis (RD9), and the 
third line is the flow control. 
 
 
The results of the analytical sensitivity of the duplex LAMP assays were as follows: M. 
tuberculosis IS6110 and RD9 products were detected until the dilution containing 12.5 
pg/ l of template DNA (Figure 4.3). A similar detection limit of 12.2 pg/ l was found 
for the assay targeting the IS6110 and the flanking RD4 region of M. bovis (Figure 4.3).  






Figure 4.3. Detection limit of the dLAMP-LFD assays. (A) Results for the dLAMP-
LFD #B assay in an electrophoresis gel run (above) and in the lateral flow strips 





 dilutions (lane 1 to 6) (initial concentration was 12.2 ng/µl). Lanes M and 7 
represent DNA ladder marker and negative control (H2O), respectively. (B) Results for 
the dLAMP-LFD #A assay in an electrophoresis gel run (above) and in the lateral flow 





 dilutions [lane 8 to 13) (initial concentration was 12.5ng/µl). 
Lanes M and 14 represent DNA ladder marker and negative control (H2O), respectively. 
 
Testing of DNA templates extracted directly from BACTEC liquid cultures 
The dLAMP-LFD #B, targeting the IS6110 element and the flanking RD4 region, was 
tested using DNA extracted directly from a set of 117 sequential BACTEC liquid 
cultures, using a simple boiling method, obtained under the routine testing of TB-
suspected tissue samples originally collected from bovines (n = 69), deer (n = 15) and 
wild boar (n = 33) (Table 4.3; Figure 4.4A).  





Figure 4.4. Examples of the dLAMP-LFD amplification results obtained with 
clinical isolates of animal and human origins. (A) DNA templates extracted from 
animal isolates tested with the dLAMP-LFD #B assay: 1 - M. bovis LNIV 7257; 2 - 
37481/1; 3 - 37481/2; 4 - 35690; 5 - 37707/2; 6 - 31389; 7 - 37481/3; 8 - 41680/1; 9 - 
31784; 10 - 31093; 11 - 31094; 12 - 31388; 13 - 31786; 14 - 33761; 15 - H2O. (B) DNA 
templates extracted from human isolates tested with the dLAMP-LFD #A: 1 - IHMT 1; 
2 - IHMT 2; 3 - IHMT 3; 4 - IHMT 4; 5 - IHMT 5; 6 - IHMT 6; 7 - IHMT 7; 8 - IHMT 
8; 9 - IHMT 9; 10 - IHMT 10; 11 - IHMT 39; 12 - IHMT 46; 13 - IHMT 33; 14 - IHMT 
34; 15 - M. bovis LNIV 7257; 16 - H2O. Lane M represent DNA ladder marker. 




Fifty five BACTEC cultures were identified as M. bovis by the routine bacteriological 
analysis and no bacterial growth was detected in 52 BACTEC samples. Ten samples 
were found to be infected with non-MTC isolates (Table 4.3). The IS6110 element and 
the flanking RD4 region were only amplified from all M. bovis infected cultures by the 
dLAMP-LFD #B assay, while all other samples wielded negative amplification results 
for both loci (Table 4.3). These results correspond to a perfect agreement with the 
results of the routine bacteriological analysis, with a kappa coefficient of 1 (CIP95% 
1.000).  
 
Testing of DNA templates extracted directly from BACTEC liquid cultures 
The dLAMP-LFD #A, targeting the IS6110 element and the RD9 locus, was tested 
using DNA extracted from a set of 50 mycobacterial human isolates, collected from 
sputum samples of individuals suffering with tuberculosis (Table 4.2; Figure 4.4B). 




Forty cultures were identified as M. tuberculosis by the routine bacteriological analysis, 
six as M. bovis BCG and four as M. africanum. The duplex LAMP assay identified the 
forty M. tuberculosis samples as IS6110 and RD9 positive and the ten other MTC-
belonging species as IS6110 positive and RD9 negative (Table 4.2). Therefore, the 
optimized assay also presented a perfect agreement with the results of the routine 
bacteriological analysis (Table 4.2), with a kappa coefficient of 1 (CIP95% 1.000). 
 
4.5. Discussion 
Pressing needs include more rapid diagnostic tests without sacrificing sensitivity, and 
point-of-care or point-of-need tests for use in low-resource settings and in-field 
situations. It is therefore critical to develop simple and affordable molecular tests for the 
above scenarios. In recent years, research has been focused on alternative methods to 
improve the diagnosis of pathogens. The invention of loop-mediated isothermal 
amplification (LAMP) has opened up a new horizon for molecular diagnosis. This novel 
alternative nucleic acid amplification method amplifies a target DNA under isothermal 
conditions, it is based on the principle of strand displacement DNA synthesis performed 
by a Bst DNA polymerase and production of stem-loop DNA structures under a 
constant temperature. The reaction relies on recognition of the DNA target by at least 
six independent sequences, making this assay highly specific. The method is rapid and 
has a DNA amplification efficiency equivalent to that of standard PCR-based methods. 
This method has drawn a lot of attention as it offers a fast, accurate, cost-effective, and 
user-friendly diagnosis for infectious microorganisms, do not require expensive 
equipments and all reactions can be performed in an isothermal environment [8]. To 
take LAMP to realistic point-of-need situations, lateral flow dipstick (LFD) technology 
could ease the detection of LAMP products in a closed environment. LFD works by 
immunochromatography. This method demonstrates high sensitivity and enables simple 
visual detection of the amplified DNA through an appearance of a red line in the test. A 
nucleic acid lateral flow assay is a prefabricated strip, consisting of a surface layer to 
carry the sample from the sample application pad via the conjugate release pad along 
the strip encountering the detection zone up to the absorbent pad, designed for 
diagnostic purposes to test the presence or absence of pathogens, in this case, DNA 




targets that belongs to MTC species. In our nucleic acid lateral flow format, the LAMP 
products are labelled with one of two different tags (digoxigenin or biotin), which binds 
to tag-specific antibodies in distinct test lines of the strip assay.  
Herein we implemented two Lateral Flow Dipstick assays, based on commercially 
available Milenia Biotec HybriDetect 2T® strips, combined with LAMP reactions able 
to detect and identify MTC-, M. tuberculosis- and M. bovis-specific genomic products.  
Two dLAMP assays were developed, the first dLAMP-LFD #A assay is able to identify 
MTC species and M. tuberculosis by the specific dual amplification of the IS6110 and 
RD9 genomic regions, respectively. The second dLAMP-LFD #B assay also detects the 
IS6110 region and, additionally, detects the absence of RD4 by amplifying the flanking 
regions (a M. bovis-specific feature). Both assays were tested with a wide range of MTC 
and non-MTC reference strains and clinical isolates, yielding an identification 
specificity of 100% for their target organisms. No cross-reactions to other mycobacteria 
were observed. The analytical sensitivities of the dLAMP-LFD assays were comparable 
to that of common standard PCR assays used for the amplification of MTB genomic 
targets. 
By integrating the LAMP and LFD technologies, the analysis time of isothermal 
amplified products could be shortened in about an hour and a half, because of the 
elimination of the cumbersome electrophoretic step. In addition, the dLAMP-LFD 
assays can confirm the identity of the specific amplicons by hybridization with specific 
FITC-labeled probes and avoids the use of carcinogens, such as ethidium bromide 
reagent. In this study, the dLAMP-LFD assays were carried out in a total of 70 min (not 
including DNA preparation time), which was faster than typical PCR methods that 
require 2-3 h for the PCR cycling. The assays does not require expensive equipments, 
just a thermostatic water bath, enabling their use in low-resource settings and less 
equipped laboratories. The two optimized dLAMP-LFD assays represent a potential, 
rapid and reliable diagnostic tool useful or a point-of-need utilization, based in a user-
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Final Conclusions and Perspectives 





5.1. Final Conclusions 
Diagnostic tests are key tools in the control of infectious diseases, which remain of the 
major challenges for human life. Molecular diagnosis, commonly known as Nucleic 
Acid Testing (NAT), is one of the most promising and exciting fields of the In Vitro 
Diagnostics (IVD) market, presenting a growth rate of about 20% per year. The market 
trend is the increasing utilization of NAT technologies, which seems also really 
promising for a more rapid and specific diagnosis of tuberculosis (TB), including 
animal TB. Molecular methods for detection and identification of species of the 
Mycobacterium tuberculosis complex (MTC) have undergone a great development in 
recent years, showing improvements in sensitivity, specificity and reproducibility. In 
addition to contributing to shorten the diagnosis of tuberculosis, these methods are also 
of great importance for the epidemiological study of this disease.  
Most of the available animal and human TB diagnostic NAT assays are still ‘in house’ 
optimized for each laboratory, usually demanding highly qualified personnel and 
sophisticated equipments, albeit some expensive commercial applications exist (e.g. 
GenoType® MTBDR, Hain LifeScience). Furthermore, the development of NAT-based 
tools for studying animal TB and its agents is still in its infancy when compared to the 
already available assays for human TB. In this context, it is necessary that NAT 
technologies become simpler, standardized and affordable to make them effectively and 
widely used in routine clinical laboratories, including laboratories in the developing 
world where animal and human TB is still a huge scourge [1].  Consequently, this work 
focused on the study of new alternative and user-friendly NAT assays for the rapid and 
specific detection and identification of the most relevant MTC members in animal 
biological samples and in pure cultures.  
The high genetic homology of MTC members reduces the number of unique genomic 
regions of each species, making it difficult to discriminate the members of the complex. 
In fact, the regions commonly used for identification of Mycobacterium spp., and 
bacteria in general, such as the sequences of the ribosomal DNA (rDNA) of 16 subunit 
(16S) and the intergenic 16S-23S rDNA [2], proved useless for the differentiation of 
species of the MTC. In addition to these, also the genes which nucleotide sequences 
allows the differentiation between species of MTC and non-MTC, such as the hsp65 [3], 
rpoB [4, 5] and dnaJ [6] genes, have identical sequences among members of the MTC. 





On the other hand, although the high genetic homology among MTC members, there is 
a considerable degree of polymorphisms associated with repetitive DNA, namely in 
insertion sequences (IS) and in the direct repeats region (DR), which appear useful for 
the identification and typing of MTC strains.  
The analysis of the DR region by spoligotyping allows the differentiation between M. 
bovis and M. tuberculosis, besides the typing of the strains [7, 8]. However, the 
demanding execution and complexity of interpretation of patterns obtained by this 
technique prevent their use in routine use for discrimination of those species. Despite 
the difficulties caused by the high genetic homology between members of the MTC, the 
evolution of molecular methods and knowledge accumulated on the genomes of M. 
tuberculosis and M. bovis have contributed to the identification of several genomic 
regions used as target for the detection and identification of the species gathered in the 
complex. The gyrB gene encoding the B subunit of topoisomerase II is universally 
present among bacteria and the analysis of their polymorphisms is used in various 
bacterial genera for the discrimination of species and inferring of phylogenies [9]. The 
analysis of this gene polymorphisms by PCR-RFLP, using the restriction enzymes RsaI, 
TaqI and SacII, distinguishes the main MTC species, except M. tuberculosis, M. 
africanum subtype II and M. canettii [10, 11]. Goh and collaborators (2006) [12] 
introduced two enzymes, HinfI and HaeIII, to the algorithm proposed by Niemman et 
al. (2000) [11] for the differentiation of species of the MTC, which shows new 
restriction patterns, particularly for M. canettii, besides allowing the differentiation 
between M. tuberculosis and M. africanum.  
Other regions, such as the oxyR pseudogene and pncA gene, the last one encodes the 
pyrazinamidase enzyme, present single nucleotide polymorphisms (SNPs) that allows 
the identification of M. bovis, without permit the differentiation from other members of 
the MTC [13, 14, 15]. In another example, the hupB gene, encoding a histone, only 
allows the differentiation between M. tuberculosis and M. bovis [16, 17]. The analysis 
of the mtp40 gene, which encodes for a phospholipase C, has also been used to 
distinguish M. tuberculosis and M. bovis, being this gene absent in the second species 
[18]. However, the use of this gene is not appropriate for the discrimination between 
these species because several strains of M. tuberculosis have been identified in which 
the gene is also absent [19, 20].  





Molecular tests used by laboratories to differentiate the species of MTC are usually 
implemented and standardized "in house". As far as we know, there is only one 
commercially available NAT test that can discriminate among the MTC members 
(Genotype MTBC, Hain Diagnostics, Germany). This is a reverse hybridization assay 
based on the polymorphism of sequences of the gyrB gene and the RD1 deletion of M. 
bovis BCG. However, in addition to being applicable only for the identification of 
mycobacteria in culture, this test is very expensive for a widespread use in routine 
diagnosis of tuberculosis. 
It is noteworthy that real-time PCR technology has been extensively evaluated in the 
diagnosis of human tuberculosis, but there are scarce studies on its application to the 
diagnosis of animal tuberculosis [1, 21, 22, 23]. Therefore, in this work we described 
the development of two methods based on real-time PCR technology for the 
identification and differentiation of the most relevant MTC species (Chapters II and III).  
Regarding bovine tuberculosis diagnostics, as mentioned in Chapter I, several molecular 
methods have been described over the years for the detection and identification of M. 
bovis in either clinical isolates or directly in histopathological sections or lesion samples 
(clinical samples). These methods are mainly based in sequences amplification by PCR. 
NAT assays based in the use of hybridization probes, despite having a sensitivity near 
100%, usually require the presence of a high number of bacilli (10
5
/ml) and are 
therefore mainly used for the identification of clinical isolates [24]. The PCR-based 
methods directly applied to histopathological and clinical samples have the advantage of 
allowing a much more rapid diagnosis, although the sensitivities of these methods rarely 
exceed 75% [17, 22, 23, 25-31]. The low sensitivity of molecular assays, when applied 
directly to clinical samples, is often caused by the presence of a small number of bacilli. 
In addition to the paucibacillary nature of the samples, also fibrosis and calcification of 
the lesions of bovine tuberculosis poses difficulties the DNA extraction of mycobacteria 
[25]. Amplification of DNA may be further compromised by the presence of a high 
ratio of eukaryotic genomic DNA [32]. Another major limitation of the PCR reaction is 
the presence of DNA polymerase inhibitors in the samples, giving rise to false negatives 
[26]. On the other hand, the occurrence of false positives due to cross contamination of 
samples during the processing is a commonly described problem in molecular 
techniques [33]. 





The amplification of insertion sequences specific of the species of MTC, including 
IS6110 [34] and IS1081 [35], do not allow the differentiation between the MTC species, 
but have the advantage to increase the sensitivity of detection of the complex due to the 
presence of multiple copies of these sequences in the genome. This is one major reason 
why, in Chapter II, we used one of these sequences as target for developing an 
alternative approach for enhancing MTC detection sensitivities directly from fresh 
animal tissues. An user-friendly DNA extraction protocol, mainly based in the use of 
simple commercially obtainable extraction kits, was coupled with an IS6110-targeted 
semi-nested real-time PCR assay that allows the direct detection of MTC members in 
animal tissue specimens with very high sensitivity, specificity and positive and negative 
predictive values, namely in bovine specimens [36]. With this approach we could solve 
the problem of the lack of sensitivity usually described by previous works. 
Another recent molecular approach for the identification of MTC is based on the 
analysis of certain regions of difference in the genome of these species [37, 38]. As 
already mentioned in Chapter I, the pattern of presence or absence of certain RDs seems 
to reflect its evolutionary history, and has been useful to correctly identify the species of 
the complex [1, 21, 39, 40]. Also the distinction between the virulent and vaccine 
strains (BCG) is possible by the analysis of RDs, since RD1 is absent in BCG strain, in 
which genes involved in the production of virulence factors are located, namely the 
ESAT-6 protein [41]. In Chapter III we described a rapid and robust two-step five-target 
TaqMan
®
-based real-time PCR identification algorithm, based on genomic deletion 
analysis, to identify the MTC species most commonly associated with TB in livestock 
and other animals, namely M. bovis and M. caprae. The first step allows the 
confirmation of the cultures as MTC members, by targeting their IS6110 element, or as 
a mycobacterial species, if only a 16S rDNA product is detected in the duplex 
amplification reaction. If a MTC member is identified, the second amplification step 
allows to assess the presence or absence of the RD1 (Rv3875 locus, esat6), RD4 
(Rv1510) and RD9 (Rv2073c) genomic regions in the respective genome. The 
correspondent pattern allows to infer the species of the isolate as M. tuberculosis (if all 
RDs are present), M. caprae (if only RD1 and RD4 are present), M. bovis (if only RD1 
is present) or as M. bovis BCG (if all regions are absent). The assay is significantly 
faster and simpler than other SNPs-targeted restriction analysis or reverse line probe 





hybridization-based molecular assays, since it bypasses any post-amplification 
experimental steps and can be used with DNA templates extracted directly from liquid 
cultures using a simple, low-cost and fast boiling-based method. The assay is able to be 
further automated and implemented in the routine diagnostics framework of veterinary 
diagnostics laboratories, with a particular focus for reference laboratories. 
The development of rapid and autonomous diagnostic methods, independent of the use 
of expensive or sophisticated equipment, is also very relevant. The PCR reaction is a 
limiting factor in this regard. Consequently, as already mentioned above in this 
dissertation, it is quite interesting to study the possibilities of replacing this step in the 
experimental procedures for the identification of members of the Mycobacterium 
tuberculosis complex. Particularly interesting to analyse are the techniques of 
isothermal amplification and detection of specific nucleic acids. The application of 
these simplified methods will be particularly interesting for use in laboratories with 
fewer resources and in developing countries, where tuberculosis is still one of the most 
important cause of morbidity and mortality. Isothermal DNA amplification processes 
could facilitate their integration into bench NAT kits independent of the utilization of 
sophisticated equipment. One such technology is Loop-Mediated Isothermal DNA 
Amplification (LAMP) [42, 43, 44]. LAMP relies upon an auto-cycling strand 
displacement DNA synthesis, being also more tolerant to the presence of inhibitory 
substances [43]. The high potential of LAMP for the development of improved NAT 
kits fully justifies the increasing number of reports on its utilization, including for the 
detection of M. tuberculosis in sputum [45, 46, 47]. In Chapter IV, a multiplex LAMP-
based assay was proposed, coupled to lateral flow dipstick technology for the detection 
and differentiation of MTC members. Two Lateral Flow Dipstick assays were 
implemented, based on commercially available Milenia Biotec HybriDetect 2T
®
 strips. 
These strips were combined with LAMP technology and the assays were able to identify 
MTC-, M. tuberculosis- and M. bovis-specific genomic products obtained in duplex 
isothermal DNA amplification reactions. The multiplex utilization of these primers 
allowed not only the detection of MTC species, but also the discrimination between the 
main two members of this complex, M. bovis and M. tuberculosis. The first assay is able 
to identify MTC species and M. tuberculosis by the specific dual amplification of the 
IS6110 and RD9 genomic regions, respectively. The second assay also detects the 





IS6110 region and, additionally, detects the absence of the RD4 region (a M. bovis-
specific feature). Our system involved two steps. The first step involves the utilization 
of the designed primer sets in a multiplex format, leading to the LAMP-based 
amplification of the respective DNA fragments from the MTC members. Templates for 
the reaction can be extracted DNA from purified MTC cultures from bovine samples. In 
the second step, the amplified products are colorimetrically identified by lateral flow 
dipstick technology. This NAT strategy may the basis of an autonomous, user-friendly 
and affordable diagnostic kit for the detection and identification of tuberculous 
mycobacteria. 
During the course of this work, we had the opportunity to investigate new evidences on 
the circulation of MTC species in wild carnivores from mainland Portugal, in a parallel 
study where we could apply the nested real-time PCR assay described in Chapter II. 
Animal tuberculosis, caused by MTC bacteria, continues to affect domestic and wild 
mammals in Iberia, with the potential to influence the structure and stability of natural 
communities. In Portugal, the indicators of the bovine TB eradication plan demonstrate 
an incidence increase, with new outbreaks and areas of high prevalence, which have 
been partially associated with the sylvatic cycle of Mycobacterium bovis and the 
potential overlap of wildlife habitat with cattle under extensive husbandry. The increase 
of the abundance, spatial aggregation and artificial management of wild ungulates in 
touristic areas of big game hunting, as well as facilitating hunting practices, may 
increase the risk of transmission to other species and undermine the efforts associated 
with eradication campaigns. Therefore, we had the opportunity to integrate a larger 
consortium studying these topics, where we used our nested real-time PCR assay to 
assess the presence of MTC-associated DNA in 268 tissue samples collected from a set 
of six species of widely distributed wild carnivores from mainland Portugal. The tissues 
(lung, liver, and lymph nodes) were obtained during necropsy of road-killed animals or 
animals collected in corrective actions of predators. Despite the high degree of autolysis 
of a significant part of the tissues and the absence of gross lesions, suspect microscopic 
lesions were identified in the liver and lungs of foxes and Egyptian mongooses that can 
be grouped into two types: one, characterized by microgranulomas with mononuclear 
cells, and another with lesions of varying intensity and specificity, characterized by 
small foci of infiltrating mononuclear cells. M. bovis was isolated from the tissues of 





two Egyptian mongooses. The presence of MTC-specific DNA was assessed using 
DNA extracted from the tissues as template for the semi-nested real-time PCR. Our 
assay revealed that around 10% of the tissue samples were infected with MTC species, 
with a particular emphasis for samples from foxes and mongooses. These preliminary 
results suggest that MTC circulates in wild carnivores of mainland Portugal and that the 
host spectrum affected by those agents is increasing. These results will soon be 
integrated and published in a broader study, aiming the clarification of the presence of 
tuberculosis in sylvatic animals in Portugal. 
At the end of this work we have demonstrated the development of novel post-mortem 
NAT assays for the laboratorial diagnosis of bovine TB and for the discrimination of 
MTC members. Two methods based on real-time PCR technology, a semi-nested real-
time PCR assay for the direct detection of MTC in animal samples and an identification 
algorithm based on TaqMan
®
 technology to identify the key members of MTC, and a 
third method based on LAMP coupled to Lateral Flow Dipstick (LFD) technology, have 
been developed. The first method allowed the identification of species belonging to 
MTC, the other two methods allowed the identification and differentiation of the most 
relevant members of the complex. These methods have been tested with reference 
strains and clinical isolates, proving to be highly sensitive and specific. The work herein 
described aimed to make a small contribution to the improvement of the molecular 
diagnosis of animal tuberculosis and to an accurate identification of the most relevant 
species of the MTC. The results presented are the basis for the setting of improved 
diagnostic NAT kits that will surely represent a potential breakthrough with expected 
high impact on the improved diagnosis and control strategies of animal tuberculosis. 
 
5.2. Perspectives 
More than to repeat and discuss the results obtained in this work, we intend, in these 
concluding remarks, to raise some proposals and modestly contribute to the launch of 
some clues for future work. As already mentioned, the species belonging to MTC are 
genetically very similar but differ in their epidemiology and antimicrobial susceptibility 
characteristics. M. bovis and M. caprae also represents a high potential for zoonotic 
transmission to humans [48, 49], with evidence for the possibility of person-to-person 





transmission [50]. However, the main routes of transmission are the contact with 
infected animals and ingestion of unpasteurized dairy products. These zoonotic MTC 
species are responsible for up to 7.2% and 15% of the human TB cases in industrialized 
and developing countries, respectively [51]. Studies on the prevalence of human TB 
caused by these species in Portugal are scarce and it is still unknown the zoonotic 
potential of animal-associated members of the MTC as agents of human TB in Portugal. 
It would be interesting to perform a retrospective analysis of a large collection of MTC 
isolates from patients with TB, which will allow to account for representative strains of 
M. bovis and M. caprae responsible for any cases of human TB and to assess the public 
health impact of these zoonotic mycobacteria in Portugal. The NAT tools developed in 
this work will be useful to track any past or current outbreaks of human TB of zoonotic 
origin in Portugal. The strains of M. bovis and M. caprae could be genotyped by 
spoligotyping and MIRU-VNTR and profiles of the human-associated isolates could be 
compared with the ones of animal origin circulating in our country, in order to evaluate 
their potential zoonotic origin. Achieving this is only possible with the intimate 
cooperation of research units devoted to animal and human health.  
Another interesting topic is the development of alternative approaches for the extraction 
of mycobacterial DNA from bovine tissue samples. Immunomagnetic capture 
techniques to selectively separate and physically concentrate MTC cells from infected 
tissues could be an appropriate proposal. Previous preliminary works exploring this 
approach to recover M. bovis or M. tuberculosis cells from soil [52], cerebrospinal fluid 
[53] and bovine tissues [54, 55, 56] showed some promise but improvements are needed 
to allow its wider use in routine diagnostics. The improvement of the DNA extraction 
procedures from tissues will allow an easier application of our multiplex real-time PCR 
(Chapter III) and dLAMP-LFD (Chapter IV) assays to the direct analysis of animal 
tissues samples. This will be important to improve the diagnosis of animal tuberculosis 
and consequently contribute to a more effective control and eradication of the disease in 
our country. 
In a previous work, we developed an alternative concept for the colorimetric 
identification of relevant MTC members based in the detection of their PCR-amplified 
gyrB gene using species-specific gold-nanoprobes [57]. It was not possible, in the 
current work, to continue exploring this concept. However, it would be very interesting 





to continue improving this technology regarding three main aspects. First, on the design 
of novel sets of gold-nanoprobes that will allow the identification of more MTC species, 
namely of M. caprae, and reinforce the identification of M. tuberculosis and M. bovis. 
Besides the gyrB gene, the already referred RDs and DRs could be used as targets [37], 
allowing a more efficient and robust species discrimination. Secondly, investigate the 
possibility to replace the PCR step of the assay by an isothermal DNA amplification 
technology, such as LAMP [58]. Thirdly, optimize the assay for the analysis of 
mycobacterial DNA extracted directly from presumptive infected tissue samples. 
Finally, it’s our purpose to contribute to the enormous task of controlling and 
preventing the spread of human and animal TB. 
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